US20010021820A1 - Syringe system for transfer of medication from a prefilled medication container - Google Patents

Syringe system for transfer of medication from a prefilled medication container Download PDF

Info

Publication number
US20010021820A1
US20010021820A1 US09/818,673 US81867301A US2001021820A1 US 20010021820 A1 US20010021820 A1 US 20010021820A1 US 81867301 A US81867301 A US 81867301A US 2001021820 A1 US2001021820 A1 US 2001021820A1
Authority
US
United States
Prior art keywords
barrel
vial
stopper
drug
syringe
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US09/818,673
Inventor
Lawrence Lynn
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to US09/818,673 priority Critical patent/US20010021820A1/en
Publication of US20010021820A1 publication Critical patent/US20010021820A1/en
Priority to US10/207,113 priority patent/US7470261B2/en
Abandoned legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178Syringes
    • A61M5/24Ampoule syringes, i.e. syringes with needle for use in combination with replaceable ampoules or carpules, e.g. automatic
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/002Packages specially adapted therefor, e.g. for syringes or needles, kits for diabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178Syringes
    • A61M5/31Details
    • A61M5/315Pistons; Piston-rods; Guiding, blocking or restricting the movement of the rod or piston; Appliances on the rod for facilitating dosing ; Dosing mechanisms
    • A61M5/31596Pistons; Piston-rods; Guiding, blocking or restricting the movement of the rod or piston; Appliances on the rod for facilitating dosing ; Dosing mechanisms comprising means for injection of two or more media, e.g. by mixing
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61JCONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/14Details; Accessories therefor
    • A61J1/20Arrangements for transferring or mixing fluids, e.g. from vial to syringe
    • A61J1/2003Accessories used in combination with means for transfer or mixing of fluids, e.g. for activating fluid flow, separating fluids, filtering fluid or venting
    • A61J1/2006Piercing means
    • A61J1/201Piercing means having one piercing end
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61JCONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/14Details; Accessories therefor
    • A61J1/20Arrangements for transferring or mixing fluids, e.g. from vial to syringe
    • A61J1/2003Accessories used in combination with means for transfer or mixing of fluids, e.g. for activating fluid flow, separating fluids, filtering fluid or venting
    • A61J1/202Separating means
    • A61J1/2037Separating means having valve means
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61JCONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/14Details; Accessories therefor
    • A61J1/20Arrangements for transferring or mixing fluids, e.g. from vial to syringe
    • A61J1/2003Accessories used in combination with means for transfer or mixing of fluids, e.g. for activating fluid flow, separating fluids, filtering fluid or venting
    • A61J1/2048Connecting means
    • A61J1/2055Connecting means having gripping means
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61JCONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/14Details; Accessories therefor
    • A61J1/20Arrangements for transferring or mixing fluids, e.g. from vial to syringe
    • A61J1/2003Accessories used in combination with means for transfer or mixing of fluids, e.g. for activating fluid flow, separating fluids, filtering fluid or venting
    • A61J1/2048Connecting means
    • A61J1/2058Connecting means having multiple connecting ports
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61JCONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/14Details; Accessories therefor
    • A61J1/20Arrangements for transferring or mixing fluids, e.g. from vial to syringe
    • A61J1/2003Accessories used in combination with means for transfer or mixing of fluids, e.g. for activating fluid flow, separating fluids, filtering fluid or venting
    • A61J1/2048Connecting means
    • A61J1/2058Connecting means having multiple connecting ports
    • A61J1/2062Connecting means having multiple connecting ports with directional valves
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61JCONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/14Details; Accessories therefor
    • A61J1/20Arrangements for transferring or mixing fluids, e.g. from vial to syringe
    • A61J1/2003Accessories used in combination with means for transfer or mixing of fluids, e.g. for activating fluid flow, separating fluids, filtering fluid or venting
    • A61J1/2068Venting means
    • A61J1/2072Venting means for internal venting
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61JCONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/14Details; Accessories therefor
    • A61J1/20Arrangements for transferring or mixing fluids, e.g. from vial to syringe
    • A61J1/2096Combination of a vial and a syringe for transferring or mixing their contents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/14Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A61M2005/1401Functional features
    • A61M2005/1403Flushing or purging
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178Syringes
    • A61M2005/1787Syringes for sequential delivery of fluids, e.g. first medicament and then flushing liquid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178Syringes
    • A61M5/31Details
    • A61M2005/3103Leak prevention means for distal end of syringes, i.e. syringe end for mounting a needle
    • A61M2005/3104Caps for syringes without needle
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178Syringes
    • A61M5/31Details
    • A61M2005/3117Means preventing contamination of the medicament compartment of a syringe
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178Syringes
    • A61M5/31Details
    • A61M2005/3128Incorporating one-way valves, e.g. pressure-relief or non-return valves
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178Syringes
    • A61M5/31Details
    • A61M5/3129Syringe barrels
    • A61M2005/3132Syringe barrels having flow passages for injection agents at the distal end of the barrel to bypass a sealing stopper after its displacement to this end due to internal pressure increase
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178Syringes
    • A61M5/31Details
    • A61M5/315Pistons; Piston-rods; Guiding, blocking or restricting the movement of the rod or piston; Appliances on the rod for facilitating dosing ; Dosing mechanisms
    • A61M5/31596Pistons; Piston-rods; Guiding, blocking or restricting the movement of the rod or piston; Appliances on the rod for facilitating dosing ; Dosing mechanisms comprising means for injection of two or more media, e.g. by mixing
    • A61M2005/31598Pistons; Piston-rods; Guiding, blocking or restricting the movement of the rod or piston; Appliances on the rod for facilitating dosing ; Dosing mechanisms comprising means for injection of two or more media, e.g. by mixing having multiple telescopically sliding coaxial pistons encompassing volumes for components to be mixed
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178Syringes
    • A61M5/31Details
    • A61M5/32Needles; Details of needles pertaining to their connection with syringe or hub; Accessories for bringing the needle into, or holding the needle on, the body; Devices for protection of needles
    • A61M5/3205Apparatus for removing or disposing of used needles or syringes, e.g. containers; Means for protection against accidental injuries from used needles
    • A61M5/321Means for protection against accidental injuries by used needles
    • A61M5/322Retractable needles, i.e. disconnected from and withdrawn into the syringe barrel by the piston
    • A61M5/3221Constructional features thereof, e.g. to improve manipulation or functioning
    • A61M2005/3223Means impeding or disabling repositioning of used needles at the syringe nozzle
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178Syringes
    • A61M5/1782Devices aiding filling of syringes in situ
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178Syringes
    • A61M5/24Ampoule syringes, i.e. syringes with needle for use in combination with replaceable ampoules or carpules, e.g. automatic
    • A61M5/2422Ampoule syringes, i.e. syringes with needle for use in combination with replaceable ampoules or carpules, e.g. automatic using emptying means to expel or eject media, e.g. pistons, deformation of the ampoule, or telescoping of the ampoule
    • A61M5/2429Ampoule syringes, i.e. syringes with needle for use in combination with replaceable ampoules or carpules, e.g. automatic using emptying means to expel or eject media, e.g. pistons, deformation of the ampoule, or telescoping of the ampoule by telescoping of ampoules or carpules with the syringe body
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178Syringes
    • A61M5/31Details
    • A61M5/32Needles; Details of needles pertaining to their connection with syringe or hub; Accessories for bringing the needle into, or holding the needle on, the body; Devices for protection of needles
    • A61M5/34Constructions for connecting the needle, e.g. to syringe nozzle or needle hub
    • A61M5/347Constructions for connecting the needle, e.g. to syringe nozzle or needle hub rotatable, e.g. bayonet or screw

Definitions

  • Appln Ser. No. 08/196,455 presents the background of multi-chambered syringes which are used for sequential injection and/or the mixing of drugs and solutions. Additional background of enclosed drug-mixing systems is provided in U.S. Pat. No. 4,614,267. As described within the backgrounds of the many patents presented in the aforementioned application, it is advantageous to store a drug in a powdered or liquid form and then mix the drug in the same enclosure which is subsequently placed in fluid connection with the patient. More specifically, it is advantageous to provide mixing within a syringe so that reconstitution within a separate drug vial becomes unnecessary.
  • the sequential aspiration, mixing, and injection syringe includes a barrel having an inner wall and a main bore which is preferably conventional and smooth along substantially its entire length.
  • the syringe includes a piston assembly having a proximal portion and a distal portion and a connecting element intermediate the portions.
  • the portions are sized to be received into a main bore of the barrel and to fit snugly against the barrel wall.
  • This distal portion preferably includes at least one projecting lateral member for engaging the inner walls of the barrel, thereby effectively fixing the position of the distal portion at a maximally advanced position along the barrel which preferably adjacent the distal end of the barrel, although the position could be midway along the barrel.
  • the connecting element can be a fluid reservoir or a drug vial which can be comprised of glass or the connecting element can be a conduit or tube, or can be a tether or other tensile element.
  • the glass vial can have a proximal end and a distal end. In one embodiment, both ends of the vial are open.
  • the proximal portion can be a piston and can be positioned to occlude the proximal end and the distal portion can be a stopper to occlude the distal end of a drug vial or the distal end of a fluid reservoir or tube.
  • the connecting element provides for mutually equivalent advancement of the proximal and distal portions along the barrel.
  • the combined piston assembly and the connecting element can be seen to represent a reservoir or drug vial piston connectable to a syringe handle.
  • the distal stopper is displaceable from the fluid reservoir or drug vial by retraction of the reservoir or vial away from the distal stopper and by frictional or other engagement of the distal stopper and the barrel after the reservoir or vial and the attached piston assembly have been moved to an advanced position and then the reservoir or vial is retracted from the advanced position.
  • This allows for retraction of the proximal piston away from the distal stopper after displacement of the stopper from sealing engagement with the fluid reservoir or drug.
  • the proximal piston is further moveable along the vial toward the distal stopper. Relative advancement of the proximal piston along the vial can be caused by advancement of the handle in one embodiment wherein the proximal piston is attached to the handle.
  • proximal piston is connected to the displaced distal stopper by a tensile element
  • relative advancement is achieved by retraction of the vial and subsequent tensile force transmitted through the tensile element.
  • the distal portion and the proximal portion are preferably carried by the drug vial, the distal portion being displaceable from the drug vial to open the vial into the mixing chamber, the proximal portion being moveable along the vial to displace the drug from the vial into the mixing chamber, the proximal portion effectively converting the open-ended drug vial into a closed-ended vial piston and thereafter functioning to push the drug solution within the mixing chamber out of the syringe and into a recipient with minimal deadspace-trapped drug remaining within the syringe after injection.
  • a method of drug injection is provided using an embodiment having a main piston or vial piston having a handle.
  • the vial piston includes a drug vial having a proximal end and a distal end and containing stopper piston assembly having a proximal portion connected to a distal portion by a connecting element which can be a tensile element or which can be the drug vial itself, as will be described.
  • the syringe operates, after assembly, to achieve the following drug injection method with a single retraction and advancement of the handle, steps of: 1. aspirate diluent into the main bore; 2. open the end of a drug vial into the main bore; 3. positively expel the drug from the vial; 4. subsequently convert an open-ended drug vial into a closed-ended injection piston; 5. inject the mixed drug and diluent with minimal residual drug remaining in the syringe after injection.
  • the present invention can utilize a drug container or vial which can be cylindrical for insertion into a syringe barrel.
  • the drug vial is preferably made of glass or other material which can safely contain a large variety of different drugs, either in powder or liquid form.
  • the drug vial includes a closed bottom or proximal end which may include a small air vent and an open top or distal end which is preferably widely open and can, therefore, easily be filled by conventional automated drug dispensing systems.
  • the drug vial can include a narrow neck and larger body to facilitate handling by automated equipment.
  • the drug vial further preferably includes an outer housing member which can be polymeric.
  • At least one sliding member is preferably provided about the vial to slidably engage the syringe barrel bore to facilitate advancement and retraction of the drug vial along the syringe barrel bore.
  • the sliding member can be a thin rubber boot or sleeve.
  • the polymeric housing member may itself be sized to sealingly engage the bore.
  • the sliding member can be a rubber wiper of the type utilized in conventional syringe pistons or can be an o-ring or soft polymeric ring or otherwise fashioned.
  • the sliding member is preferably carried by the housing or vial and may be positioned proximal, distal to, or along the length of the housing or vial.
  • the outer member further can have a recess for receiving the retainer of the handle of a conventional syringe piston or, alternatively, the handle can be molded integrally with the outer vial housing member.
  • the vial can, therefore, be connected to or contained within the handle or can be integral with a handle.
  • the vial and handle are made of glass and are integral and molded together, thereby eliminating the need for the outer polymeric housing member.
  • the vial piston includes a piston stopper assembly with a proximal stopper portion for positioning adjacent the closed end of the drug vial and a distal stopper piston portion for occluding the open end of the drug vial.
  • Both portions can be comprised of conventional material utilized for rubber stoppers in drug vials so that contact with the drug and the rubber stopper piston assembly is provided, as is conventional, thereby eliminating the potential for material-related incompatibility.
  • the proximal and distal portions are connected or linked by the drug vial and can be carried by the drug vial.
  • the portions are further preferably connected by a tether or by bands or other tensile connecting elements which can be comprised of conventional material used in the construction of rubber stopper pistons so as again to allow direct contact with the drug within the glass container without the need for further study to determine compatibility.
  • the two stopper pistons can be molded as a single part with the connecting rubber tether.
  • a vent is provided for providing vent connection between the proximal face or end of the proximal piston and the atmosphere or between the proximal face of the proximal piston and the distal face or end of the distal stopper.
  • the vent passes through the tether, the tether comprising a hollow tube having a bore and extending to connect bores through the proximal piston and the distal stopper.
  • the vent passes through a small opening in the otherwise closed bottom of the drug vial, the vent being occluded by the proximal piston prior to use.
  • the vent can pass into a large volume space within a hollow handle to provide a sealed source of sterile vented atmosphere or liquid with a minimal induction of negative pressure.
  • the width of the outer wiper may be varied so as to allow use of the same housing and vial within syringes of variable diameter and volume. This allows modification of only the wiper when different volumes of diluent are intended for use with, for example, a powdered drug so that a wide variety of variable sized vials and housings need not be constructed for syringes having bores of variable diameters.
  • the proximal piston is inserted into the glass vial and this can be performed, for example, by radial compression of the proximal piston and insertion such that the proximal piston is fully advanced against the closed bottom of the glass vial.
  • the tether or bands are preferably of adequate length to extend out through the open top of the glass vial such that the top or distal stopper does not, at this time, occlude the opening in the top of the drug vial so that powdered or liquid drug may easily be inserted at this time into the drug vial as by automated drug dispensing systems.
  • the distal stopper with its associated residual tether is inserted into the top of the drug vial to occlude the opening in the drug vial.
  • the stopper may have a laterally projecting rim and a main stopper portion which can be received by a compression fit, as is known in the art, into the glass opening to seal the opening.
  • a distal sealing vial cover may then be provided to sealingly retain the cap and drug within the vial for long-term storage. After the vial cover has been removed, the distal stopper may be displaced from the glass opening by longitudinal force directed against the rim, away from the opening of the vial.
  • the distal vial stopper preferably includes flow channels.
  • the flow channels preferably do not provide communication of the vial chamber with the atmosphere when the stopper is within the vial
  • the flow channels can be slots along the outer laterally projecting rim or perimeter of the stopper or can otherwise be through the stopper piston.
  • the flow channels may be defined by the inner barrel wall and the distal stopper.
  • the channels can be longitudinally slit valves or other valves which are tightly closed at rest, but which are opened by contact with the distal end of the syringe.
  • the laterally projecting portion of the distal stopper preferably has a diameter exceeding the diameter of the syringe bore so that the distal stopper is radially compressed by the barrel and is tightly fit within the barrel by elastic compression against the barrel wall.
  • each drug vial may be sized to be received into conventional automated drug dispensing equipment and can be covered and maintained for long-term storage within a conventional securely sealed polymeric enclosure.
  • the vial can then be connected with the handle and can be packaged in a flexible sterile container along with the barrel, cannula, cannula cover, and even the diluent material in a single flexible sterile packaging enclosure for shipment and storage.
  • the components can be completely assembled within the closed or partially closed sterile package immediately prior to use. This allows for easy packaging and storage and assures sterile assembly, which is otherwise difficult to reliably achieve when loading a piston into a syringe barrel in an open environment.
  • the handle with its vial piston is packaged with a separate syringe barrel within a single sterile flexible enclosure and constructed so that the vial piston may be unsealed and loaded into the barrel within the same sterile package which was used for storage.
  • the pharmacist can grasp a projecting tear tab on the sealing vial cover through the flexible package and remove the cover from the vial stopper, thereby exposing the enclosed distal stopper.
  • the vial piston is then inserted into the syringe barrel by contacting the outside of the barrel through the package and inserting the distal end of the vial piston into the barrel.
  • the vial piston is then fully advanced until the distal stopper contacts the distal end.
  • the cannula can then be inserted into a liquid-filled compartment or container within the sterile enclosure.
  • the vial piston can then be retracted.
  • the syringe will then be filled by aspirating liquid enclosed within the enclosure into the barrel.
  • the filled and mixed syringe can then be sent to the floor or to the patient's home for use, or can be frozen for long-term storage, still within the unopened and sealed original sterile enclosure.
  • the handle In operation for injection, the handle is advanced until the distal stopper piston reaches a venting position along the barrel, if the handle had not previously been advanced to that position during assembly.
  • the location of the venting position depends on the position of the source of diluent. In the preferred embodiment, the venting position is adjacent the distal end of the barrel. However, if the diluent is positioned within the syringe, the venting position can be, for example, midway along the barrel.
  • the handle is then retracted, pulling the drug vial away from the distal stopper which includes a member or portion which is tightly retained against a portion of the barrel. This causes opening of the drug vial, thereby allowing fluid to flow into the drug vial and the drug to mix with fluid.
  • the diluent fluid is stored external the syringe and the venting position is adjacent the distal end of the syringe barrel, leaving the distal stopper retained adjacent the distal end upon retraction of the vial.
  • the distal stopper is preferably retained by tight frictional engagement with the smooth barrel or can be retained by detents along the barrel.
  • the tensile element will become extended, thereby transmitting tensile force to the proximal piston so that further retraction of the handle and the attached vial will cause the proximal piston to be advanced relative to the retracting drug vial so that substantially all drug and solution within the vial is pushed distally by the advancing proximal piston into the main bore or mixing chamber of the syringe.
  • the vent preferably provides fluid communication between the vial intermediate the proximal piston and the closed vial end, thereby relieving any negative pressure within the newly enlarging closed proximal vial chamber by the passage of fluid or air through the vent into the vial proximal the proximal piston.
  • the solution in the mixing chamber can be agitated. If preferred, an amount of air can be initially provided during manufacture within the vial to facilitate agitation.
  • the proximal piston is received and retained within the distal end of the drug vial, thereby occluding the distal end of the drug vial so that the drug vial itself with its now distally occluding stopper piston now can function as a closed injection piston with the fully advanced proximal piston as its distal face.
  • the vial can be advanced to cause injection of the mixed drug and solution into the patient with minimal residual remaining in the syringe.
  • the diluent stored within the enlarging proximal chamber is later used to provide subsequent flushing of the syringe and can provide flushing of the injected drug from the deadspace of the recipient tubing.
  • proximal stopper is displaced from the end of the drug vial and the fluid which had been received through the vent and stored within the vial proximal the proximal piston is now displaced by the forced movement of the proximal piston back toward the closed end of the drug vial.
  • Flow channels provided within the proximal piston allow displacement and flow of fluid from the drug vial chamber into the now virtually absent mixing chamber and out the distal conduit to flush the syringe, the conduit, and the deadspace of the tubing which is connected to the conduit and which has previously received the drug solution mixture from the conduit.
  • This embodiment therefore, provides for: 1) enclosed sterile insertion of a handle and piston assembly containing a powdered or liquid drug into a syringe barrel; 2) enclosed wide opening of the drug vial within the syringe barrel; 3) aspiration of diluent into free contact with the now exposed drugs from within the vial and for positive expulsion of all drug from within the vial; 4) aspiration of diluent which can later serve as a flush solution into an enlarging proximal chamber within the drug vial; 5) injection of the mixed drug solution through or around the displaced stopper into the recipient; 6) injection of the flush solution through the distal portion of the syringe and out the distal conduit to flush the syringe, the distal conduit, and at least a portion of the recipient tubing free of drug solution.
  • the diluent is contained within the distal portion of the syringe for mixing within the drug vial.
  • the distal conduit end of the syringe can be connected to a flexible bag containing a specific volume of diluent for aspiration into the syringe which can be stored within or can be a compartment of the main enclosing flexible package for enclosed aspiration.
  • the conduit can be placed in fluid connection with a fluid source through a cannula connected to the distal end of the syringe.
  • the fluid source may be sealingly engaged to the syringe during manufacture and then enclosed in a main flexible package.
  • a third embodiment utilizes a system wherein the syringe tip is inserted into a receiver having a one-way valve and connected to a multi-dose large volume reservoir of diluent in a hospital pharmacy of I.V. mixing area. When drug mixing is desired, the tip is inserted into the receiver and a specific volume of diluent is aspirated. The maximum aspirated volume can be preset by stops or by the length of the tether. The one-way valve prevents any potential for reflux of mixed drug solution into the reservoir.
  • the stopper assembly is provided including a connecting element intermediate the proximal piston and the distal stopper.
  • the embodiment preferably includes an inner wall defining a main bore and extending to a distal tip and a conduit extending through the distal tip.
  • the distal stopper includes projecting lateral walls for engaging.
  • a seal is preferably provided occluding the conduit adjacent the distal tip.
  • a diluent reservoir is further provided proximal the proximal piston and is preferably contained within the handle of the syringe.
  • the diluent reservoir is preferably a flexible bag of fluid and is comprised of conventional material for making flexible intravenous bags of fluids, such as PVC.
  • the flow passage way is occluded by the distal stopper or can preferably be occluded by a cap which can be extracted from its occluding position along the flow passage way by the distal stopper.
  • the distal stopper is integral with or is otherwise joined with the cap.
  • the distal stopper preferably includes at least one membrane such as projecting lateral walls engaging as by tight frictional contact the inner wall or walls of the barrel, thereby effectively fixing the position of the distal stopper piston at a maximally advanced position along the barrel which is preferably adjacent the distal end of the barrel, although the position could be midway along the barrel.
  • the flexible fluid reservoir can contain the first pharmaceutical component, which is preferably diluent or liquid drug.
  • a second pharmaceutical component can be contained within the proximal portion of the barrel distal to the maximum advancing position of the distal stopper or can be within a drug vial connectable to a drug vial connector carried by the proximal end of the reservoir.
  • the proximal end of the reservoir can include a reversibly sealed opening for transferring fluid from the reservoir into the drug vial and for transferring mixed drug and fluid out of the drug vial into the reservoir. In operation, the handle which has been advanced to a fully advanced position, is retracted.
  • the handle with its retained reservoir and proximal piston are pulled away from the distal stopper, thereby opening the distal end of the reservoir into the barrel of the syringe.
  • the handle results in negative pressure developing within the distal end of the syringe, thereby withdrawing fluid from the open end of the reservoir into the barrel.
  • the flexible container collapses until all of the fluid is withdrawn into the barrel, at which time further retraction cannot be accomplished due to the development of a vacuum within the container.
  • a detent can be provided which prevents further retraction to assure that excessive vacuum does not develop within the syringe.
  • the flexible package dynamically collapses, thereby producing a collapsing valve mechanism preventing substantial transmission of negative pressure from the distal end of the syringe to the drug vial; although, such transmission of negative pressure would not have significant adverse consequences with the preferred embodiment in any regard.
  • all of the mixed fluid and diluent have been displaced into a nascent mixing chamber intermediate the distal stopper and the proximal piston and subsequently this fluid can be injected by advancing the proximal piston, thereby pushing the fluid through the flow channels and the distal stopper and out the distal end of the syringe after the seal has been removed from the distal end of the syringe.
  • a one-way valve can be provided in the flow channel through the proximal piston to prevent reflux or displacement of fluids from the mixing chamber back into the flexible reservoir during injection.
  • this invention provides a drug positioned between a piston stopper assembly connected by a tensile element within a vial so that the drug can be pushed out of the vial into a mixing area by traction on the tensile element. It is further the purpose of this invention to provide a closed drug vial which can be selectively widely opened within a closed container to allow free mixing of the drug contained within the vial with a diluent.
  • a drug vial and piston stopper assembly wherein the drug vial first has a closed end containing the drug and wherein the end can be opened so that the drug can mix with a diluent and wherein the end can again be subsequently closed so that the drug vial can function as a deadspace-free piston for injecting the mixed drug solution into the patient. It is further the purpose of the invention to provide a syringe handle containing a drug vial and defining a drug vial piston within the syringe.
  • a multi-compartment injection system having a syringe barrel and a piston and including a glass drug vial compartment for long-term storage of a drug, and a second compartment for storage of a specific volume of diluent and wherein the second compartment is sealed and can be positioned inside or outside the syringe so that solution may be displaced into the vial to mix with the drug by retraction of the piston along the barrel and simultaneous unsealing of the vial or the diluent compartment.
  • this invention provides a drug storage, mixing, and injection apparatus which allows long-term storage of a drug within a glass vial comprehensively enclosed mixture within a syringe and then complete positive expulsion of all of the contained drug into a mixing chamber within the syringe. It is further the purpose of this invention to provide a system which allows positive displacement of diluent into a syringe compartment containing powdered drug within an open-mouthed glass vial and subsequent injection of the diluent mixed with the drug utilizing closure and subsequent advancement of the glass vial within the syringe.
  • this invention provides a system and method for the enclosed sterile assembly of a drug mixing syringe and to provide a system for enclosed aspiration of fluid into the syringe for mixing with the drug within a single inexpensive sterile flexible enclosure. It is further the purpose of the invention to provide a syringe which can sequentially aspirate a diluent and flush solution into two separate compartments, provide for drug mixing with the diluent, and then provide sequential injection of the drug solution followed by the flush solution to flush substantially all drug from the syringe and to flush the injection site free of drug solution.
  • the diluent in a manner such that the diluent is packaged within a syringe component wherein the drug vial can be packaged external to the syringe and where free and complete mixing between the drug vial and the diluent can be performed within a syringe component.
  • the connection of a sealing capping member of the diluent reservoir to a cap extraction member can fixedly engage a portion of the syringe barrel so that the cap can be extracted from the diluent reservoir by retraction of the diluent reservoir away from the fixed cap extraction member connected to the cap.
  • the cap extraction member includes flow channels for allowing passage of the mixed drug solution by the cap extraction member and out the syringe.
  • sealing occlusion of the distal tip of the syringe is provided so that negative pressure induced within the syringe withdraws fluid from a compartment proximal to the distal tip of the syringe, thereby withdrawing fluid into the syringe without the need for the fluid to be external and in fluid communication with the distal tip of the syringe.
  • the reservoir of fluid can carry a drug vial engaging member for connecting the drug vial to the diluent reservoir to allow free mixing between the drug vial and the diluent reservoir so that after the drug has been mixed with the diluent, the cap can be extracted by the cap extracting member and the mixed drug solution can be withdrawn into the syringe by negative pressure induced within the syringe barrel.
  • FIG. 1 is an exploded view, in partial cross-section, of a syringe according to the present invention
  • FIG. 1A is a top plan view of a distal stopper
  • FIG. 1B is a bottom plan view of a distal stopper of FIG. 1A;
  • FIG. 1C is a cross-sectional view of the proximal and distal stopper and connecting tether
  • FIG. 2 is an exploded view, in partial cross section, of a syringe according to the present invention
  • FIG. 2A is a perspective view of the detached vial piston end cover
  • FIG. 3A is a partial cross-sectional view of the syringe as the plunger or vial piston is being inserted into the barrel;
  • FIG. 3B is a partial cross-sectional view similar to FIG. 3A, with the plunger fully inserted into the barrel;
  • FIG. 4A is a partial cross-sectional view similar to FIG. 3A, showing the plunger being retracted;
  • FIG. 4B is a partial cross-sectional view similar to FIG. 3A, showing the tether fully extended;
  • FIG. 4C is a partial cross-sectional view similar to FIG. 3A, showing a repositioned proximal stopper which is advanced relative to the retracted drug vial;
  • FIG. 5A is a partial cross-sectional view similar to FIG. 3A showing the plunger in an injection mode
  • FIG. 5B is a partial cross-sectional view similar to FIG. 3A, showing the completion of the injection
  • FIG. 6 is an exploded view, in partial cross-section, of another syringe embodiment of the present invention.
  • FIG. 6A is a top plan view of a distal stopper
  • FIG. 6B is a bottom plan view of a distal stopper
  • FIG. 6C is an enlarged cross-sectional view of a proximal stopper
  • FIG. 6D is an enlarged cross-sectional view of the distal stopper
  • FIG. 7A is a cross-sectional view of a vial piston open and ready to be filled
  • FIG. 7B is a partial cross-sectional view of the vial piston of FIG. 7A, mounted on a handle in a closed and sealed condition;
  • FIG. 7C is a top plan view of a sterile package for enclosed assembly and aspiration
  • FIG. 8A is a top plan view of another embodiment of a sterile packaging system, according to the present invention, showing a syringe compartment and a liquid compartment;
  • FIG. 8B is a top plan view similar to FIG. 8A, showing the syringe tip advanced through a weakened sealed section in the package;
  • FIG. 8C is a cross-sectional view of the package, through lines 8 C- 8 C, showing the upper and lower planar members;
  • FIG. 8D is a cross-sectional, view through lines 8 D- 8 D, showing the weakened section between the fluid compartment and the syringe compartment, engaged by the distal tip of the syringe;
  • FIG. 8E is a cross-sectional view, similar to FIG. 8D, showing the syringe tip pushed through the weakened section to enter the fluid compartment;
  • FIG. 9 is an exploded view in partial section of another embodiment according to the present invention.
  • FIG. 9A is a top plan view of a distal stopper in the embodiment shown in FIG. 9;
  • FIG. 9B is a bottom plan view of the distal stopper, shown in FIG. 9A;
  • FIG. 9C is a cross-sectional view of a distal stopper, taken along lines 9 C- 9 C of FIG. 9B;
  • FIG. 9D is a top plan view of a proximal stopper in the embodiment of FIG. 9;
  • FIG. 9E is a cross-sectional view taken along lines 9 E- 9 E of FIG. 9D;
  • FIG. 9F is a cross-sectional view of the proximal and distal stopper used in FIG. 9 when interengaged during operation;
  • FIG. 10A is a partial cross-sectional view of the syringe of the embodiment of FIG. 9 with the plunger inserted into the barrel;
  • FIG. 10B is a partial cross-sectional view of the syringe of FIG. 9 with the drug vial partially retracted;
  • FIG. 11A is a partial cross-sectional view of the syringe of FIG. 9 with the drug vial fully retracted;
  • FIG. 11B is a partial cross-sectional view of the syringe of FIG. 9 with the drug vial partially advanced as the mixed drug is injected;
  • FIG. 12 A is a partial cross-sectional view of the syringe of FIG. 10 at the initiation of the flush sequence
  • FIG. 12B is a partial cross-sectional view of the syringe of FIG. 9 with the plunger fully advanced at the conclusion of the drug injection and flushing;
  • FIG. 13 is an exploded cross-sectional view of a syringe, according to another embodiment of the present invention having an integral drug vial and handle;
  • FIG. 14 is an exploded cross-sectional view of a syringe, according to another embodiment of the present invention having a voluminous hollow handle reservoir;
  • FIG. 14A is a top plan view of a distal stopper in the embodiment shown in FIG. 14;
  • FIG. 14B is a bottom plan view of the distal stopper, shown in FIG. 14A;
  • FIG. 14C is a cross-sectional view of the bottom and distal stoppers from the embodiment shown in FIG. 14;
  • FIG. 15 is a cross-sectional view of another embodiment of a syringe, according to the present invention.
  • FIG. 15A is an enlarged cross-sectional view of a portion of the distal end of the syringe of FIG. 15;
  • FIG. 15B is a cross-sectional view taken along line 15 B- 15 B in FIG. 15A;
  • FIG. 15C is a cross-sectional view taken along line 15 C- 15 C in FIG. 15;
  • FIG. 15D is a cross-sectional view of another embodiment having a drug vial sized to be received within the syringe;
  • FIG. 15E is a cross-sectional view of the embodiment of FIG. 15D, after the stopper has been displaced into the flexible diluent container;
  • FIG. 15F is a cross-sectional view of the embodiment of FIG. 15D, showing withdrawal of the handle and displacement of liquid from the flexible container into contact with the syringe barrel;
  • FIG. 15G is a partial cross-section view according to the embodiment of FIG. 15D, engaging a syringe pump and connecting to a catheter;
  • FIG. 16 is a partial cross-sectional view of another embodiment of a syringe, according to the present invention.
  • FIG. 16A is a top plan view of a distal stopper used in the embodiment shown in FIG. 16;
  • FIG. 16B is a cross-sectional view taken along line 16 B- 16 B in FIG. 16A;
  • FIG. 16C is a cross-sectional view of the proximal and distal pistons from the embodiment of FIG. 16 when interengaged during operation;
  • FIG. 17A is a top plan view of a sterile package showing a pleated syringe compartment
  • FIG. 17B is a top plan view of the package of FIG. 17A with the syringe handle fully retracted;
  • FIG. 18A is a cross-sectional view of another embodiment of a syringe, according to the present invention.
  • FIG. 18B is a cross-sectional view of the embodiment of FIG. 18A with the syringe handle partially retracted;
  • FIG. 18C is a cross-sectional view of FIG. 18B across lines C-C;
  • FIG. 18D is a cross-sectional view of the embodiment of FIG. 18A with the handle fully retracted, demonstrating positive drug expulsion and conversion of the open-ended drug vial into a closed-ended piston;
  • FIG. 18E is a cross-sectional view of the embodiment of FIG. 18A with the handle partially advanced after complete retraction, demonstrating drug solution injection by the now closed-ended drug vial.
  • a drug-mixing and injection syringe 5 (shown disassembled in FIG. 1) has syringe barrel 10 with inner wall 12 and smooth barrel bore 22 .
  • the barrel 10 extends to distal tapered end 14 .
  • the syringe 5 has a distal tip 18 and distal conduit 26 in fluid connection with bore 22 .
  • the syringe 5 further includes handle 34 having a stop 35 .
  • a main vial piston 38 is provided including an outer housing 39 and having a distal sealing cover 45 and weakened tear regions 46 , and projecting tear tab 48 enclosing a vial 50 having a vial chamber 51 having an inner wall 52 and an outer wall 53 .
  • the vial 50 is preferably made of glass.
  • the housing 39 and cover 45 can be comprised of polypropylene or other suitable material.
  • the main vial piston 38 further includes an annular wiper or o-ring 54 for sealingly engaging wall 12 of bore 22 .
  • the vial 50 includes a closed proximal end 55 and a distal open end 60 .
  • the vial 50 contains a stopper piston assembly 68 , including proximal piston 70 and distal stopper 74 .
  • the vial piston 38 further includes handle receiving recess 79 for receiving handle distal end 80 , as shown in FIG. 1C.
  • Piston 70 and stopper 74 are connected by a tether portion 84 that includes a tether vent channel 86 extending between a proximal vent portion 87 and a distal vent portion 88 .
  • Stopper pistons 70 and 74 are preferably comprised of conventional rubber stopper material.
  • the tether 84 is likewise comprised of conventional rubber so that it is compatible with a variety of drugs and is flexible and capable of transmitting tensile force.
  • a silicone tubular rubber insert (not shown) may be used if desired within the tether 84 to provide added strength and reduce stretching.
  • Distal stopper 74 includes a distal face 75 and a lateral projecting portion 76 and a proximal vial sealing portion 77 .
  • the wall portion 76 projects beyond the diameter of distal opening 60 and the outer vial wall 52 of the drug vial 50 and includes multiple lateral flow channels 78 extending through the wall 76 and over the face 75 .
  • These flow channels do not communicate with the vial chamber 51 since a distal opening 60 of vial 50 is sealed by the side wall of sealing portion 77 . Therefore, flow channels 78 do not require a valve or other means for closure when the chamber 51 is sealed by the stopper 74 , thereby reducing both the cost of manufacture and the operating complexity.
  • the vial sealing portion 77 seals tightly about the distal vial end 60 .
  • the flow channels 78 are formed by the stopper 74 and the barrel wall 12 , but can otherwise be provided entirely through the stopper 74 .
  • the proximal piston 70 is fully advanced against the closed proximal end 55 of the vial 50 .
  • the tether 84 which preferably is longer than the vial 50 extends out the open end 60 of the vial 50 and the distal stopper 74 is preferably positioned away from the open end 60 of the vial 50 so that the vial 50 can be filled with a powder or liquid drug.
  • the vial sealing portion 77 of distal stopper 74 can be slightly compressed and inserted into the open distal end 60 of the drug vial 50 to provide a tight sealing fit.
  • Vial 50 further includes annular retainer 94 , and proximal piston stop 96 for tightly retaining the proximal piston 70 in the fully advanced position, as will be described.
  • the cover 45 (FIG. 2A) is removed by removing tear tab 48 , the vial piston 38 is then inserted into barrel 10 (FIG. 3A) and fully advanced against the end 14 of the barrel 10 (FIG. 3B).
  • the distal stopper 74 is radially compressed by the barrel wall 12 to provide a tight friction fit and to fix the stopper 74 in the fully advanced venting position, as shown in FIG. 3B.
  • the distal conduit 26 is then placed in fluid communication with a source of diluent, (such as that shown in FIG. 8B), if a source of diluent is not already attached adjacent the distal end 18 of the syringe.
  • the handle 34 is then retracted (FIG. 4A). As the handle 34 is retracted, the drug vial 50 is extracted away from the distal stopper 74 since the distal stopper 74 is tightly held by tight compressive frictional engagement of the laterally projecting portion 76 with the barrel wall 12 .
  • the retraction of the vial 50 forms a nascent mixing chamber 90 intermediate the vial 50 and the distal stopper 74 .
  • the displacement of the distal stopper 74 out of sealing engagement with vial opening 60 completely opens the vial chamber 51 into the enlarging nascent mixing chamber 90 .
  • the negative pressure within the mixing chamber 90 caused by retraction of the handle 34 causes diluent fluid to pass through conduit 26 , through the flow channels 78 of the distal stopper 74 and on into the mixing chamber 90 .
  • the mixing chamber 90 is enlarged, continued circumferential fluid flow enters the mixing chamber 90 through the flow channels 78 .
  • tether 84 becomes fully extended, as in FIG. 4B. After tether extension, further retraction of the handle 34 causes the vial 50 to be moved relative to the now fixed proximal piston 70 so that the proximal piston 70 advances and slides along inner wall 52 relative to the vial 50 , thereby reducing vial chamber 51 .
  • proximal piston 70 engages stop 96 and is retained within the distal end 60 of the drug vial 50 by stop 96 and by retainer 94 .
  • proximal piston 70 now functions as a stopper and sealingly occludes distal end 60 of drug vial 50 , thereby converting the formerly widely open drug vial 50 into a closed injection piston 100 (FIG. 5A and FIG. 5B).
  • fluid can flow through the tether vent channel 86 from the conduit 26 into the enlarging reservoir 104 proximal to the piston 70 within vial 50 .
  • This will fill the reservoir 104 with diluent.
  • the syringe 5 can then be rocked or rolled to facilitate mixing.
  • Gas can be initially provided in the vial 50 with the drug during initial manufacture and filling to enhance mixing after expulsion of the air from the vial chamber 51 along with the drug into the mixing chamber 90 . All of the drug and solution is now contained within the mixing chamber 90 and, therefore, should be visible through the barrel 22 , which is preferably comprised of relatively transparent polypropylene. This is advantageous since residual clumps of powdered drug might otherwise be contained within the drug vial 50 and adequate mixing would not, therefore, be easily confirmable by visible inspection.
  • the syringe can be positioned so that the distal tip 18 is in an upward position and the handle 34 can be moved back and forth to facilitate mixing.
  • Retraction of the handle 34 is preferably limited by a proximal handle detent 110 along barrel 10 which is positioned so that tether 84 is fully extended when proximal detent 110 is engaged by the handle stop 35 . This engagement prevents excessive tensile force from being transmitted to the rubber tether 84 and assists in fixing the volume of diluent for mixing with the drug.
  • any residual air can be expelled.
  • the drug solution can then be injected (as depicted by the arrows (in FIG. 5A and FIG. 5B) or the syringe 5 can be capped for transport from the pharmacy to the nursing station for subsequent use.
  • the syringe barrel 10 and the piston handle 34 and vial piston 38 are enclosed within a single sterile flexible plastic envelope 120 in an unassembled configuration with an attached cannula 122 and a cannula cover 124 .
  • the plastic envelope 120 is preferably of conventional flexible transparent and medically sterilizable material, such as polyethylene or polyvinylchloride, so that the syringe handle 34 and syringe barrel 10 may be manipulated within the material for enclosed assembly within the envelope 120 .
  • the projecting tear tab 48 is grasped by the thumb and forefinger through the flexible envelope 120 and the tear tab 48 is held in position while the syringe handle 34 is rotated until the cover 45 is separated from the vial piston 38 .
  • the tear tab 48 can be 1.5 - 2 centimeters or larger in length to provide ease in grasping through the envelope 120 .
  • the handle 34 and the barrel 10 are then grasped and aligned within the envelope 120 .
  • the envelope 120 is provided with sufficient length so as to allow room for such alignment.
  • the handle 34 is then inserted into the barrel 10 and advanced until the distal stopper 74 engages the distal end 14 , as previously discussed. Assembly is then complete.
  • the envelope 120 can then be opened, removed, and the conduit 26 placed in fluid communication with a source of diluent for aspiration of diluent into the syringe 5 .
  • envelope 120 can include a compartment 130 containing a sterile diluent, such as a saline or dextrose solution, and a syringe compartment 140 containing the syringe 5 components separated from the fluid compartment 130 by a thermoformed seal or bond 145 .
  • a membrane or septum 146 intermediate the compartments can be provided for penetration by the distal tip 18 or an attached cannula 122 so that diluent could be directly aspirated from within the diluent compartment 130 and so that the entire process could be accomplished within a completely enclosed sterile environment.
  • an inexpensive diluent container as for example, a molded polypropylene bottle (not shown) can be enclosed with the syringe components in the main envelope 120 .
  • the syringe tip 18 may be sealingly capped and packaged with the distal tip 18 projecting into, and sealed within, the diluent or fluid compartment 130 .
  • This allows simplified packaging by placing the syringe tip 18 in a position such that the dividing seal 145 between the syringe compartment 140 and the diluent compartment 130 extends across and includes the distal tip 18 .
  • the fluid compartment 130 may be only partially distended so that the syringe cap or cover 124 , which can include an additional sealing cover (not shown), can be easily grasped through the fluid and envelope 120 and removed to unseal conduit 26 at tip 18 when aspiration of fluid is desired. Once disengaged from tip 18 , the cap or cover 124 can be discarded within the compartment 130 .
  • This comprehensively enclosed system is especially useful when the contained drug is a chemotherapeutic agent, thereby greatly eliminating occupational exposure of even minute amounts of chemotherapeutic drugs wherein cumulative occupational exposure may be hazardous to the healthcare worker. It is further advantageous to utilize such assembly of the syringe 5 within envelope 120 when the syringes are being prepared and the drugs are being mixed within the syringes at a site remote from the site of the syringes intended use or when there will be a significant delay between assembly and use. Examples include home healthcare, mobile intensive care units, emergency medicine mobile units, and in hospitals when preparation is performed in a centralized pharmacy for distribution to floor units.
  • the syringe be assembled and the drug mixed with solution while the syringe is maintained within the original sterile container.
  • liquid other than a diluent can be utilized and withdrawn into the syringe.
  • a drug solution which can subsequently be mixed with the powdered or liquid drug within the vial can be provided and subsequently drawn into the syringe for mixing, as described for the diluent.
  • the syringe 5 is shown after assembly within a sealed, sterile transparent envelope 120 ′ with the cover 45 removed from the vial piston 38 and the vial piston 38 inserted into the barrel 10 .
  • Envelope 120 ′ includes a syringe chamber 140 ′ and a liquid chamber 130 ′.
  • the envelope 120 ′ is preferably comprised of two planar sheets (FIG. 8C) of polyvinyl chloride, an upper sheet 122 ′ and a lower sheet 124 ′. These sheets are bonded or thermoformed to enclose the syringe compartment 140 ′ and the liquid compartment 130 ′.
  • a recess 144 ′ is provided intermediate the liquid compartment 130 ′ and the syringe compartment 140 ′.
  • a weakened sealed region 146 ′ (shown in FIG. 8D) is provided adjacent the liquid compartment 130 ′ and the recess 144 ′.
  • the syringe tip 18 may be inserted into the recess 144 ′ and subsequently wedge apart the weakened region 146 ′ to enter the liquid compartment 130 ′.
  • the handle 34 ′ can be retracted to draw fluid into the syringe 5 .
  • another envelope 120 ′′ (such as is shown in FIG. 17A) can be provided with a pleated, bunched, folded portion 150 ′′, or otherwise redundant portion to facilitate retraction of the handle 34 .
  • a tear or weakened portion 121 ′′ can be provided so that the envelope 120 ′′ can be removed once the fluid has been withdrawn into the syringe 5 and the drug properly mixed with the fluid. It can be seen that utilizing this comprehensive packaging system, the entire process can be complete without exposing the syringe 5 to potential contamination to the environment and without exposing the preparing personnel to even minute quantities of drug.
  • FIG. 6 Another preferred embodiment is shown in FIG. 6.
  • This embodiment utilizes a cylindrical drug vial 50 ′ which is open at the distal end 60 ′ and the proximal end 55 ′.
  • a proximal piston 70 ′ includes a handle recess 79 ′ for threadingly receiving a threaded end 80 ′ of syringe handle 34 ′.
  • the proximal piston 70 ′ is sealingly received into the proximal end 61 ′.
  • a cover 45 ′ having weakened areas 46 ′ and a tear tab 48 ′ is provided over the proximal piston 70 ′ and extends over the distal stopper 74 ′. Upon removal of the tear tab 48 ′ along the weakened areas 46 ′, the entire cover 45 ′ can be removed from the vial piston 38 ′. Alternatively, separate proximal and a distal covers (not shown) could be provided with two separate tear tabs.
  • a barrel 10 ′ is provided with bore 22 ′ having interior wall 12 ′ for receiving the vial piston 38 ′.
  • a stop 35 ′ can be provided on handle 34 ′ to preset the volume of diluent to be aspirated into the barrel 10 ′, as will be described.
  • a covered drug vial piston assembly 38 ′, the handle 34 ′, and the barrel 10 ′ are preferably enclosed within a sterile envelope, as previously shown in FIG. 7C.
  • the envelope can include a region permeable to gas, such as TyvekTM, (not shown) for gas sterilization, as is known in the art.
  • the sterile envelope is flexible and comprised, for example, of a material such as polyethylene or polyvinyl chloride, so that the components within the envelope can remain sterilely sealed yet be easily grasped, manipulated, and assembled therein.
  • the tear tab 48 ′ is grasped and the tear tab 48 ′ and cover 45 ′ are removed from the vial piston assembly 38 ′
  • the handle 34 ′ is then inserted into recess 79 ′ which can be threaded, as shown, to receive the handle end 80 ′ without substantial longitudinal force exerted against the proximal piston 70 ′.
  • the tear tab 48 ′ is located adjacent proximal piston 70 ′ of the vial piston assembly 38 ′ so that the proximal portion of the cover 45 ′ could first be removed, handle 34 ′ threadably received into the recess 79 ′, and handle 34 ′ grasped for more easy removal of the distal portion of the cover 45 ′ through a flexible envelope (such as is shown in FIG. 8A). Once the entire cover 45 ′ is removed, the piston assembly 38 ′ and its attached handle 34 ′ are inserted into the barrel 10 ′ and fully advanced to the end of the barrel 14 ′.
  • the projecting lateral wall 76 ′ of distal stopper 74 ′ is of greater diameter than the barrel bore 22 ′ so that the lateral wall 76 ′ can be pressed very tightly against the interior wall 12 ′ of the barrel 10 ′. This assures a tight friction fit between the distal stopper 74 ′ and the barrel 10 ′ so that, while the piston 74 ′ can be slidingly advanced by force along the barrel 10 ′ to the distal end 14 ′. Once positioned at the distal end of barrel 10 ′, piston 74 ′ will stay in place.
  • vial 50 ′ upon retraction of the handle, vial 50 ′ will be extracted away from the distal stopper 74 ′ since the position of distal stopper 74 ′ is fixed by the tight fit against the barrel wall 12 ′.
  • the distal end 60 ′ is pulled away from stopper 74 ′, thereby widely opening drug vial 50 ′ and forming a mixing chamber intermediate the open-ended drug vial 50 ′ and the distally retained distal stopper 74 ′, as described and shown in the previous embodiments.
  • fluid can flow through the flow channels 78 ′ adjacent the distal stopper 74 ′ to fill the mixing chamber and to mix drug with the fluid entering through the flow channels 78 ′.
  • the syringe can be agitated to mix the drug with the fluid.
  • the syringe conduit 26 ′ can then be placed in fluid connection with the intended recipient of the drug and the piston handle 34 ′ can be advanced. As piston handle 34 ′ is advanced, fluid exits the flow channels 78 ′ adjacent the distal stopper 74 ′.
  • the proximal piston 70 ′ can be sized so that the frictional fit against vial wall 52 ′ induces less resistance to advancement than the frictional fit of the wiper 54 ′ against the inner barrel wall 12 ′. Therefore, upon advancement of the handle 34 ′, the proximal piston 70 ′ first advances along vial wall 52 ′ until it is fully advanced to seal the distal end 60 ′ of vial 50 ′. Retaining detents 94 ′ can be provided to retain the proximal piston 70 ′ in its fully advanced position at opening 60 ′ against piston stop 96 ′. At this time, further advancement of handle 34 ′ will cause the entire vial 50 ′ with fully advanced piston 70 ′ to advance, thereby continuing the injection of fluid from the mixing chamber out the conduit 26 ′ and into the intended recipient.
  • diluent could be stored within a portion of the syringe, rather than external to the syringe.
  • a bypass region and detents could be provided along the syringe barrel to provide the flow channel function, positioned at the distal end or midway along the syringe.
  • the syringe handle could be positioned within the barrel during storage.
  • Hooks could be provided along the wall of the syringe for catching the tear tabs upon rotation or advancement of the handle so that the tear tab and sealing cover is automatically displaced from the distal end of the syringe upon engagement of the hooks and rotation or advancement of the handle, thereby separating the tight seal between the drug vial and the cover within the syringe barrel.
  • a tether valve can be provided within the distal stopper, as described in the aforementioned Patent Application # 08 / 196 , 455 to allow a flow channel through the distal stopper when the distal stopper is fully advanced against the end of the syringe.
  • the sealing fit of the distal stopper can be adjusted so that it is quite tight and the sealing fit of the proximal piston within the drug vial can be adjusted so that it is quite loose, thereby assuring that the distal stopper will be retained in the distal end as the tether pulls the proximal stopper piston along the drug vial to expel the drug into the mixing chamber. It can be seen that, with such an embodiment if a tether and a valve are provided, the tether need not be connected to the valve, but rather the valve may be designed to open on contact with the distal end and remain open with the tether being otherwise connected to the upper face of the distal stopper.
  • FIG. 9 Another preferred embodiment, shown in FIG. 9, utilizes the previously described flow of liquid through the vent to allow storage of liquid within a proximal portion of the syringe for subsequent injection after the injection of the drug solution, thereby flushing the syringe and the injection site free of drug solution.
  • a syringe barrel 10 ′′ is provided with bore 22 ′′ and inner wall 12 ′′.
  • the handle 34 ′′ continues to include a stop 35 ′′.
  • the handle is connected to a vial piston assembly 38 ′′ having a polymeric portion 39 ′′ and a glass drug vial 50 ′′ with a closed proximal end 55 ′′ and an open distal end 60 ′′.
  • the vial piston 38 ′′ includes cover 45 ′′ having tear tab 48 ′′.
  • the vial piston 38 ′′ further includes a thin circumferentially extending rubber wiper sleeve 54 ′′.
  • a proximal stopper piston 70 ′′ is provided connected by a tether 84 ′′ to a distal stopper 74 ′′.
  • the distal stopper 74 ′′ includes vial sealing portion 77 ′′ which seals tightly about inner vial wall 52 ′′ at opening 60 ′′.
  • the vial sealing portion 77 ′′ further includes a series of longitudinal slots 150 which extend to a distal end 156 .
  • a projecting wall portion 76 ′′ is provided having radially projecting flow channel slots 78 ′′.
  • These radial slots 78 ′′ are provided about the entire perimeter of the lateral wall portion 76 ′′ so as to provide complete circumferential fluid influx for more complete and rapid mixing of drug with the fluid to provide circumferential afflux of fluid to allow the drug solution to exit uniformly, and for the complete circumferential flush of drug solution from the syringe 10 ′′.
  • the proximal piston 70 ′′ includes several flow channels 160 and a contact-activated longitudinal slit valve 164 which includes longitudinal slit 168 .
  • the entire proximal piston 70 ′′, including the slit valve 164 is preferably comprised of conventional rubber stopper material.
  • the slit valve 164 extends to tip 170 .
  • the slit 168 is tightly closed at rest, preventing flow of fluid through from channel 160 out slit 168 and further preventing flow in the reverse direction through slit 168 and into flow channel 160 .
  • Slit valve 164 will open upon forceful contact of tip 170 against distal stopper 74 ′′, as shown in FIG. 9F. This allows free fluid communication between flow channels 160 and slots 150 .
  • the slit valves preferably cannot be completely compressed so as to horizontally close slit 168 even with high pressure against distal piston 74 ′′. This can be provided by including thickened walls 166 which provide resistance to excessive longitudinal compression, as shown in FIG. 9F. Further, this provides for a space 180 between proximal piston 70 ′′ and distal piston 74 ′′, allowing free flow of fluid into longitudinal slots 150 , as will be described.
  • Tether 84 ′′ which again includes a tether vent, (as illustrated in previous embodiments), is provided intermediate the proximal piston 70 ′′ and the distal piston 74 ′′, thereby connecting together the proximal piston vent portion 87 ′′ and distal vent portion 88 ′′.
  • the distal vent portion 88 ′′ can be compressed and closed by radial compression of the vial sealing portion 77 ′′, as by sloping inner vial wall 52 ′′ adjacent the distal vial end 60 ′′ when the stopper 74 ′′ is sealingly engaged with the vial 50 ′′, as shown in FIG. 9.
  • the piston assembly 38 ′′ is loaded into the barrel 10 ′′ and advanced, as shown in FIG. 10A.
  • Distal conduit 26 ′′ is then connected to a source of diluent (if the source of diluent is not already attached to the distal conduit end) and the handle 34 ′′ is retracted and the diluent is withdrawn into the syringe 5 ′′ since stopper 74 ′′ is retained by tight frictional fit with the wall 12 ′′ and, thereby the drug vial 50 ′′ is extracted away from the stopper 74 ′′.
  • diluent flows through flow channels 78 ′′ defined by wall portions 76 ′′ and barrel wall 12 ′′ and into a nascent mixing chamber 90 ′′.
  • the tether 84 ′′ becomes extended (FIG. 11A), applying tensile force to the proximal piston 70 ′′ and effectively advancing the proximal piston 70 ′′ along the drug vial 50 ′′.
  • a nascent flush fluid chamber 104 ′′ is formed within drug vial 50 ′′, intermediate the closed end 55 ′′ of drug vial 50 ′′ and the proximal piston 70 ′′.
  • mixing chamber 90 ′′ is filled with diluent and drug and the flush chamber 104 ′′ is filled with flush solution.
  • the syringe 5 ′′ is now ready for sequential injection and flush, as in FIG. 11B.
  • the distal conduit 26 ′′ is placed in fluid connection with a receiver, such as an intravenous saline well, as shown in the aforementioned patent application Ser. No. 08/196,455.
  • the handle 34 ′′ is then advanced (FIG. 12) and the drug solution is injected into the recipient.
  • the drug solution flows from the mixing chamber 90 ′′ through the flow channel slots 78 ′′ and out the conduit 26 ′′.
  • slit valve 164 contacts the distal piston 74 ′′ (as in FIG. 12A and FIG. 12B), the slits 168 open, allowing fluid connection between space 180 and flush compartment 104 ′′ through flow channels 160 .
  • the vial 50 ′′ passes over distal stopper 74 ′′, pushing proximal piston 70 ′′ in a proximal direction, this compresses flush chamber 104 ′′ within vial 50 ′′ to force fluid out flow channels 160 through slits 168 and into space 180 , whereby the fluid flows through the distal stopper slots 150 and the adjacent drug vial wall 52 ′′ until the fluid escapes past distal end 60 ′′ of the drug vial and out radial slots 78 ′′ and distal stopper 74 ′′ and then through conduit 26 ′′.
  • a drug vial 250 is integral with a handle 234 and detents 220 are provided along barrel 210 for retaining the distal stopper 274 in a distal venting position adjacent bypass vents 278 .
  • the handle 234 ′ can be hollow and contain a large sealed chamber 230 ′ which can store and provide the sterile gas or liquid to relieve the negative pressure within the drug vial 250 ′ when the proximal piston 270 ′ is advanced along the drug vial 250 ′. This eliminates the need for a tether vent in tether 284 .
  • the large volume within the handle 234 ′ allows the proximal piston 270 ′ to advance with minimal negative pressure development within the drug vial 250 ′ and handle 234 ′, thereby facilitating ease of advancement while maintaining a sealed environment.
  • the handle 234 ′ could alternatively store flush solution and a one-way valve (not shown) could be provided intermediate the vial 250 ′ and the sealed handle chamber 230 ′ so that fluid transferred into the vial 250 ′ from the handle 234 ′ can later be selectively displaced into the barrel 210 ′, as through slit valves in the proximal piston (as shown in the previous embodiment) for subsequently flushing of the syringe 205 ′ after drug injection.
  • a drug-mixing and injection syringe has a syringe barrel 10 ′′′ with inner wall 12 ′′′ and a smooth barrel bore 22 ′′′.
  • the barrel 10 ′′′ extends to distal tapered end 14 ′′′.
  • the syringe 5 ′′′ has distal tip 18 ′′′ and distal conduit 26 ′′′ in fluid connection with bore 22 ′′′.
  • the conduit 26 ′′′ is occluded by a sealing cap or cover 19 .
  • the syringe further includes handle 34 .′. which includes a pair of opposing rigid support members 300 (which are also shown in FIG.
  • the handle 34 ′′′ further includes a flexible diluent reservoir 350 having a distal end 354 and a proximal end 358 and a folded or gathered region 359 adjacent the proximal end 358 .
  • the proximal end 358 is occluded by reservoir plug member 360 having a finger contact rim 364 and a including a male vial plug engaging member 368 for retentive engagement with vial plug 330 .
  • the support members 300 are spaced apart to define intermediate finger contact windows 366 for allowing direct finger contact of flexible reservoir 350 adjacent contact rim 364 to allow easy displacement of plug 360 , as will be discussed.
  • the flexible fluid reservoir 350 includes a inner chamber 370 .
  • the inner chamber 370 is in fluid connection with tube 374 (FIG. 15A), defining a lumen 378 extending to a distal lumen opening 380 .
  • a one-way valve 384 shown generically in FIG. 15A, is provided within the lumen 378 for occluding the lumen 378 .
  • the one-way valve 384 can be one of any number of conventional one-way valves which are opened by relative negative pressure distal the one-way valve 384 and which are closed by relative positive pressure distal the one-way valve 384 .
  • a ball and cage valve for example, a ball and cage valve, a flap valve (as utilizing a thin, flexible polymeric or rubber flap, the deflection of which is responsive to a pressure differential across the flap), or other conventional valve may be utilized.
  • the lumen 378 of tube 374 is occluded by sealing cap 390 connected to distal stopper 74 ′′′.
  • a piston stopper assembly 68 ′′′ is provided and shown enlarged in FIG. 15A.
  • the piston stopper assembly 68 ′′′ includes distal stopper 74 ′′′ and proximal piston 70 ′′′. Prior to use, distal stopper 74 ′′′ and proximal piston 70 ′′′ are connected by tube 374 , which thereby comprises a connecting element.
  • distal stopper 74 ′′′ includes radial flow channels or slots 78 ′′′.
  • the distal stopper 74 ′′′ has a diameter which is greater than the diameter of bore 22 ′′′ so that distal stopper 74 ′′′ is compressably received within bore 22 ′′′ to provide a tight frictional fit against inner wall 12 ′′′.
  • Distal stopper 74 ′′′ is, therefore, fixedly engaged with inner wall 12 ′′′ after distal stopper 74 ′′′ has been forcibly advanced to the maximum position within the barrel 10 ′′′ adjacent barrel end 14 ′′′.
  • a flange 395 may be provided adjacent the drug vial 350 to allow the drug vial 350 and handle 34 ′′′ to be more easily retracted and advanced.
  • the flange 395 can be sized to be received within an automatic, mechanical, or electronic syringe pump 398 (FIG. 15G).
  • the drug vial 350 can be sized to be slidably received within the syringe barrel 10 ′′′ for more conventional operation and ease of interface with conventional syringe pumps.
  • a neck (not shown) having the configuration of a conventional syringe handle can be provided intermediate the flange 395 and adjacent the drug vial 350 to facilitate operation with conventional syringe pump designs.
  • drug vial 50 ′′′ with the attached sealing plug 330 is threadably engaged with the drug vial retainer 324 so that plug 330 is tightly retained about reservoir plug 360 (FIG. 15E) prior to complete insertion into barrel 10 ′′′ of handle 34 ′′′.
  • the user can then contact plug rim 364 through windows 366 and advance plug 360 distally so that the reservoir plug 360 and the retained vial plug 330 are displaced away from vial opening 60 ′′′.
  • Diluent from reservoir 370 can then freely flow into drug vial chamber 51 ′′′ through opening 60 ′′′ to mix the drug formerly retained within the vial 50 ′′′ and the diluent formerly retained within the reservoir 350 .
  • Free flow of diluent and mixed solution can be achieved through the large vial opening 60 ′′′.
  • the syringe 5 ′′′ can be rocked and rolled so as to provide complete mixing.
  • handle 34 ′′′ can be grasped and retracted. Retraction of handle 34 ′′′ will cause proximal piston 70 ′′′ to be displaced away from the retained distal stopper 74 ′′′ so that cap 390 is disengaged from tube 374 .
  • the retraction maneuver is preferably performed with the syringe 5 ′′′ in a position wherein the distal tip 18 ′′′ is directed downward to assist in the free flow of fluid out lumen 378 and into contact with inner barrel wall 12 ′′′.
  • flexible reservoir 350 Upon complete withdrawal of handle 34 ′′′ (FIG. 15F), flexible reservoir 350 has collapsed, effectively reducing the transmission of negative pressure from within the syringe barrel 22 ′′ to within the drug vial 50 ′′′, although such transmission of negative pressure is not seen as detrimental with the presently preferred embodiment.
  • Distal tip cap 19 can then be removed and conduit 26 ′′′ placed in fluid connection with the intended recipient of the drug solution for subsequent injection of the drug solution.
  • the drug solution is injected by advancing handle 34 ′′′, thereby advancing proximal piston 70 ′′′.
  • positive pressure within bore 22 ′′′ distal the proximal piston 70 ′′′ causes the one-way 384 to close so that drug solution does not reflux through lumen 378 back into reservoir 350 .
  • a further embodiment functions in a manner similar to the embodiment of FIG. 6, but having the advantage of providing for positive displacement of a proximal piston along an inner drug vial wall to displace the drug from the drug vial, as will be discussed.
  • This embodiment (numbered similar to FIG. 6, but with 600s) utilizes a vial piston assembly 638 including a cylindrical drug vial 650 which is open at a distal end 660 and a proximal end 661 .
  • a distal piston 674 having circumferential flow channels or slots 678 is sealingly received into the distal end 660 of vial 650 .
  • the proximal piston 670 is sealingly received into the proximal end 661 .
  • a barrel 610 is provided with a bore 622 , having an inner wall 612 for receiving a slideable rubber, circumferential, sealing wiper 654 surrounding the drug vial 650 .
  • a handle 634 is provided, having distal retainers 636 for retaining the handle 634 within the circumferential wiper 654 .
  • a stop-rod 680 is provided, having a pair of proximal stops 682 and a threaded distal end 684 . The threaded end 684 is sized to be threadably received within proximal stopper 670 . The stop-rod slides within opposing slots 685 and 686 along handle 634 .
  • the length of slots 685 and 686 is equal to the relative displacement length of the proximal piston 670 along drug vial 650 , as will be described.
  • the stops 682 are sized to engage a proximal detent 688 along barrel 610 upon retraction of handle 634 .
  • the operation of this embodiment is quite similar to the embodiment of FIG. 6, except that this syringe 605 provides positive displacement of the contents of drug vial 650 into the mixing chamber 690 upon retraction of handle 634 , as will be discussed.
  • the handle 634 and attached vial piston assembly 638 is loaded into the syringe barrel 610 and fully advanced to the distal tapered end 614 .
  • the distal stopper 674 has a greater diameter than the syringe barrel bore 622 so that the distal stopper 674 is compressed by the syringe barrel 610 to provide tight frictional engagement in the maximally advanced position of FIG. 18A.
  • Withdrawal of handle 634 as in FIG. 18B, causes drug vial 650 to be displaced away from distal stopper 674 to widely open the drug vial chamber 651 into a nascent mixing chamber 690 .
  • retraction of handle 634 causes negative pressure to develop in chamber 690 and thereby causes fluid to flow through conduit 626 and through slots 678 into mixing chamber 690 .
  • the stop-rod 680 is slidably displaced along slots 685 and 686 .
  • further retraction of handle 634 and the attached vial 650 causes stops 682 to engage annular detent 688 , thereby causing positive relative advancement of stop-rod 680 and the attached piston 670 along drug vial wall 652 and past drug vial detent 694 so that the proximal piston 670 is retained adjacent the distal end 660 of drug vial 650 .
  • the distal conduit 626 through distal tip 618 can be placed in fluid connection with the intended recipient.
  • the handle 634 is then advanced.
  • the proximal piston 670 and the stop-rod 680 are prevented from proximal displacement by retainer 694 .
  • complementing detents could be provided along the slots 685 and 686 and stop-rod 680 to prevent displacement of the proximal piston 670 once the proximal piston 670 has been advanced along the vial 650 , thereby eliminating the need for the vial retainers 694 .
  • the drug solution contained within mixing chamber 690 is pushed through slots 678 , out conduit 626 , and into the intended recipient.
  • this embodiment allows positive displacement of substantially all drug out of a drug vial 650 and into a mixing chamber 690 within a syringe 605 with a single handle 634 retraction maneuver.
  • the embodiment further does not require the use of a tether, as described for some of the previous embodiments.
  • This embodiment therefore, has the advantage of simplified operation and manufacture. Markers or detents (not shown) can be provided along the handle 634 and the syringe barrel 610 for indicating that complete withdrawal and locking of the proximal piston 670 in the fully advanced position of FIG. 18D has been achieved.

Abstract

A system is provided for the storage and injection of a beneficial agent. The system includes a barrel, the barrel having a loading end and a distal end, and a piston having an elastomeric portion slidably disposed in the barrel bore. A receptacle pre-filled with the beneficial agent is loaded into the loading end of the barrel and is movable with the piston. A tubular flow connector is carried by the piston for connecting the receptacle to a distal chamber of the barrel so that the agent can flow from the storage receptacle into the distal chamber when the piston is retracted away from the distal end of the barrel. A structure is provided along a portion of the receptacle to allow the agent to flow from the receptacle, through the flow connector and into the distal chamber without being inhibited by the development of negative pressure within the receptacle.

Description

  • This is a division of application Ser. No. 08/699,979, filed Aug. 20, 1996, which was a division of application Ser. No. 08/655,754, filed May 30, 1996, which was a continuation of application Ser. No. 08/231,430, filed Apr. 22, 1994, which was a Continuation-in-Part of application Ser. No. 08/196,455, filed Feb. 15, 1994, the disclosure of each of which is hereby incorporated by reference as if completely disclosed herein.[0001]
  • BACKGROUND AND SUMMARY OF THE INVENTION
  • Appln Ser. No. 08/196,455 presents the background of multi-chambered syringes which are used for sequential injection and/or the mixing of drugs and solutions. Additional background of enclosed drug-mixing systems is provided in U.S. Pat. No. 4,614,267. As described within the backgrounds of the many patents presented in the aforementioned application, it is advantageous to store a drug in a powdered or liquid form and then mix the drug in the same enclosure which is subsequently placed in fluid connection with the patient. More specifically, it is advantageous to provide mixing within a syringe so that reconstitution within a separate drug vial becomes unnecessary. This, however, must be provided at minimum cost and would preferably utilize materials to store the drug, such as glass, which have been determined appropriate by the U.S. Food and Drug Administration for long-term storage of drugs so that the evaluation of the leaching or interaction between the drug and the drug container is unnecessary. Such compatibility evaluations are associated with considerable delay and development expenses. PCT Patent Application # WO 92/01485 describes a syringe for this purpose having a glass insert and including dual pistons. The syringe, however, includes a complex barrel having multiple bores and bypass regions. This syringe requires complex molding, assembly, and sealing. However, with respect to drug administration systems, reduced cost, simplicity of design and molding, versatility of use, compatibility with automated drug dispensing systems, and ease of sterile assembly and use are the major factors defining success. It is particularly useful to provide a system using a conventional type glass vial and a convention smooth bore syringe barrel of the type in wide use and inexpensively molded of polypropylene in mass quantities and in a wide variation of bore sizes. As will be evident from the following discussion, the present invention operates to overcome many existing problems in the present art. [0002]
  • The sequential aspiration, mixing, and injection syringe includes a barrel having an inner wall and a main bore which is preferably conventional and smooth along substantially its entire length. The syringe includes a piston assembly having a proximal portion and a distal portion and a connecting element intermediate the portions. The portions are sized to be received into a main bore of the barrel and to fit snugly against the barrel wall. This distal portion preferably includes at least one projecting lateral member for engaging the inner walls of the barrel, thereby effectively fixing the position of the distal portion at a maximally advanced position along the barrel which preferably adjacent the distal end of the barrel, although the position could be midway along the barrel. After the pistons have been received into the barrel, the proximal portion is moveable along the barrel away from the distal portion and moveable along the barrel toward the distal portion to define a variable volume mixing chamber intermediate the proximal portion and the distal portion. The connecting element can be a fluid reservoir or a drug vial which can be comprised of glass or the connecting element can be a conduit or tube, or can be a tether or other tensile element. The glass vial can have a proximal end and a distal end. In one embodiment, both ends of the vial are open. The proximal portion can be a piston and can be positioned to occlude the proximal end and the distal portion can be a stopper to occlude the distal end of a drug vial or the distal end of a fluid reservoir or tube. The connecting element provides for mutually equivalent advancement of the proximal and distal portions along the barrel. The combined piston assembly and the connecting element can be seen to represent a reservoir or drug vial piston connectable to a syringe handle. The distal stopper is displaceable from the fluid reservoir or drug vial by retraction of the reservoir or vial away from the distal stopper and by frictional or other engagement of the distal stopper and the barrel after the reservoir or vial and the attached piston assembly have been moved to an advanced position and then the reservoir or vial is retracted from the advanced position. This allows for retraction of the proximal piston away from the distal stopper after displacement of the stopper from sealing engagement with the fluid reservoir or drug. In several embodiments, the proximal piston is further moveable along the vial toward the distal stopper. Relative advancement of the proximal piston along the vial can be caused by advancement of the handle in one embodiment wherein the proximal piston is attached to the handle. In another embodiment, wherein the proximal piston is connected to the displaced distal stopper by a tensile element, relative advancement is achieved by retraction of the vial and subsequent tensile force transmitted through the tensile element. The distal portion and the proximal portion are preferably carried by the drug vial, the distal portion being displaceable from the drug vial to open the vial into the mixing chamber, the proximal portion being moveable along the vial to displace the drug from the vial into the mixing chamber, the proximal portion effectively converting the open-ended drug vial into a closed-ended vial piston and thereafter functioning to push the drug solution within the mixing chamber out of the syringe and into a recipient with minimal deadspace-trapped drug remaining within the syringe after injection. [0003]
  • A method of drug injection is provided using an embodiment having a main piston or vial piston having a handle. The vial piston includes a drug vial having a proximal end and a distal end and containing stopper piston assembly having a proximal portion connected to a distal portion by a connecting element which can be a tensile element or which can be the drug vial itself, as will be described. The syringe operates, after assembly, to achieve the following drug injection method with a single retraction and advancement of the handle, steps of: 1. aspirate diluent into the main bore; 2. open the end of a drug vial into the main bore; 3. positively expel the drug from the vial; 4. subsequently convert an open-ended drug vial into a closed-ended injection piston; 5. inject the mixed drug and diluent with minimal residual drug remaining in the syringe after injection. [0004]
  • As noted, the present invention can utilize a drug container or vial which can be cylindrical for insertion into a syringe barrel. The drug vial is preferably made of glass or other material which can safely contain a large variety of different drugs, either in powder or liquid form. In one embodiment, the drug vial includes a closed bottom or proximal end which may include a small air vent and an open top or distal end which is preferably widely open and can, therefore, easily be filled by conventional automated drug dispensing systems. The drug vial can include a narrow neck and larger body to facilitate handling by automated equipment. The drug vial further preferably includes an outer housing member which can be polymeric. At least one sliding member is preferably provided about the vial to slidably engage the syringe barrel bore to facilitate advancement and retraction of the drug vial along the syringe barrel bore. The sliding member can be a thin rubber boot or sleeve. Alternatively, the polymeric housing member may itself be sized to sealingly engage the bore. The sliding member can be a rubber wiper of the type utilized in conventional syringe pistons or can be an o-ring or soft polymeric ring or otherwise fashioned. The sliding member is preferably carried by the housing or vial and may be positioned proximal, distal to, or along the length of the housing or vial. The outer member further can have a recess for receiving the retainer of the handle of a conventional syringe piston or, alternatively, the handle can be molded integrally with the outer vial housing member. The vial can, therefore, be connected to or contained within the handle or can be integral with a handle. In an embodiment, the vial and handle are made of glass and are integral and molded together, thereby eliminating the need for the outer polymeric housing member. In one embodiment, the vial piston includes a piston stopper assembly with a proximal stopper portion for positioning adjacent the closed end of the drug vial and a distal stopper piston portion for occluding the open end of the drug vial. Both portions can be comprised of conventional material utilized for rubber stoppers in drug vials so that contact with the drug and the rubber stopper piston assembly is provided, as is conventional, thereby eliminating the potential for material-related incompatibility. The proximal and distal portions are connected or linked by the drug vial and can be carried by the drug vial. In one embodiment, the portions are further preferably connected by a tether or by bands or other tensile connecting elements which can be comprised of conventional material used in the construction of rubber stopper pistons so as again to allow direct contact with the drug within the glass container without the need for further study to determine compatibility. The two stopper pistons can be molded as a single part with the connecting rubber tether. In one embodiment, a vent is provided for providing vent connection between the proximal face or end of the proximal piston and the atmosphere or between the proximal face of the proximal piston and the distal face or end of the distal stopper. In one preferred embodiment, the vent passes through the tether, the tether comprising a hollow tube having a bore and extending to connect bores through the proximal piston and the distal stopper. This defines a flexible tether vent which operates to limit retraction movement of the proximal piston, thereby to cause advancement of the proximal piston relative to the retracting drug vial and further to vent fluid or air into the drug vial intermediate the proximal piston and the closed end to permit advancement and to allow enlargement of an otherwise sealed nascent proximal compartment within the vial and to fill the enlarging proximal compartment with fluid. In another embodiment, the vent passes through a small opening in the otherwise closed bottom of the drug vial, the vent being occluded by the proximal piston prior to use. The vent can pass into a large volume space within a hollow handle to provide a sealed source of sterile vented atmosphere or liquid with a minimal induction of negative pressure. The width of the outer wiper may be varied so as to allow use of the same housing and vial within syringes of variable diameter and volume. This allows modification of only the wiper when different volumes of diluent are intended for use with, for example, a powdered drug so that a wide variety of variable sized vials and housings need not be constructed for syringes having bores of variable diameters. [0005]
  • In the manufacture of one preferred embodiment having a drug vial with a closed bottom, the proximal piston is inserted into the glass vial and this can be performed, for example, by radial compression of the proximal piston and insertion such that the proximal piston is fully advanced against the closed bottom of the glass vial. The tether or bands are preferably of adequate length to extend out through the open top of the glass vial such that the top or distal stopper does not, at this time, occlude the opening in the top of the drug vial so that powdered or liquid drug may easily be inserted at this time into the drug vial as by automated drug dispensing systems. Once an adequate volume of powdered or liquid drug has been inserted into the drug vial, the distal stopper with its associated residual tether is inserted into the top of the drug vial to occlude the opening in the drug vial. The stopper may have a laterally projecting rim and a main stopper portion which can be received by a compression fit, as is known in the art, into the glass opening to seal the opening. A distal sealing vial cover may then be provided to sealingly retain the cap and drug within the vial for long-term storage. After the vial cover has been removed, the distal stopper may be displaced from the glass opening by longitudinal force directed against the rim, away from the opening of the vial. [0006]
  • The distal vial stopper preferably includes flow channels. The flow channels preferably do not provide communication of the vial chamber with the atmosphere when the stopper is within the vial The flow channels can be slots along the outer laterally projecting rim or perimeter of the stopper or can otherwise be through the stopper piston. The flow channels may be defined by the inner barrel wall and the distal stopper. The channels can be longitudinally slit valves or other valves which are tightly closed at rest, but which are opened by contact with the distal end of the syringe. The laterally projecting portion of the distal stopper preferably has a diameter exceeding the diameter of the syringe bore so that the distal stopper is radially compressed by the barrel and is tightly fit within the barrel by elastic compression against the barrel wall. This allows for reliable fixation of the distal stopper within the barrel at the maximum point of advancement into the barrel, which can be adjacent the distal end of the main barrel bore. This allows the vial to be reliably and easily opened within the barrel by single handle retraction. Since the distal stopper will be fixed by tight elastic compression and frictional engagement with the wall, longitudinal retraction force on the vial will displace the vial away from the distal stopper. [0007]
  • In this way, each drug vial may be sized to be received into conventional automated drug dispensing equipment and can be covered and maintained for long-term storage within a conventional securely sealed polymeric enclosure. The vial can then be connected with the handle and can be packaged in a flexible sterile container along with the barrel, cannula, cannula cover, and even the diluent material in a single flexible sterile packaging enclosure for shipment and storage. The components can be completely assembled within the closed or partially closed sterile package immediately prior to use. This allows for easy packaging and storage and assures sterile assembly, which is otherwise difficult to reliably achieve when loading a piston into a syringe barrel in an open environment. [0008]
  • As noted, in a preferred embodiment, the handle with its vial piston is packaged with a separate syringe barrel within a single sterile flexible enclosure and constructed so that the vial piston may be unsealed and loaded into the barrel within the same sterile package which was used for storage. To prepare the vial for activation, the pharmacist can grasp a projecting tear tab on the sealing vial cover through the flexible package and remove the cover from the vial stopper, thereby exposing the enclosed distal stopper. The vial piston is then inserted into the syringe barrel by contacting the outside of the barrel through the package and inserting the distal end of the vial piston into the barrel. The vial piston is then fully advanced until the distal stopper contacts the distal end. The cannula can then be inserted into a liquid-filled compartment or container within the sterile enclosure. The vial piston can then be retracted. The syringe will then be filled by aspirating liquid enclosed within the enclosure into the barrel. The filled and mixed syringe can then be sent to the floor or to the patient's home for use, or can be frozen for long-term storage, still within the unopened and sealed original sterile enclosure. [0009]
  • In operation for injection, the handle is advanced until the distal stopper piston reaches a venting position along the barrel, if the handle had not previously been advanced to that position during assembly. The location of the venting position depends on the position of the source of diluent. In the preferred embodiment, the venting position is adjacent the distal end of the barrel. However, if the diluent is positioned within the syringe, the venting position can be, for example, midway along the barrel. The handle is then retracted, pulling the drug vial away from the distal stopper which includes a member or portion which is tightly retained against a portion of the barrel. This causes opening of the drug vial, thereby allowing fluid to flow into the drug vial and the drug to mix with fluid. In the preferred embodiment, the diluent fluid is stored external the syringe and the venting position is adjacent the distal end of the syringe barrel, leaving the distal stopper retained adjacent the distal end upon retraction of the vial. The distal stopper is preferably retained by tight frictional engagement with the smooth barrel or can be retained by detents along the barrel. In embodiments utilizing a tensile element, as the handle is further retracted, the tensile element will become extended, thereby transmitting tensile force to the proximal piston so that further retraction of the handle and the attached vial will cause the proximal piston to be advanced relative to the retracting drug vial so that substantially all drug and solution within the vial is pushed distally by the advancing proximal piston into the main bore or mixing chamber of the syringe. The vent preferably provides fluid communication between the vial intermediate the proximal piston and the closed vial end, thereby relieving any negative pressure within the newly enlarging closed proximal vial chamber by the passage of fluid or air through the vent into the vial proximal the proximal piston. After retraction, the solution in the mixing chamber can be agitated. If preferred, an amount of air can be initially provided during manufacture within the vial to facilitate agitation. Once the handle has been fully retracted, the proximal piston is received and retained within the distal end of the drug vial, thereby occluding the distal end of the drug vial so that the drug vial itself with its now distally occluding stopper piston now can function as a closed injection piston with the fully advanced proximal piston as its distal face. The vial can be advanced to cause injection of the mixed drug and solution into the patient with minimal residual remaining in the syringe. In one preferred embodiment, the diluent stored within the enlarging proximal chamber is later used to provide subsequent flushing of the syringe and can provide flushing of the injected drug from the deadspace of the recipient tubing. Utilizing this embodiment, during injection, once the vial piston has been fully advanced against the distal stopper, the proximal stopper is displaced from the end of the drug vial and the fluid which had been received through the vent and stored within the vial proximal the proximal piston is now displaced by the forced movement of the proximal piston back toward the closed end of the drug vial. Flow channels provided within the proximal piston allow displacement and flow of fluid from the drug vial chamber into the now virtually absent mixing chamber and out the distal conduit to flush the syringe, the conduit, and the deadspace of the tubing which is connected to the conduit and which has previously received the drug solution mixture from the conduit. This embodiment, therefore, provides for: 1) enclosed sterile insertion of a handle and piston assembly containing a powdered or liquid drug into a syringe barrel; 2) enclosed wide opening of the drug vial within the syringe barrel; 3) aspiration of diluent into free contact with the now exposed drugs from within the vial and for positive expulsion of all drug from within the vial; 4) aspiration of diluent which can later serve as a flush solution into an enlarging proximal chamber within the drug vial; 5) injection of the mixed drug solution through or around the displaced stopper into the recipient; 6) injection of the flush solution through the distal portion of the syringe and out the distal conduit to flush the syringe, the distal conduit, and at least a portion of the recipient tubing free of drug solution. It can be seen, therefore, that whether a tensile element is utilized or whether the piston handle is connected to the proximal piston, advancement of the proximal piston can be achieved for positive expulsion of the drug and, at the same time, an enlarging proximal chamber is formed within the vial which can receive fluids which can subsequently be displaced back through the distal portion of the syringe to flush the syringe. [0010]
  • In one embodiment, the diluent is contained within the distal portion of the syringe for mixing within the drug vial. In another embodiment, the distal conduit end of the syringe can be connected to a flexible bag containing a specific volume of diluent for aspiration into the syringe which can be stored within or can be a compartment of the main enclosing flexible package for enclosed aspiration. The conduit can be placed in fluid connection with a fluid source through a cannula connected to the distal end of the syringe. Alternatively, the fluid source may be sealingly engaged to the syringe during manufacture and then enclosed in a main flexible package. Further, alternatively, a compartment of the main flexible package containing the diluent can be sealed about the distal end of the syringe to minimize the amount of packaging required while further eliminating exposure during aspiration. A third embodiment utilizes a system wherein the syringe tip is inserted into a receiver having a one-way valve and connected to a multi-dose large volume reservoir of diluent in a hospital pharmacy of I.V. mixing area. When drug mixing is desired, the tip is inserted into the receiver and a specific volume of diluent is aspirated. The maximum aspirated volume can be preset by stops or by the length of the tether. The one-way valve prevents any potential for reflux of mixed drug solution into the reservoir. [0011]
  • In another preferred embodiment, the stopper assembly is provided including a connecting element intermediate the proximal piston and the distal stopper. Like the previous embodiments, the embodiment preferably includes an inner wall defining a main bore and extending to a distal tip and a conduit extending through the distal tip. The distal stopper includes projecting lateral walls for engaging. A seal is preferably provided occluding the conduit adjacent the distal tip. A diluent reservoir is further provided proximal the proximal piston and is preferably contained within the handle of the syringe. The diluent reservoir is preferably a flexible bag of fluid and is comprised of conventional material for making flexible intravenous bags of fluids, such as PVC. A flow passage way which can be a tubular extension of the PVC reservoir, is preferably provided through the proximal piston. The flow passage way is occluded by the distal stopper or can preferably be occluded by a cap which can be extracted from its occluding position along the flow passage way by the distal stopper. In the preferred embodiment, the distal stopper is integral with or is otherwise joined with the cap. The distal stopper preferably includes at least one membrane such as projecting lateral walls engaging as by tight frictional contact the inner wall or walls of the barrel, thereby effectively fixing the position of the distal stopper piston at a maximally advanced position along the barrel which is preferably adjacent the distal end of the barrel, although the position could be midway along the barrel. The flexible fluid reservoir can contain the first pharmaceutical component, which is preferably diluent or liquid drug. A second pharmaceutical component can be contained within the proximal portion of the barrel distal to the maximum advancing position of the distal stopper or can be within a drug vial connectable to a drug vial connector carried by the proximal end of the reservoir. The proximal end of the reservoir can include a reversibly sealed opening for transferring fluid from the reservoir into the drug vial and for transferring mixed drug and fluid out of the drug vial into the reservoir. In operation, the handle which has been advanced to a fully advanced position, is retracted. During retraction of the handle, the handle with its retained reservoir and proximal piston are pulled away from the distal stopper, thereby opening the distal end of the reservoir into the barrel of the syringe. Continued retraction of the handle results in negative pressure developing within the distal end of the syringe, thereby withdrawing fluid from the open end of the reservoir into the barrel. As the fluid is withdrawn, the flexible container collapses until all of the fluid is withdrawn into the barrel, at which time further retraction cannot be accomplished due to the development of a vacuum within the container. Furthermore, a detent can be provided which prevents further retraction to assure that excessive vacuum does not develop within the syringe. The flexible package dynamically collapses, thereby producing a collapsing valve mechanism preventing substantial transmission of negative pressure from the distal end of the syringe to the drug vial; although, such transmission of negative pressure would not have significant adverse consequences with the preferred embodiment in any regard. At this time, all of the mixed fluid and diluent have been displaced into a nascent mixing chamber intermediate the distal stopper and the proximal piston and subsequently this fluid can be injected by advancing the proximal piston, thereby pushing the fluid through the flow channels and the distal stopper and out the distal end of the syringe after the seal has been removed from the distal end of the syringe. A one-way valve can be provided in the flow channel through the proximal piston to prevent reflux or displacement of fluids from the mixing chamber back into the flexible reservoir during injection. [0012]
  • It is the purpose of the present invention to provide a drug injector which can provide long-term storage of powdered or liquid drug and subsequently allow enclosed mixing of this powdered or liquid drug with a diluent within the injector through a large opening to assure complete and easy mixing. It is the purpose of this invention to provide a distal vial stopper which can seal a reservoir or drug vial during storage, but which can provide a flow of fluid through or about the stopper once the reservoir or vial has been inserted into a syringe barrel and once the stopper has been displaced from the vial. It is further the purpose of this invention to provide a drug positioned between a piston stopper assembly connected by a tensile element within a vial so that the drug can be pushed out of the vial into a mixing area by traction on the tensile element. It is further the purpose of this invention to provide a closed drug vial which can be selectively widely opened within a closed container to allow free mixing of the drug contained within the vial with a diluent. It is further the purpose of this invention to provide a drug vial and piston stopper assembly wherein the drug vial first has a closed end containing the drug and wherein the end can be opened so that the drug can mix with a diluent and wherein the end can again be subsequently closed so that the drug vial can function as a deadspace-free piston for injecting the mixed drug solution into the patient. It is further the purpose of the invention to provide a syringe handle containing a drug vial and defining a drug vial piston within the syringe. It is further the purpose of this invention to provide a multi-compartment injection system having a syringe barrel and a piston and including a glass drug vial compartment for long-term storage of a drug, and a second compartment for storage of a specific volume of diluent and wherein the second compartment is sealed and can be positioned inside or outside the syringe so that solution may be displaced into the vial to mix with the drug by retraction of the piston along the barrel and simultaneous unsealing of the vial or the diluent compartment. It is further the purpose of this invention to provide a drug storage, mixing, and injection apparatus which allows long-term storage of a drug within a glass vial comprehensively enclosed mixture within a syringe and then complete positive expulsion of all of the contained drug into a mixing chamber within the syringe. It is further the purpose of this invention to provide a system which allows positive displacement of diluent into a syringe compartment containing powdered drug within an open-mouthed glass vial and subsequent injection of the diluent mixed with the drug utilizing closure and subsequent advancement of the glass vial within the syringe. It is further the purpose of this invention to provide a system and method for the enclosed sterile assembly of a drug mixing syringe and to provide a system for enclosed aspiration of fluid into the syringe for mixing with the drug within a single inexpensive sterile flexible enclosure. It is further the purpose of the invention to provide a syringe which can sequentially aspirate a diluent and flush solution into two separate compartments, provide for drug mixing with the diluent, and then provide sequential injection of the drug solution followed by the flush solution to flush substantially all drug from the syringe and to flush the injection site free of drug solution. For some purposes, it is preferable to provide the diluent in a manner such that the diluent is packaged within a syringe component wherein the drug vial can be packaged external to the syringe and where free and complete mixing between the drug vial and the diluent can be performed within a syringe component. In one feature of the invention, the connection of a sealing capping member of the diluent reservoir to a cap extraction member can fixedly engage a portion of the syringe barrel so that the cap can be extracted from the diluent reservoir by retraction of the diluent reservoir away from the fixed cap extraction member connected to the cap. This allows enclosed opening of a previously sealed diluent reservoir within the barrel of a syringe. In another feature of the invention, the cap extraction member includes flow channels for allowing passage of the mixed drug solution by the cap extraction member and out the syringe. In another feature of the invention, sealing occlusion of the distal tip of the syringe is provided so that negative pressure induced within the syringe withdraws fluid from a compartment proximal to the distal tip of the syringe, thereby withdrawing fluid into the syringe without the need for the fluid to be external and in fluid communication with the distal tip of the syringe. In another feature of the invention, the reservoir of fluid can carry a drug vial engaging member for connecting the drug vial to the diluent reservoir to allow free mixing between the drug vial and the diluent reservoir so that after the drug has been mixed with the diluent, the cap can be extracted by the cap extracting member and the mixed drug solution can be withdrawn into the syringe by negative pressure induced within the syringe barrel. These and other features will become evident from the summary and detailed description described below. Furthermore, these and other objects and advantages of the invention will be further set forth in the description which follows and, in part, will be learned from the description or may be learned by practice of the invention. The objects and advantages of the invention may be realized by means of the instrumentalities and combinations particularly pointed out in the appended claims.[0013]
  • BRIEF DESCRIPTION OF THE DRAWINGS
  • FIG. 1 is an exploded view, in partial cross-section, of a syringe according to the present invention; [0014]
  • FIG. 1A is a top plan view of a distal stopper; [0015]
  • FIG. 1B is a bottom plan view of a distal stopper of FIG. 1A; [0016]
  • FIG. 1C is a cross-sectional view of the proximal and distal stopper and connecting tether; [0017]
  • FIG. 2 is an exploded view, in partial cross section, of a syringe according to the present invention; [0018]
  • FIG. 2A is a perspective view of the detached vial piston end cover; [0019]
  • FIG. 3A is a partial cross-sectional view of the syringe as the plunger or vial piston is being inserted into the barrel; [0020]
  • FIG. 3B is a partial cross-sectional view similar to FIG. 3A, with the plunger fully inserted into the barrel; [0021]
  • FIG. 4A is a partial cross-sectional view similar to FIG. 3A, showing the plunger being retracted; [0022]
  • FIG. 4B is a partial cross-sectional view similar to FIG. 3A, showing the tether fully extended; [0023]
  • FIG. 4C is a partial cross-sectional view similar to FIG. 3A, showing a repositioned proximal stopper which is advanced relative to the retracted drug vial; [0024]
  • FIG. 5A is a partial cross-sectional view similar to FIG. 3A showing the plunger in an injection mode; [0025]
  • FIG. 5B is a partial cross-sectional view similar to FIG. 3A, showing the completion of the injection; [0026]
  • FIG. 6 is an exploded view, in partial cross-section, of another syringe embodiment of the present invention; [0027]
  • FIG. 6A is a top plan view of a distal stopper; [0028]
  • FIG. 6B is a bottom plan view of a distal stopper; [0029]
  • FIG. 6C is an enlarged cross-sectional view of a proximal stopper; [0030]
  • FIG. 6D is an enlarged cross-sectional view of the distal stopper; [0031]
  • FIG. 7A is a cross-sectional view of a vial piston open and ready to be filled; [0032]
  • FIG. 7B is a partial cross-sectional view of the vial piston of FIG. 7A, mounted on a handle in a closed and sealed condition; [0033]
  • FIG. 7C is a top plan view of a sterile package for enclosed assembly and aspiration; [0034]
  • FIG. 8A is a top plan view of another embodiment of a sterile packaging system, according to the present invention, showing a syringe compartment and a liquid compartment; [0035]
  • FIG. 8B is a top plan view similar to FIG. 8A, showing the syringe tip advanced through a weakened sealed section in the package; [0036]
  • FIG. 8C is a cross-sectional view of the package, through [0037] lines 8C-8C, showing the upper and lower planar members;
  • FIG. 8D is a cross-sectional, view through [0038] lines 8D-8D, showing the weakened section between the fluid compartment and the syringe compartment, engaged by the distal tip of the syringe;
  • FIG. 8E is a cross-sectional view, similar to FIG. 8D, showing the syringe tip pushed through the weakened section to enter the fluid compartment; [0039]
  • FIG. 9 is an exploded view in partial section of another embodiment according to the present invention; [0040]
  • FIG. 9A is a top plan view of a distal stopper in the embodiment shown in FIG. 9; [0041]
  • FIG. 9B is a bottom plan view of the distal stopper, shown in FIG. 9A; [0042]
  • FIG. 9C is a cross-sectional view of a distal stopper, taken along [0043] lines 9C-9C of FIG. 9B;
  • FIG. 9D is a top plan view of a proximal stopper in the embodiment of FIG. 9; [0044]
  • FIG. 9E is a cross-sectional view taken along [0045] lines 9E-9E of FIG. 9D;
  • FIG. 9F is a cross-sectional view of the proximal and distal stopper used in FIG. 9 when interengaged during operation; [0046]
  • FIG. 10A is a partial cross-sectional view of the syringe of the embodiment of FIG. 9 with the plunger inserted into the barrel; [0047]
  • FIG. 10B is a partial cross-sectional view of the syringe of FIG. 9 with the drug vial partially retracted; [0048]
  • FIG. 11A is a partial cross-sectional view of the syringe of FIG. 9 with the drug vial fully retracted; [0049]
  • FIG. 11B is a partial cross-sectional view of the syringe of FIG. 9 with the drug vial partially advanced as the mixed drug is injected; [0050]
  • FIG. 12 A is a partial cross-sectional view of the syringe of FIG. 10 at the initiation of the flush sequence; [0051]
  • FIG. 12B is a partial cross-sectional view of the syringe of FIG. 9 with the plunger fully advanced at the conclusion of the drug injection and flushing; [0052]
  • FIG. 13 is an exploded cross-sectional view of a syringe, according to another embodiment of the present invention having an integral drug vial and handle; [0053]
  • FIG. 14 is an exploded cross-sectional view of a syringe, according to another embodiment of the present invention having a voluminous hollow handle reservoir; [0054]
  • FIG. 14A is a top plan view of a distal stopper in the embodiment shown in FIG. 14; [0055]
  • FIG. 14B is a bottom plan view of the distal stopper, shown in FIG. 14A; [0056]
  • FIG. 14C is a cross-sectional view of the bottom and distal stoppers from the embodiment shown in FIG. 14; [0057]
  • FIG. 15 is a cross-sectional view of another embodiment of a syringe, according to the present invention; [0058]
  • FIG. 15A is an enlarged cross-sectional view of a portion of the distal end of the syringe of FIG. 15; [0059]
  • FIG. 15B is a cross-sectional view taken along [0060] line 15B-15B in FIG. 15A;
  • FIG. 15C is a cross-sectional view taken along [0061] line 15C-15C in FIG. 15;
  • FIG. 15D is a cross-sectional view of another embodiment having a drug vial sized to be received within the syringe; [0062]
  • FIG. 15E is a cross-sectional view of the embodiment of FIG. 15D, after the stopper has been displaced into the flexible diluent container; [0063]
  • FIG. 15F is a cross-sectional view of the embodiment of FIG. 15D, showing withdrawal of the handle and displacement of liquid from the flexible container into contact with the syringe barrel; [0064]
  • FIG. 15G is a partial cross-section view according to the embodiment of FIG. 15D, engaging a syringe pump and connecting to a catheter; [0065]
  • FIG. 16 is a partial cross-sectional view of another embodiment of a syringe, according to the present invention; [0066]
  • FIG. 16A is a top plan view of a distal stopper used in the embodiment shown in FIG. 16; [0067]
  • FIG. 16B is a cross-sectional view taken along [0068] line 16B-16B in FIG. 16A;
  • FIG. 16C is a cross-sectional view of the proximal and distal pistons from the embodiment of FIG. 16 when interengaged during operation; [0069]
  • FIG. 17A is a top plan view of a sterile package showing a pleated syringe compartment; [0070]
  • FIG. 17B is a top plan view of the package of FIG. 17A with the syringe handle fully retracted; [0071]
  • FIG. 18A is a cross-sectional view of another embodiment of a syringe, according to the present invention; [0072]
  • FIG. 18B is a cross-sectional view of the embodiment of FIG. 18A with the syringe handle partially retracted; [0073]
  • FIG. 18C is a cross-sectional view of FIG. 18B across lines C-C; [0074]
  • FIG. 18D is a cross-sectional view of the embodiment of FIG. 18A with the handle fully retracted, demonstrating positive drug expulsion and conversion of the open-ended drug vial into a closed-ended piston; [0075]
  • FIG. 18E is a cross-sectional view of the embodiment of FIG. 18A with the handle partially advanced after complete retraction, demonstrating drug solution injection by the now closed-ended drug vial.[0076]
  • DESCRIPTION OF THE PRESENTLY PREFERRED EMBODIMENTS
  • For more easy understanding of the preferred embodiments, reference can be made to the aforementioned co-pending patent application which utilizes, for continuity and convenience, many similar figures and numbers to the presently disclosed invention. With reference to one preferred embodiment of the instant invention, a drug-mixing and injection syringe [0077] 5 (shown disassembled in FIG. 1) has syringe barrel 10 with inner wall 12 and smooth barrel bore 22. The barrel 10 extends to distal tapered end 14. The syringe 5 has a distal tip 18 and distal conduit 26 in fluid connection with bore 22. The syringe 5 further includes handle 34 having a stop 35. A main vial piston 38 is provided including an outer housing 39 and having a distal sealing cover 45 and weakened tear regions 46, and projecting tear tab 48 enclosing a vial 50 having a vial chamber 51 having an inner wall 52 and an outer wall 53. The vial 50 is preferably made of glass. The housing 39 and cover 45 can be comprised of polypropylene or other suitable material. The main vial piston 38 further includes an annular wiper or o-ring 54 for sealingly engaging wall 12 of bore 22. The vial 50 includes a closed proximal end 55 and a distal open end 60. The vial 50 contains a stopper piston assembly 68, including proximal piston 70 and distal stopper 74. The vial piston 38 further includes handle receiving recess 79 for receiving handle distal end 80, as shown in FIG. 1C. Piston 70 and stopper 74 are connected by a tether portion 84 that includes a tether vent channel 86 extending between a proximal vent portion 87 and a distal vent portion 88. Stopper pistons 70 and 74 are preferably comprised of conventional rubber stopper material. The tether 84 is likewise comprised of conventional rubber so that it is compatible with a variety of drugs and is flexible and capable of transmitting tensile force. A silicone tubular rubber insert (not shown) may be used if desired within the tether 84 to provide added strength and reduce stretching. Distal stopper 74 includes a distal face 75 and a lateral projecting portion 76 and a proximal vial sealing portion 77. The wall portion 76 projects beyond the diameter of distal opening 60 and the outer vial wall 52 of the drug vial 50 and includes multiple lateral flow channels 78 extending through the wall 76 and over the face 75. These flow channels do not communicate with the vial chamber 51 since a distal opening 60 of vial 50 is sealed by the side wall of sealing portion 77. Therefore, flow channels 78 do not require a valve or other means for closure when the chamber 51 is sealed by the stopper 74, thereby reducing both the cost of manufacture and the operating complexity. The vial sealing portion 77 seals tightly about the distal vial end 60. The flow channels 78 are formed by the stopper 74 and the barrel wall 12, but can otherwise be provided entirely through the stopper 74.
  • In assembly, the [0078] proximal piston 70 is fully advanced against the closed proximal end 55 of the vial 50. At this time, as shown in FIG. 7A, the tether 84 which preferably is longer than the vial 50 extends out the open end 60 of the vial 50 and the distal stopper 74 is preferably positioned away from the open end 60 of the vial 50 so that the vial 50 can be filled with a powder or liquid drug. Once the drug vial 50 is filled with powder or liquid drug, the vial sealing portion 77 of distal stopper 74 can be slightly compressed and inserted into the open distal end 60 of the drug vial 50 to provide a tight sealing fit. Vial 50 further includes annular retainer 94, and proximal piston stop 96 for tightly retaining the proximal piston 70 in the fully advanced position, as will be described.
  • In operation, when mixture of the drug with a diluent is desired, the cover [0079] 45 (FIG. 2A) is removed by removing tear tab 48, the vial piston 38 is then inserted into barrel 10 (FIG. 3A) and fully advanced against the end 14 of the barrel 10 (FIG. 3B). The distal stopper 74 is radially compressed by the barrel wall 12 to provide a tight friction fit and to fix the stopper 74 in the fully advanced venting position, as shown in FIG. 3B. The distal conduit 26 is then placed in fluid communication with a source of diluent, (such as that shown in FIG. 8B), if a source of diluent is not already attached adjacent the distal end 18 of the syringe. The handle 34 is then retracted (FIG. 4A). As the handle 34 is retracted, the drug vial 50 is extracted away from the distal stopper 74 since the distal stopper 74 is tightly held by tight compressive frictional engagement of the laterally projecting portion 76 with the barrel wall 12.
  • The retraction of the [0080] vial 50 forms a nascent mixing chamber 90 intermediate the vial 50 and the distal stopper 74. The displacement of the distal stopper 74 out of sealing engagement with vial opening 60 completely opens the vial chamber 51 into the enlarging nascent mixing chamber 90.
  • During this time, the negative pressure within the mixing [0081] chamber 90 caused by retraction of the handle 34 causes diluent fluid to pass through conduit 26, through the flow channels 78 of the distal stopper 74 and on into the mixing chamber 90. As the mixing chamber 90 is enlarged, continued circumferential fluid flow enters the mixing chamber 90 through the flow channels 78. As the handle 34 is further retracted, tether 84 becomes fully extended, as in FIG. 4B. After tether extension, further retraction of the handle 34 causes the vial 50 to be moved relative to the now fixed proximal piston 70 so that the proximal piston 70 advances and slides along inner wall 52 relative to the vial 50, thereby reducing vial chamber 51. This expels any liquid or solid contents held within vial chamber 51 into the mixing chamber 90. When piston handle 34 has been fully retracted (FIG. 4C), proximal piston 70 engages stop 96 and is retained within the distal end 60 of the drug vial 50 by stop 96 and by retainer 94. In this position,, as in FIG. 4C, proximal piston 70 now functions as a stopper and sealingly occludes distal end 60 of drug vial 50, thereby converting the formerly widely open drug vial 50 into a closed injection piston 100 (FIG. 5A and FIG. 5B). During relative advancement of the proximal piston 70 along vial wall 52, fluid can flow through the tether vent channel 86 from the conduit 26 into the enlarging reservoir 104 proximal to the piston 70 within vial 50. This will fill the reservoir 104 with diluent. The syringe 5 can then be rocked or rolled to facilitate mixing. Gas can be initially provided in the vial 50 with the drug during initial manufacture and filling to enhance mixing after expulsion of the air from the vial chamber 51 along with the drug into the mixing chamber 90. All of the drug and solution is now contained within the mixing chamber 90 and, therefore, should be visible through the barrel 22, which is preferably comprised of relatively transparent polypropylene. This is advantageous since residual clumps of powdered drug might otherwise be contained within the drug vial 50 and adequate mixing would not, therefore, be easily confirmable by visible inspection.
  • Some air, which was formerly present in the distal conduit and/or the [0082] drug vial chamber 51 will also be present within the mixing chamber 90 and will also allow for agitation of the mixing chamber 90 to assist in mixing of the drug and diluent.
  • To further facilitate adequate mixing, the syringe can be positioned so that the [0083] distal tip 18 is in an upward position and the handle 34 can be moved back and forth to facilitate mixing. Retraction of the handle 34 is preferably limited by a proximal handle detent 110 along barrel 10 which is positioned so that tether 84 is fully extended when proximal detent 110 is engaged by the handle stop 35. This engagement prevents excessive tensile force from being transmitted to the rubber tether 84 and assists in fixing the volume of diluent for mixing with the drug.
  • Once adequate mixing has been achieved and with the [0084] distal tip 18 in the upright position, any residual air can be expelled. The drug solution can then be injected (as depicted by the arrows (in FIG. 5A and FIG. 5B) or the syringe 5 can be capped for transport from the pharmacy to the nursing station for subsequent use.
  • In a preferred embodiment (shown in FIG. 7C), the [0085] syringe barrel 10 and the piston handle 34 and vial piston 38 are enclosed within a single sterile flexible plastic envelope 120 in an unassembled configuration with an attached cannula 122 and a cannula cover 124. The plastic envelope 120 is preferably of conventional flexible transparent and medically sterilizable material, such as polyethylene or polyvinylchloride, so that the syringe handle 34 and syringe barrel 10 may be manipulated within the material for enclosed assembly within the envelope 120. In operation, the projecting tear tab 48 is grasped by the thumb and forefinger through the flexible envelope 120 and the tear tab 48 is held in position while the syringe handle 34 is rotated until the cover 45 is separated from the vial piston 38. The tear tab 48 can be 1.5 - 2 centimeters or larger in length to provide ease in grasping through the envelope 120. The handle 34 and the barrel 10 are then grasped and aligned within the envelope 120. The envelope 120 is provided with sufficient length so as to allow room for such alignment. The handle 34 is then inserted into the barrel 10 and advanced until the distal stopper 74 engages the distal end 14, as previously discussed. Assembly is then complete. The envelope 120 can then be opened, removed, and the conduit 26 placed in fluid communication with a source of diluent for aspiration of diluent into the syringe 5.
  • Alternatively, as in FIG. 7C, [0086] envelope 120 can include a compartment 130 containing a sterile diluent, such as a saline or dextrose solution, and a syringe compartment 140 containing the syringe 5 components separated from the fluid compartment 130 by a thermoformed seal or bond 145. A membrane or septum 146 intermediate the compartments can be provided for penetration by the distal tip 18 or an attached cannula 122 so that diluent could be directly aspirated from within the diluent compartment 130 and so that the entire process could be accomplished within a completely enclosed sterile environment. Alternatively, an inexpensive diluent container, as for example, a molded polypropylene bottle (not shown) can be enclosed with the syringe components in the main envelope 120.
  • In a further embodiment (not shown), the [0087] syringe tip 18 may be sealingly capped and packaged with the distal tip 18 projecting into, and sealed within, the diluent or fluid compartment 130. This allows simplified packaging by placing the syringe tip 18 in a position such that the dividing seal 145 between the syringe compartment 140 and the diluent compartment 130 extends across and includes the distal tip 18. With this embodiment, the fluid compartment 130 may be only partially distended so that the syringe cap or cover 124, which can include an additional sealing cover (not shown), can be easily grasped through the fluid and envelope 120 and removed to unseal conduit 26 at tip 18 when aspiration of fluid is desired. Once disengaged from tip 18, the cap or cover 124 can be discarded within the compartment 130.
  • This comprehensively enclosed system is especially useful when the contained drug is a chemotherapeutic agent, thereby greatly eliminating occupational exposure of even minute amounts of chemotherapeutic drugs wherein cumulative occupational exposure may be hazardous to the healthcare worker. It is further advantageous to utilize such assembly of the [0088] syringe 5 within envelope 120 when the syringes are being prepared and the drugs are being mixed within the syringes at a site remote from the site of the syringes intended use or when there will be a significant delay between assembly and use. Examples include home healthcare, mobile intensive care units, emergency medicine mobile units, and in hospitals when preparation is performed in a centralized pharmacy for distribution to floor units.
  • It can be seen that unless subsequent resterilization is contemplated, assembly of a syringe utilizing a sterile piston and handle and a sterile barrel must be accomplished with care and generally must be accomplished with sterile gloves and masks. This is so since contact or droplet contamination of the handle could subsequently result in contact contamination of the barrel, which later may be filled with solution, thereby resulting in contamination of the solution. In addition, during storage, organisms can potentially enter a stored assembled syringe from the barrel side and contaminate the syringe, especially if use of the syringe is delayed. It would therefore be preferable, in situations described above, that the syringe be assembled and the drug mixed with solution while the syringe is maintained within the original sterile container. This effectively eliminates the need to repackage the syringe for later use, minimizes packaging cost and expense, and further eliminates the need for assembly personnel to wear masks and gloves while handling the syringe and substantially reduces the risk of potential for exposure of the assembly personnel to drugs or other potentially toxic material which may be reconstituted within the syringe. It should also be noted that liquid other than a diluent can be utilized and withdrawn into the syringe. For example, a drug solution which can subsequently be mixed with the powdered or liquid drug within the vial can be provided and subsequently drawn into the syringe for mixing, as described for the diluent. [0089]
  • In a further embodiment (as shown in FIG. 8A) for inexpensive enclosed packaging and preparation, the [0090] syringe 5 is shown after assembly within a sealed, sterile transparent envelope 120′ with the cover 45 removed from the vial piston 38 and the vial piston 38 inserted into the barrel 10. Envelope 120′ includes a syringe chamber 140′ and a liquid chamber 130′. The envelope 120′ is preferably comprised of two planar sheets (FIG. 8C) of polyvinyl chloride, an upper sheet 122′ and a lower sheet 124′. These sheets are bonded or thermoformed to enclose the syringe compartment 140′ and the liquid compartment 130′. A recess 144′ is provided intermediate the liquid compartment 130′ and the syringe compartment 140′. A weakened sealed region 146′ (shown in FIG. 8D) is provided adjacent the liquid compartment 130′ and the recess 144′. In operation, after the cover is removed from the vial piston 38 and the vial piston inserted into the barrel 10. Then, shown in FIG. 8D and FIG. 8E, the syringe tip 18 may be inserted into the recess 144′ and subsequently wedge apart the weakened region 146′ to enter the liquid compartment 130′. At this time, the handle 34′ can be retracted to draw fluid into the syringe 5. If preferred, another envelope 120″ (such as is shown in FIG. 17A) can be provided with a pleated, bunched, folded portion 150″, or otherwise redundant portion to facilitate retraction of the handle 34. A tear or weakened portion 121″ can be provided so that the envelope 120″ can be removed once the fluid has been withdrawn into the syringe 5 and the drug properly mixed with the fluid. It can be seen that utilizing this comprehensive packaging system, the entire process can be complete without exposing the syringe 5 to potential contamination to the environment and without exposing the preparing personnel to even minute quantities of drug.
  • Another preferred embodiment is shown in FIG. 6. This embodiment utilizes a [0091] cylindrical drug vial 50′ which is open at the distal end 60′ and the proximal end 55′. A distal piston 74′ having circumferential flow channels or slots 78′, as described for the previous embodiment, is sealingly received into the distal end 60′ of vial 50′. A proximal piston 70′ includes a handle recess 79′ for threadingly receiving a threaded end 80′ of syringe handle 34′. The proximal piston 70′ is sealingly received into the proximal end 61′. A cover 45′ having weakened areas 46′ and a tear tab 48′ is provided over the proximal piston 70′ and extends over the distal stopper 74′. Upon removal of the tear tab 48′ along the weakened areas 46′, the entire cover 45′ can be removed from the vial piston 38′. Alternatively, separate proximal and a distal covers (not shown) could be provided with two separate tear tabs. A barrel 10′ is provided with bore 22′ having interior wall 12′ for receiving the vial piston 38′. A stop 35′ can be provided on handle 34′ to preset the volume of diluent to be aspirated into the barrel 10′, as will be described.
  • In assembly, a covered drug [0092] vial piston assembly 38′, the handle 34′, and the barrel 10′ are preferably enclosed within a sterile envelope, as previously shown in FIG. 7C. If desired, at least one portion of the envelope can include a region permeable to gas, such as Tyvek™, (not shown) for gas sterilization, as is known in the art. As noted previously, the sterile envelope is flexible and comprised, for example, of a material such as polyethylene or polyvinyl chloride, so that the components within the envelope can remain sterilely sealed yet be easily grasped, manipulated, and assembled therein.
  • In operation, the [0093] tear tab 48′ is grasped and the tear tab 48′ and cover 45′ are removed from the vial piston assembly 38′ The handle 34′ is then inserted into recess 79′ which can be threaded, as shown, to receive the handle end 80′ without substantial longitudinal force exerted against the proximal piston 70′. If preferred, the tear tab 48′ is located adjacent proximal piston 70′ of the vial piston assembly 38′ so that the proximal portion of the cover 45′ could first be removed, handle 34′ threadably received into the recess 79′, and handle 34′ grasped for more easy removal of the distal portion of the cover 45′ through a flexible envelope (such as is shown in FIG. 8A). Once the entire cover 45′ is removed, the piston assembly 38′ and its attached handle 34′ are inserted into the barrel 10′ and fully advanced to the end of the barrel 14′. As described in the previous embodiment, the projecting lateral wall 76′ of distal stopper 74′ is of greater diameter than the barrel bore 22′ so that the lateral wall 76′ can be pressed very tightly against the interior wall 12′ of the barrel 10′. This assures a tight friction fit between the distal stopper 74′ and the barrel 10′ so that, while the piston 74′ can be slidingly advanced by force along the barrel 10′ to the distal end 14′. Once positioned at the distal end of barrel 10′, piston 74′ will stay in place. Consequently, upon retraction of the handle, vial 50′ will be extracted away from the distal stopper 74′ since the position of distal stopper 74′ is fixed by the tight fit against the barrel wall 12′. As the handle 34′ is retracted, the distal end 60′ is pulled away from stopper 74′, thereby widely opening drug vial 50′ and forming a mixing chamber intermediate the open-ended drug vial 50′ and the distally retained distal stopper 74′, as described and shown in the previous embodiments.
  • During this time, fluid can flow through the [0094] flow channels 78′ adjacent the distal stopper 74′ to fill the mixing chamber and to mix drug with the fluid entering through the flow channels 78′. When the handle 34′ syringe has been fully retracted to draw the desired fluid volume into the syringe, the syringe can be agitated to mix the drug with the fluid. The syringe conduit 26′ can then be placed in fluid connection with the intended recipient of the drug and the piston handle 34′ can be advanced. As piston handle 34′ is advanced, fluid exits the flow channels 78′ adjacent the distal stopper 74′.
  • The [0095] proximal piston 70′ can be sized so that the frictional fit against vial wall 52′ induces less resistance to advancement than the frictional fit of the wiper 54′ against the inner barrel wall 12′. Therefore, upon advancement of the handle 34′, the proximal piston 70′ first advances along vial wall 52′ until it is fully advanced to seal the distal end 60′ of vial 50′. Retaining detents 94′ can be provided to retain the proximal piston 70′ in its fully advanced position at opening 60′ against piston stop 96′. At this time, further advancement of handle 34′ will cause the entire vial 50′ with fully advanced piston 70′ to advance, thereby continuing the injection of fluid from the mixing chamber out the conduit 26′ and into the intended recipient.
  • It is clear that many modifications may be made within the scope of this teaching. For example, diluent could be stored within a portion of the syringe, rather than external to the syringe. A bypass region and detents could be provided along the syringe barrel to provide the flow channel function, positioned at the distal end or midway along the syringe. The syringe handle could be positioned within the barrel during storage. Hooks could be provided along the wall of the syringe for catching the tear tabs upon rotation or advancement of the handle so that the tear tab and sealing cover is automatically displaced from the distal end of the syringe upon engagement of the hooks and rotation or advancement of the handle, thereby separating the tight seal between the drug vial and the cover within the syringe barrel. A tether valve can be provided within the distal stopper, as described in the aforementioned Patent Application #[0096] 08/196,455 to allow a flow channel through the distal stopper when the distal stopper is fully advanced against the end of the syringe. The sealing fit of the distal stopper can be adjusted so that it is quite tight and the sealing fit of the proximal piston within the drug vial can be adjusted so that it is quite loose, thereby assuring that the distal stopper will be retained in the distal end as the tether pulls the proximal stopper piston along the drug vial to expel the drug into the mixing chamber. It can be seen that, with such an embodiment if a tether and a valve are provided, the tether need not be connected to the valve, but rather the valve may be designed to open on contact with the distal end and remain open with the tether being otherwise connected to the upper face of the distal stopper.
  • Another preferred embodiment, shown in FIG. 9, utilizes the previously described flow of liquid through the vent to allow storage of liquid within a proximal portion of the syringe for subsequent injection after the injection of the drug solution, thereby flushing the syringe and the injection site free of drug solution. A [0097] syringe barrel 10″ is provided with bore 22″ and inner wall 12″. The handle 34″ continues to include a stop 35″. The handle is connected to a vial piston assembly 38″ having a polymeric portion 39″ and a glass drug vial 50″ with a closed proximal end 55″ and an open distal end 60″. The vial piston 38″ includes cover 45″ having tear tab 48″. The vial piston 38″ further includes a thin circumferentially extending rubber wiper sleeve 54″. A proximal stopper piston 70″ is provided connected by a tether 84″ to a distal stopper 74″. The distal stopper 74″ includes vial sealing portion 77″ which seals tightly about inner vial wall 52″ at opening 60″. The vial sealing portion 77″ further includes a series of longitudinal slots 150 which extend to a distal end 156. A projecting wall portion 76″ is provided having radially projecting flow channel slots 78″. These radial slots 78″ are provided about the entire perimeter of the lateral wall portion 76″ so as to provide complete circumferential fluid influx for more complete and rapid mixing of drug with the fluid to provide circumferential afflux of fluid to allow the drug solution to exit uniformly, and for the complete circumferential flush of drug solution from the syringe 10″.
  • The [0098] proximal piston 70″ includes several flow channels 160 and a contact-activated longitudinal slit valve 164 which includes longitudinal slit 168. The entire proximal piston 70″, including the slit valve 164, is preferably comprised of conventional rubber stopper material. The slit valve 164 extends to tip 170. The slit 168 is tightly closed at rest, preventing flow of fluid through from channel 160 out slit 168 and further preventing flow in the reverse direction through slit 168 and into flow channel 160.
  • [0099] Slit valve 164 will open upon forceful contact of tip 170 against distal stopper 74″, as shown in FIG. 9F. This allows free fluid communication between flow channels 160 and slots 150. The slit valves preferably cannot be completely compressed so as to horizontally close slit 168 even with high pressure against distal piston 74″. This can be provided by including thickened walls 166 which provide resistance to excessive longitudinal compression, as shown in FIG. 9F. Further, this provides for a space 180 between proximal piston 70″ and distal piston 74″, allowing free flow of fluid into longitudinal slots 150, as will be described.
  • [0100] Tether 84″, which again includes a tether vent, (as illustrated in previous embodiments), is provided intermediate the proximal piston 70″ and the distal piston 74″, thereby connecting together the proximal piston vent portion 87″ and distal vent portion 88″. The distal vent portion 88″ can be compressed and closed by radial compression of the vial sealing portion 77″, as by sloping inner vial wall 52″ adjacent the distal vial end 60″ when the stopper 74″ is sealingly engaged with the vial 50″, as shown in FIG. 9.
  • In operation, the [0101] piston assembly 38″ is loaded into the barrel 10″ and advanced, as shown in FIG. 10A. Distal conduit 26″ is then connected to a source of diluent (if the source of diluent is not already attached to the distal conduit end) and the handle 34″ is retracted and the diluent is withdrawn into the syringe 5″ since stopper 74″ is retained by tight frictional fit with the wall 12″ and, thereby the drug vial 50″ is extracted away from the stopper 74″. As described for the previous embodiments, diluent flows through flow channels 78″ defined by wall portions 76″ and barrel wall 12″ and into a nascent mixing chamber 90″. With continued retraction, the tether 84″ becomes extended (FIG. 11A), applying tensile force to the proximal piston 70″ and effectively advancing the proximal piston 70″ along the drug vial 50″.
  • As the [0102] proximal piston 70″ advances along the drug vial 50″, a nascent flush fluid chamber 104″ is formed within drug vial 50″, intermediate the closed end 55″ of drug vial 50″ and the proximal piston 70″. When aspiration is complete, mixing chamber 90″ is filled with diluent and drug and the flush chamber 104″ is filled with flush solution. The syringe 5″ is now ready for sequential injection and flush, as in FIG. 11B. The distal conduit 26″ is placed in fluid connection with a receiver, such as an intravenous saline well, as shown in the aforementioned patent application Ser. No. 08/196,455. The handle 34″ is then advanced (FIG. 12) and the drug solution is injected into the recipient. The drug solution flows from the mixing chamber 90″ through the flow channel slots 78″ and out the conduit 26″. When slit valve 164 contacts the distal piston 74″ (as in FIG. 12A and FIG. 12B), the slits 168 open, allowing fluid connection between space 180 and flush compartment 104″ through flow channels 160. As the handle 34″ is further advanced, the vial 50″ passes over distal stopper 74″, pushing proximal piston 70″ in a proximal direction, this compresses flush chamber 104″ within vial 50″ to force fluid out flow channels 160 through slits 168 and into space 180, whereby the fluid flows through the distal stopper slots 150 and the adjacent drug vial wall 52″ until the fluid escapes past distal end 60″ of the drug vial and out radial slots 78″ and distal stopper 74″ and then through conduit 26″. This effectively flushes the residual drug from syringe 5″ and further flushes the distal conduit 26″ and its connecting receiver (such as a saline well, not shown) free of drug, thereby completing the drug injection and flush maneuver with a single piston advancement.
  • It is clear that many modifications may be made to the aforementioned exemplary embodiments. For example, in another embodiment (shown in FIG. 13), a [0103] drug vial 250 is integral with a handle 234 and detents 220 are provided along barrel 210 for retaining the distal stopper 274 in a distal venting position adjacent bypass vents 278. In another embodiment (as shown in FIG. 14), the handle 234′ can be hollow and contain a large sealed chamber 230′ which can store and provide the sterile gas or liquid to relieve the negative pressure within the drug vial 250′ when the proximal piston 270′ is advanced along the drug vial 250′. This eliminates the need for a tether vent in tether 284. The large volume within the handle 234′ allows the proximal piston 270′ to advance with minimal negative pressure development within the drug vial 250′ and handle 234′, thereby facilitating ease of advancement while maintaining a sealed environment. The handle 234′ could alternatively store flush solution and a one-way valve (not shown) could be provided intermediate the vial 250′ and the sealed handle chamber 230′ so that fluid transferred into the vial 250′ from the handle 234′ can later be selectively displaced into the barrel 210′, as through slit valves in the proximal piston (as shown in the previous embodiment) for subsequently flushing of the syringe 205′ after drug injection. Another embodiment (FIG. 16) shows contact-activated flush valves 464 on both the proximal piston 470 and the distal stopper 274″. This type of valve can be used to replace the tether valve of my aforementioned patent application Ser. No. 08/196,455.
  • A further preferred embodiment is shown in FIG. 15. A drug-mixing and injection syringe has a [0104] syringe barrel 10″′ with inner wall 12″′ and a smooth barrel bore 22″′. The barrel 10″′ extends to distal tapered end 14″′. The syringe 5″′ has distal tip 18″′ and distal conduit 26″′ in fluid connection with bore 22″′. The conduit 26″′ is occluded by a sealing cap or cover 19. The syringe further includes handle 34.′. which includes a pair of opposing rigid support members 300 (which are also shown in FIG. 15C) extending to a distal retainer 310 for connection to the proximal piston 70″′. The support members 300 extend to a proximal end 320 which is bonded to drug vial receiving member 324 for receiving drug vial 50″′ having sealing plug 330. The handle 34″′ further includes a flexible diluent reservoir 350 having a distal end 354 and a proximal end 358 and a folded or gathered region 359 adjacent the proximal end 358. The proximal end 358 is occluded by reservoir plug member 360 having a finger contact rim 364 and a including a male vial plug engaging member 368 for retentive engagement with vial plug 330. The support members 300 are spaced apart to define intermediate finger contact windows 366 for allowing direct finger contact of flexible reservoir 350 adjacent contact rim 364 to allow easy displacement of plug 360, as will be discussed.
  • The [0105] flexible fluid reservoir 350 includes a inner chamber 370. The inner chamber 370 is in fluid connection with tube 374 (FIG. 15A), defining a lumen 378 extending to a distal lumen opening 380. A one-way valve 384, shown generically in FIG. 15A, is provided within the lumen 378 for occluding the lumen 378. The one-way valve 384 can be one of any number of conventional one-way valves which are opened by relative negative pressure distal the one-way valve 384 and which are closed by relative positive pressure distal the one-way valve 384. For example, a ball and cage valve, a flap valve (as utilizing a thin, flexible polymeric or rubber flap, the deflection of which is responsive to a pressure differential across the flap), or other conventional valve may be utilized. The lumen 378 of tube 374 is occluded by sealing cap 390 connected to distal stopper 74″′. As described for the previously discussed embodiments, a piston stopper assembly 68″′ is provided and shown enlarged in FIG. 15A. The piston stopper assembly 68″′ includes distal stopper 74″′ and proximal piston 70″′. Prior to use, distal stopper 74″′ and proximal piston 70″′ are connected by tube 374, which thereby comprises a connecting element. As with the previous embodiments, distal stopper 74″′ includes radial flow channels or slots 78″′. The distal stopper 74″′ has a diameter which is greater than the diameter of bore 22″′ so that distal stopper 74″′ is compressably received within bore 22″′ to provide a tight frictional fit against inner wall 12″′. Distal stopper 74″′ is, therefore, fixedly engaged with inner wall 12″′ after distal stopper 74″′ has been forcibly advanced to the maximum position within the barrel 10″′ adjacent barrel end 14″′.
  • As shown in FIG. 15D, a [0106] flange 395 may be provided adjacent the drug vial 350 to allow the drug vial 350 and handle 34″′ to be more easily retracted and advanced. The flange 395 can be sized to be received within an automatic, mechanical, or electronic syringe pump 398 (FIG. 15G). Furthermore, as shown in FIG. 15D, the drug vial 350 can be sized to be slidably received within the syringe barrel 10″′ for more conventional operation and ease of interface with conventional syringe pumps. If preferred, for interfacing with syringe pumps, a neck (not shown) having the configuration of a conventional syringe handle can be provided intermediate the flange 395 and adjacent the drug vial 350 to facilitate operation with conventional syringe pump designs.
  • In operation, [0107] drug vial 50″′ with the attached sealing plug 330 is threadably engaged with the drug vial retainer 324 so that plug 330 is tightly retained about reservoir plug 360 (FIG. 15E) prior to complete insertion into barrel 10″′ of handle 34″′. The user can then contact plug rim 364 through windows 366 and advance plug 360 distally so that the reservoir plug 360 and the retained vial plug 330 are displaced away from vial opening 60″′. Diluent from reservoir 370 can then freely flow into drug vial chamber 51″′ through opening 60″′ to mix the drug formerly retained within the vial 50″′ and the diluent formerly retained within the reservoir 350. Free flow of diluent and mixed solution can be achieved through the large vial opening 60″′. The syringe 5″′ can be rocked and rolled so as to provide complete mixing. Once mixing is complete, handle 34″′ can be grasped and retracted. Retraction of handle 34″′ will cause proximal piston 70″′ to be displaced away from the retained distal stopper 74″′ so that cap 390 is disengaged from tube 374.
  • In addition, negative pressure within [0108] bore 22″′ will develop since conduit 26″′ is sealed by cap 19. This will open one-way valve 384 to cause the mixed drug solution contained within the reservoir 350 and vial 50″′ to flow into the syringe barrel bore 22″′ through the now opened lumen 378. Once all of the fluid has been displaced into the barrel 22″′, further retraction of handle 34″′ is inhibited by the development of negative pressure within the barrel 22″′ distal to piston 70″′. The retraction maneuver is preferably performed with the syringe 5″′ in a position wherein the distal tip 18″′ is directed downward to assist in the free flow of fluid out lumen 378 and into contact with inner barrel wall 12″′. Upon complete withdrawal of handle 34″′ (FIG. 15F), flexible reservoir 350 has collapsed, effectively reducing the transmission of negative pressure from within the syringe barrel 22″ to within the drug vial 50″′, although such transmission of negative pressure is not seen as detrimental with the presently preferred embodiment. After the mixed drug solution has been drawn within bore 22″′ into contact with the barrel wall 12″′ distal the retracted proximal piston 70″′, the drug solution is ready for injection. Distal tip cap 19 can then be removed and conduit 26″′ placed in fluid connection with the intended recipient of the drug solution for subsequent injection of the drug solution. The drug solution is injected by advancing handle 34″′, thereby advancing proximal piston 70″′. During advancement, positive pressure within bore 22″′ distal the proximal piston 70″′ causes the one-way 384 to close so that drug solution does not reflux through lumen 378 back into reservoir 350. A potential to reduce development costs by interfacing with a variety of conventional drug vial systems provides a substantial value to this present embodiment.
  • A further embodiment (shown in FIG. 18A), functions in a manner similar to the embodiment of FIG. 6, but having the advantage of providing for positive displacement of a proximal piston along an inner drug vial wall to displace the drug from the drug vial, as will be discussed. This embodiment, (numbered similar to FIG. 6, but with 600s) utilizes a [0109] vial piston assembly 638 including a cylindrical drug vial 650 which is open at a distal end 660 and a proximal end 661. A distal piston 674 having circumferential flow channels or slots 678 is sealingly received into the distal end 660 of vial 650. The proximal piston 670 is sealingly received into the proximal end 661. A barrel 610 is provided with a bore 622, having an inner wall 612 for receiving a slideable rubber, circumferential, sealing wiper 654 surrounding the drug vial 650. A handle 634 is provided, having distal retainers 636 for retaining the handle 634 within the circumferential wiper 654. A stop-rod 680 is provided, having a pair of proximal stops 682 and a threaded distal end 684. The threaded end 684 is sized to be threadably received within proximal stopper 670. The stop-rod slides within opposing slots 685 and 686 along handle 634. The length of slots 685 and 686 is equal to the relative displacement length of the proximal piston 670 along drug vial 650, as will be described. The stops 682 are sized to engage a proximal detent 688 along barrel 610 upon retraction of handle 634. The operation of this embodiment is quite similar to the embodiment of FIG. 6, except that this syringe 605 provides positive displacement of the contents of drug vial 650 into the mixing chamber 690 upon retraction of handle 634, as will be discussed.
  • In initial assembly, the [0110] handle 634 and attached vial piston assembly 638 is loaded into the syringe barrel 610 and fully advanced to the distal tapered end 614. As previously discussed for earlier embodiments, the distal stopper 674 has a greater diameter than the syringe barrel bore 622 so that the distal stopper 674 is compressed by the syringe barrel 610 to provide tight frictional engagement in the maximally advanced position of FIG. 18A. Withdrawal of handle 634, as in FIG. 18B, causes drug vial 650 to be displaced away from distal stopper 674 to widely open the drug vial chamber 651 into a nascent mixing chamber 690. In addition, retraction of handle 634 causes negative pressure to develop in chamber 690 and thereby causes fluid to flow through conduit 626 and through slots 678 into mixing chamber 690. During the retraction of handle 634 and the attached drug vial 650, the stop-rod 680 is slidably displaced along slots 685 and 686. As shown in FIG. 18D, further retraction of handle 634 and the attached vial 650 causes stops 682 to engage annular detent 688, thereby causing positive relative advancement of stop-rod 680 and the attached piston 670 along drug vial wall 652 and past drug vial detent 694 so that the proximal piston 670 is retained adjacent the distal end 660 of drug vial 650. Once handle 634 has been fully retracted and stop-rod 680 and attached proximal piston 670 has been fully advanced along drug vial wall 652, substantially all of the drug formerly contained within drug vial chamber 651 has been positively expressed into nascent mixing chamber 690. The syringe 605 can then be agitated to facilitate mixing.
  • When injection is desired, the [0111] distal conduit 626 through distal tip 618 can be placed in fluid connection with the intended recipient. The handle 634 is then advanced. The proximal piston 670 and the stop-rod 680 are prevented from proximal displacement by retainer 694. Alternatively, complementing detents (now shown) could be provided along the slots 685 and 686 and stop-rod 680 to prevent displacement of the proximal piston 670 once the proximal piston 670 has been advanced along the vial 650, thereby eliminating the need for the vial retainers 694. During advancement, the drug solution contained within mixing chamber 690 is pushed through slots 678, out conduit 626, and into the intended recipient. It can be seen that the operation of this embodiment allows positive displacement of substantially all drug out of a drug vial 650 and into a mixing chamber 690 within a syringe 605 with a single handle 634 retraction maneuver. The embodiment further does not require the use of a tether, as described for some of the previous embodiments. This embodiment, therefore, has the advantage of simplified operation and manufacture. Markers or detents (not shown) can be provided along the handle 634 and the syringe barrel 610 for indicating that complete withdrawal and locking of the proximal piston 670 in the fully advanced position of FIG. 18D has been achieved.
  • Although the presently preferred embodiments of this invention have been described, it will be obvious to those skilled in the art that various changes and modifications may be made therein without departing from the invention. Therefore, the claims are intended to include all such changes and modifications which may be made therein without departing from the invention. Therefore, the claims are intended to include all such changes and modifications that fall within the true spirit and scope of the invention.[0112]

Claims (49)

1. A drug-mixing syringe comprising:
a. a barrel and a main bore, the barrel having a distal end and an opening through said distal end in fluid connection with said bore;
b. a drug vial having a longitudinal axis and distal end having an opening therein defined by an outer wall adjacent said end, said drug vial being sized to be slidingly received within said barrel;
c. a stopper having a distal face and a proximal face and being sized to be received within the open distal end of said drug vial and to occlude said distal end, said stopper defining an axis and including a distal portion having at least one member for engaging said barrel, said member projecting beyond at least a portion of said outer wall of said drug vial when said drug vial and said stopper are inserted into said barrel bore, said stopper defining at least one flow channel extending adjacent said distal portion when said stopper is received into said barrel so that when fluid flows through said barrel, fluid can flow through said flow channel.
2. The drug-mixing syringe of
claim 1
wherein said distal portion has a transverse width greater than the width of the drug vial and wherein said flow channel extends through said stopper.
3. The drug-mixing syringe of
claim 1
wherein said flow channel is free from communication with said drug vial chamber when said stopper is sealingly received into said drug vial.
4. A drug-mixing syringe comprising:
a. a barrel having an inner wall and a main bore, the barrel having a distal end and an opening through said distal end in fluid connection with said bore;
b. a fluid reservoir sized to be received within said bore;
c. a distal stopper carried by said reservoir and occluding said reservoir, at least a portion of said distal stopper engaging said barrel wall to retain said distal stopper in a fixed position along said bore after said reservoir and stopper have been advanced into said bore, so that after said reservoir has been so advanced and when said reservoir is subsequently retracted along said bore, said stopper is displaced away from sealing engagement with said reservoir to define an opening in said reservoir and to open said reservoir within said barrel so that fluid may flow within said barrel from said reservoir through said opening.
5. The drug-mixing syringe of
claim 4
wherein said stopper includes at least one projecting member for engaging said barrel wall.
6. The drug-mixing syringe of
claim 4
wherein said stopper defines at least one flow channel when said stopper is received into said barrel.
7. The drug-mixing syringe of
claim 4
further including a piston assembly, the assembly including said distal stopper and a proximal piston and a connecting element intermediate said stopper and said piston.
8. The drug-mixing syringe of
claim 4
wherein a cap is provided in sealing engagement with said reservoir and wherein said stopper is connected to said cap so that when said reservoir is displaced away from said stopper, said cap is displaced from sealing engagement with said reservoir to open said reservoir within said barrel.
9. The drug-mixing syringe of
claim 4
further including a handle connected to said reservoir, said handle carrying said reservoir.
10. The drug-mixing syringe of
claim 7
wherein said connecting element is a conduit in fluid connection with said reservoir and including a one-way valve along said conduit, said valve being responsive to a difference in pressure across said valve, said valve opening when the pressure within the barrel is less than the pressure within the reservoir, said valve closing when the pressure within the barrel is greater than the pressure within the reservoir.
11. The drug-mixing syringe of
claim 9
wherein said handle is connected to said proximal piston and wherein said proximal piston is sealingly engaged with said barrel such that, when said handle is retracted and said proximal piston is retracted along said barrel, the pressure is reduced within said barrel relative the pressure within said reservoir so that fluid is displaced along the pressure gradient out said reservoir and into said barrel distal to said proximal piston.
12. The drug-mixing syringe of
claim 9
further including a drug vial receiver carried by said handle for connecting said drug vial with said reservoir.
13. A drug-mixing syringe comprising:
a. a barrel and a main bore, the barrel having a distal end and an opening through said distal end in fluid communication with said bore;
b. a drug vial having an open distal end and a proximal end;
c. a stopper occluding said distal end of said drug vial;
d. said drug vial being sized to be received within said barrel and to be advanced along said barrel to an advanced position adjacent said distal end of said barrel, said stopper being sized to engage said barrel and to be retained by said barrel adjacent said distal end of said barrel, said stopper in said advanced position being fixedly engaged with said barrel adjacent said distal end so that after said vial and said stopper have been advanced within said barrel to said advanced position, said vial is displaced away from said retained stopper when said vial is retracted along said barrel to open said vial within said barrel.
14. The drug mixing syringe of
claim 13
wherein said stopper includes at least one flow channel.
15. The drug mixing syringe of
claim 13
further including a proximal piston adjacent said proximal end of said drug vial, said proximal piston being moveable along said vial to an advanced position within said vial adjacent said distal opening of said vial, said movement effectively displacing substantially all drug from within said vial into said barrel.
16. The drug mixing syringe of
claim 15
further including a handle connected to said proximal piston, said handle functioning to advance said proximal piston along said vial, said handle further functioning to retract said vial away from said stopper when said stopper is retained by said barrel.
17. The drug mixing syringe of
claim 13
wherein said stopper is connected to said proximal piston by a tensile element.
18. The drug mixing syringe of
claim 17
wherein said tensile element is a tether.
19. The drug mixing syringe of
claim 18
further including a vent extending through said tether.
20. A medical mixing syringe for mixing a diluent with a beneficial agent, the syringe comprising:
a. a barrel having a main bore and further having an open proximal end and a distal end;
b. a lumen extending through said distal end in communication with said main bore;
c. a handle having a distal end and a proximal end and a portion intermediate said handle ends;
d. a reservoir adjacent said intermediate portion, said reservoir defining a fluid chamber for containing liquid, said reservoir having a distal open end and a proximal end, said reservoir being sized to be received into said barrel and being moveable to an advanced position along said barrel;
e. a piston sized to be received within said barrel, said piston being connected to said handle;
f. a stopper connected about said distal open end of said reservoir and occluding said distal reservoir end, said stopper including a member for engaging said barrel, said stopper being sized to be received within said barrel, said stopper being moveable with said reservoir to an advanced position along said barrel, said stopper member engaging said barrel to prevent retraction of said stopper from said advanced position and to retain said stopper in said advanced position within said barrel so that when said reservoir is retracted from said advanced position said reservoir is displaced away from said stopper to open said reservoir into said barrel so that fluid may flow from out of said reservoir and into said barrel.
21. The mixing syringe of
claim 20
wherein said reservoir is a flexible polymeric container.
22. The mixing syringe of
claim 21
wherein said reservoir is collapsible.
23. The mixing syringe of
claim 22
wherein said reservoir is comprised of polyvinyl chloride.
24. The mixing syringe of
claim 20
further including a drug vial connector adjacent said proximal reservoir end.
25. The mixing syringe of
claim 20
wherein said stopper and said piston are connected by a connecting element.
26. The mixing syringe of
claim 25
wherein said connecting element is a tube in fluid communication with said reservoir.
27. The mixing syringe of
claim 20
wherein said stopper defines, in said advanced position, at least one flow channel so that liquid within said barrel can be injected past said stopper through said channel.
28. The mixing syringe of
claim 20
wherein said advanced position is adjacent said distal end of said barrel.
29. The syringe of
claim 20
wherein said barrel defines an axis and a main bore having a transverse dimension at said advanced position and wherein said stopper defines an axis, said stopper being elastically compressible and having at least a portion being elastically compressible, the portion having a transverse dimension exceeding said transverse dimension of said bore so that when said stopper is advanced into said bore, said portion is compressed against said bore to retain said stopper within said bore.
30. The syringe of
claim 20
wherein said barrel includes a retaining member for engaging and retaining said stopper in said advanced position.
31. A syringe for mixing pharmaceutical agent with a diluent, the syringe comprising:
a. a barrel and a main bore, the barrel having a distal end and an opening through said distal end in fluid connection with said bore;
b. a drug vial defining an axis and having an open distal end and a outer wall adjacent said end, said vial being sized to be received within said barrel;
c. a stopper having a distal face and a proximal face and being sized to be received within the distal end of said drug vial and to occlude said distal end, said stopper defining an axis and including a distal portion having a member for engaging said barrel, said member projecting beyond at least a portion of said outer wall of said drug vial when said stopper is sealingly received into said drug vial and when said drug vial and said stopper are inserted into said barrel bore;
d. a handle connected to said drug vial for advancing and retracting said drug vial along said barrel;
e. a sealing member mounted adjacent one said drug vial and said handle, the sealing member being sized to seal about said bore so that when said drug vial is advanced along said barrel, said sealing member seals circumferentially against said bore so that when said vial is so advanced, the pressure is increased within said bore distal to said vial and when said vial is retracted along said barrel, the pressure is decreased within said bore distal to said vial.
32. A system for storage and the enclosed sterile assembly of a syringe containing a pharmaceutical agent, the system comprising:
a. a barrel and a main bore, the barrel having an open proximal end and a distal end and an opening through said distal end in fluid connection with said bore;
b. a drug vial defining an axis and having an open distal end and a outer wall adjacent said end, said vial being sized to be received within said barrel;
c. a stopper having a distal face and a proximal face and being sized to be received within the distal end of said drug vial and to occlude said distal end, said stopper defining an axis and including a distal portion having a member for engaging said barrel, said member projecting beyond at least a portion of said outer wall of said drug vial when said stopper is sealingly received into said drug vial and when said drug vial and said stopper are inserted into said barrel bore;
d. a handle connected to said drug vial for advancing and retracting said drug vial along said barrel;
e. a flexible envelope enclosing said barrel, said handle, and said vial within a sealed sterile environment within said envelope, said envelope being sized so that said vial and said handle can be aligned with said open proximal end, and so that said vial can be sterilely inserted into said barrel within said envelope by contacting said handle and said vial through said envelope and manipulating said vial and said handle within said envelope.
33. The system of
claim 32
further including a first syringe compartment for containing said barrel, said handle, and said vial and a second liquid compartment for enclosing a liquid for enclosed aspiration into said barrel, said syringe compartment and said liquid compartment being free from exposure to the environment outside said envelope when said liquid is aspirated into said barrel.
34. A method for the enclosed and sterile mixing of a pharmaceutical agent from a closed and sealed pharmaceutical vial with a diluent and for subsequent injection of the mixture into a patient using a syringe having a barrel, the vial having an open distal end sealed by a stopper, and having a proximal end and a piston adjacent said proximal end, the method comprising steps of:
a. inserting the closed pharmaceutical storage vial into the barrel;
b. advancing the pharmaceutical storage vial along the barrel;
c. disengaging the stopper from sealing contact with the open end of the pharmaceutical vial;
d. aspirating diluent into the main bore into contact with said pharmaceutical agent to derive a mixture of said diluent and said pharmaceutical agent;
e. advancing said proximal piston along said vial, said piston expelling the pharmaceutical agent from the vial;
f. advancing said vial to inject said mixture into a patient.
35. A drug-mixing syringe comprising:
a. a barrel and a main bore, the barrel having a distal end and an opening through said distal end in fluid connection with said bore;
b. a drug vial defining an axis and having an open distal end and a outer wall adjacent said end, said vial being sized to be received within said barrel;
c. a stopper connected about said distal open end of said reservoir and occluding said distal reservoir end, said stopper including a member for engaging said barrel, said stopper being sized to be received within said barrel, said stopper being moveable with said reservoir to an advanced position along said barrel, said stopper member engaging said barrel to prevent retraction of said stopper from said advanced position and to retain said stopper in said advanced position within said barrel so that when said reservoir is retracted from said advanced position said reservoir is displaced away from said stopper to open said reservoir into said barrel so that fluid may flow from out of said reservoir and into said barrel.
36. The syringe of
claim 35
wherein said stopper defines an axis and further includes a distal portion for engaging said barrel.
37. The syringe of
claim 35
wherein said barrel engaging member projects beyond at least a portion of said outer wall.
38. The syringe of
claim 35
wherein said stopper in said advanced position defines at least one flow channel so that when said stopper is retained in said advanced position, and when liquid flows through said barrel, liquid can flow through said flow channel.
39. The syringe of
claim 38
wherein said flow channel extends through said stopper.
40. The syringe of
claim 38
wherein said stopper forms a first wall of said flow channel and wherein said barrel forms a second wall of said flow channel.
41. The syringe of
claim 37
wherein said portion has a transverse dimension greater than the transverse dimension of the drug vial so that said portion projects transversely beyond said vial wall.
42. The syringe of
claim 35
wherein said vial has an open proximal end occluded by a piston.
43. The syringe of
claim 42
wherein said piston is connected to a handle for advancing said piston along said vial and for advancing said vial along said barrel.
44. The syringe of
claim 35
wherein said vial is connected to a handle for advancing and retracting said vial along said barrel.
45. The syringe of
claim 35
further including a sealing member mounted adjacent one said drug vial and said handle, the sealing member being sized to seal about said bore so that when said drug vial is advanced along said barrel, said sealing member seals circumferentially against said bore so that when said vial is so advanced, the pressure is increased within said bore distal to said vial and when said vial is retracted along said barrel, the pressure is decreased within said bore distal to said vial.
46. A method for the enclosed and sterile mixing of a pharmaceutical agent from a closed pharmaceutical vial having an open end occluded by a stopper with a diluent, and for subsequent injection of the mixture into a patient using a syringe having a barrel, the method comprising steps of:
a. inserting the occluded pharmaceutical storage vial into the barrel;
b. advancing the pharmaceutical storage vial along the barrel;
c. after the step of advancing, retracting said vial along said barrel;
d. disengaging the stopper within said barrel from sealing contact with the open end of the pharmaceutical vial;
e. aspirating said diluent into contact with said pharmaceutical agent;
f. advancing said vial along said barrel to inject said mixture into a patient.
47. The method of
claim 46
further including steps of disposing a flow channel through said stopper and injecting said mixture through said flow channel during the stop of advancing said vial along said barrel to inject said mixture.
48. The method of
claim 46
further including steps of aspirating diluent through said flow channel during the step of retracting said vial along said barrel.
49. The method of
claim 46
wherein said stopper is moveable along said barrel with said vial to an advanced position, said stopper including a member for engaging said barrel in said advanced position to retain said stopper in said advanced position, the method including the further step of retaining said stopper in said advanced position during the step of retracting said vial along said barrel.
US09/818,673 1994-02-15 2001-03-28 Syringe system for transfer of medication from a prefilled medication container Abandoned US20010021820A1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
US09/818,673 US20010021820A1 (en) 1994-02-15 2001-03-28 Syringe system for transfer of medication from a prefilled medication container
US10/207,113 US7470261B2 (en) 1994-04-22 2002-07-30 Medical valve

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US19645594A 1994-02-15 1994-02-15
US08/231,430 US5522804A (en) 1994-02-15 1994-04-22 Aspiration, mixing, and injection syringe
US08/655,754 US5697915A (en) 1994-02-15 1996-05-30 Displacement-activated medical check valve
US08/699,979 US5769825A (en) 1994-02-15 1996-08-20 Self-contained syringe and pharmaceutical packaging system for enclosed mixing of pharmaceutical and diluent
US09/102,082 US6228065B1 (en) 1994-02-15 1998-06-22 Displacement activated medical check valve
US09/818,673 US20010021820A1 (en) 1994-02-15 2001-03-28 Syringe system for transfer of medication from a prefilled medication container

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
US09/102,082 Continuation US6228065B1 (en) 1994-02-15 1998-06-22 Displacement activated medical check valve

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US10/207,113 Continuation-In-Part US7470261B2 (en) 1994-04-22 2002-07-30 Medical valve

Publications (1)

Publication Number Publication Date
US20010021820A1 true US20010021820A1 (en) 2001-09-13

Family

ID=22725491

Family Applications (8)

Application Number Title Priority Date Filing Date
US08/231,430 Expired - Fee Related US5522804A (en) 1994-02-15 1994-04-22 Aspiration, mixing, and injection syringe
US08/413,966 Expired - Lifetime US5549569A (en) 1994-02-15 1995-03-30 Ex vivo blood isolation system
US08/655,754 Expired - Lifetime US5697915A (en) 1994-02-15 1996-05-30 Displacement-activated medical check valve
US08/697,085 Expired - Lifetime US5743886A (en) 1994-02-15 1996-08-20 Sequential medical fluid aspiration and injection system and method
US08/699,979 Expired - Lifetime US5769825A (en) 1994-02-15 1996-08-20 Self-contained syringe and pharmaceutical packaging system for enclosed mixing of pharmaceutical and diluent
US08/697,058 Expired - Fee Related US5643218A (en) 1994-02-15 1996-08-20 Auto-flushing medical fluid injection system
US09/102,082 Expired - Lifetime US6228065B1 (en) 1994-02-15 1998-06-22 Displacement activated medical check valve
US09/818,673 Abandoned US20010021820A1 (en) 1994-02-15 2001-03-28 Syringe system for transfer of medication from a prefilled medication container

Family Applications Before (7)

Application Number Title Priority Date Filing Date
US08/231,430 Expired - Fee Related US5522804A (en) 1994-02-15 1994-04-22 Aspiration, mixing, and injection syringe
US08/413,966 Expired - Lifetime US5549569A (en) 1994-02-15 1995-03-30 Ex vivo blood isolation system
US08/655,754 Expired - Lifetime US5697915A (en) 1994-02-15 1996-05-30 Displacement-activated medical check valve
US08/697,085 Expired - Lifetime US5743886A (en) 1994-02-15 1996-08-20 Sequential medical fluid aspiration and injection system and method
US08/699,979 Expired - Lifetime US5769825A (en) 1994-02-15 1996-08-20 Self-contained syringe and pharmaceutical packaging system for enclosed mixing of pharmaceutical and diluent
US08/697,058 Expired - Fee Related US5643218A (en) 1994-02-15 1996-08-20 Auto-flushing medical fluid injection system
US09/102,082 Expired - Lifetime US6228065B1 (en) 1994-02-15 1998-06-22 Displacement activated medical check valve

Country Status (6)

Country Link
US (8) US5522804A (en)
EP (1) EP0744972B1 (en)
JP (1) JPH10500030A (en)
AU (1) AU1744095A (en)
DE (1) DE69531774T2 (en)
WO (1) WO1995021639A1 (en)

Cited By (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040162527A1 (en) * 2003-01-17 2004-08-19 Gerhard Moersdorf Sterile sheath for an injection syringe
EP1743700A1 (en) * 2005-07-15 2007-01-17 Dentaco Dentalindustrie und -marketing GmbH Pipetting device
US20090072169A1 (en) * 2007-09-17 2009-03-19 Perry Polsinelli Leak Resistant Syringe Cover
WO2009048366A1 (en) * 2007-10-10 2009-04-16 Ortoviva Ab Mixing system and mixing method for medical purposes
US20100063445A1 (en) * 2008-09-09 2010-03-11 Baxter International Inc. Device to Indicate Priming of an Infusion Line
US20110046604A1 (en) * 2009-08-21 2011-02-24 Becton Dickinson France S.A.S. Syringe Assembly with Inverse Delivery
WO2011068544A1 (en) * 2009-12-04 2011-06-09 Becton, Dickinson And Company Cartridge for containing and dispensing a medicament
USD655017S1 (en) 2010-06-17 2012-02-28 Yukon Medical, Llc Shroud
US20120271279A1 (en) * 2008-01-01 2012-10-25 Rudolf Matusch Disposable injector with a manually actuated piston and with a twin chamber system
USD681230S1 (en) 2011-09-08 2013-04-30 Yukon Medical, Llc Shroud
US8475404B2 (en) 2007-08-21 2013-07-02 Yukon Medical, Llc Vial access and injection system
US8821436B2 (en) 2008-04-01 2014-09-02 Yukon Medical, Llc Dual container fluid transfer device
US20140364813A1 (en) * 2004-12-08 2014-12-11 Roche Diagnostics International Ag Adapter for injection appliance
WO2016118336A1 (en) * 2015-01-20 2016-07-28 Paw Bioscience Products, Inc. Pre-sterilized syringe system and method of use
USD765838S1 (en) 2015-03-26 2016-09-06 Tech Group Europe Limited Syringe retention clip
USD769444S1 (en) 2012-06-28 2016-10-18 Yukon Medical, Llc Adapter device
CN113694315A (en) * 2016-09-19 2021-11-26 麦迪麦珀医疗工程有限公司 Drug delivery device and method of dispensing a drug
US11674614B2 (en) 2020-10-09 2023-06-13 Icu Medical, Inc. Fluid transfer device and method of use for same

Families Citing this family (384)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9303178D0 (en) * 1993-09-29 1993-09-29 Kabi Pharmacia Ab Improvements in injection cartridges
US5522804A (en) 1994-02-15 1996-06-04 Lynn; Lawrence A. Aspiration, mixing, and injection syringe
US5549651A (en) 1994-05-25 1996-08-27 Lynn; Lawrence A. Luer-receiving medical valve and fluid transfer method
US7033339B1 (en) 1998-05-29 2006-04-25 Becton Dickinson And Company (Part Interest) Self sealing luer receiving stopcock
USRE39334E1 (en) 1994-05-25 2006-10-10 Lynn Lawrence A Luer-receiving medical valve and fluid transfer method
DE69637457T2 (en) * 1995-04-20 2008-10-02 ACIST Medical Systems, Inc., Eden Prairie Injector for X-ray contrast agent
US6656157B1 (en) 1995-04-20 2003-12-02 Acist Medical Systems, Inc. Infinitely refillable syringe
US6099502A (en) * 1995-04-20 2000-08-08 Acist Medical Systems, Inc. Dual port syringe
US5882343A (en) * 1995-04-20 1999-03-16 Invasatec, Inc. Dual port syringe
US6221045B1 (en) 1995-04-20 2001-04-24 Acist Medical Systems, Inc. Angiographic injector system with automatic high/low pressure switching
US6296621B1 (en) * 1996-08-23 2001-10-02 Baxter International Inc. Receptacle for passive drug delivery
DE19645514C2 (en) * 1996-11-05 2000-04-13 Sarstedt Ag & Co Method and device for disposing of the cannula of a blood collection device
US6126643A (en) * 1997-03-06 2000-10-03 Vaillancouert; Vincent L. Blood collecting syringe
AU7435698A (en) * 1997-04-15 1998-11-11 Debiotech S.A. Syringe with multiple sections
US5961472A (en) * 1997-09-26 1999-10-05 Baxter International Inc. Closed, one-handed blood sampling system
DE69822216T2 (en) * 1997-10-20 2005-04-07 PRC-DeSoto International, Inc., Burbank MULTIPLE SYRINGE FOR MANUAL APPLICATION OF SUBSTANCES
JP3389983B2 (en) 1997-10-23 2003-03-24 株式会社ジェイ・エム・エス Medical injection port
US6019750A (en) 1997-12-04 2000-02-01 Baxter International Inc. Sliding reconstitution device with seal
US6382442B1 (en) 1998-04-20 2002-05-07 Becton Dickinson And Company Plastic closure for vials and other medical containers
US6681946B1 (en) 1998-02-26 2004-01-27 Becton, Dickinson And Company Resealable medical transfer set
WO1999045851A1 (en) * 1998-03-11 1999-09-16 Harvest Technologies Corporation Apparatus for the sterile transfer of fluids
US6378714B1 (en) 1998-04-20 2002-04-30 Becton Dickinson And Company Transferset for vials and other medical containers
US6209738B1 (en) 1998-04-20 2001-04-03 Becton, Dickinson And Company Transfer set for vials and medical containers
FR2778338B1 (en) * 1998-05-05 2000-09-29 Aguettant Lab DEVICE FOR INJECTION WITH CONTROLLED FLOW AND IN AMBULATORY OF A MEDICAMENT IN LIQUID FORM
EP1082159B1 (en) 1998-05-29 2009-04-01 Lawrence A. Lynn Luer receiver and method for fluid transfer
WO2000010629A1 (en) * 1998-08-21 2000-03-02 Medrad, Inc. Connector and tubing assembly for use with a syringe
US20050137566A1 (en) 2003-12-23 2005-06-23 Fowles Thomas A. Sliding reconstitution device for a diluent container
AR021220A1 (en) 1998-09-15 2002-07-03 Baxter Int CONNECTION DEVICE FOR ESTABLISHING A FLUID COMMUNICATION BETWEEN A FIRST CONTAINER AND A SECOND CONTAINER.
US6022339A (en) 1998-09-15 2000-02-08 Baxter International Inc. Sliding reconstitution device for a diluent container
IL128016A0 (en) * 1999-01-12 1999-11-30 Elcam Plastic Kibbutz Bar Am Blood sampling device
US6290690B1 (en) 1999-06-21 2001-09-18 Alcon Manufacturing, Ltd. Simultaneous injection and aspiration of viscous fluids in a surgical system
US6371936B1 (en) * 1999-06-23 2002-04-16 Mary Annette Heidick Cannula lock with plural access ports
US20040122345A1 (en) * 1999-08-02 2004-06-24 Hans Muller Body fluid aspiration and injection syringe
US6364847B1 (en) * 1999-10-07 2002-04-02 Sunscope International, Inc. Blood sampling device
US6514230B1 (en) * 1999-10-12 2003-02-04 Novo Nordisk A/S Air shot mechanism for electronic injection devices
US7458956B1 (en) * 1999-11-12 2008-12-02 Boston Scientific Scimed, Inc. Apparatus for delivery of controlled doses of therapeutic drugs in endoluminal procedures
US20020077270A1 (en) * 2000-01-31 2002-06-20 Rosen Craig A. Nucleic acids, proteins, and antibodies
CA2390477C (en) * 2000-02-16 2010-05-18 B D Medico S.A.R.L. Method for reconstituting an injection liquid and an injection appliance for carrying out such a method
FR2805166A1 (en) * 2000-02-22 2001-08-24 Sedat Injection syringe with liquid held between two pistons has stops inside barrel to hold forward piston in initial position
US6626862B1 (en) 2000-04-04 2003-09-30 Acist Medical Systems, Inc. Fluid management and component detection system
PL201030B1 (en) * 2000-05-15 2009-02-27 Ares Trading Sa Injection device
US6602220B1 (en) * 2000-05-26 2003-08-05 The Research Foundation Of State University Of New York Miniature air-controlled drug selector and delivery device portable by small animals
US6440101B1 (en) * 2000-05-31 2002-08-27 Abbott Laboratories Syringe systems for lyophilized drugs and methods for making the same
FR2809628B1 (en) * 2000-06-05 2004-07-02 Sedat PRE-FILLED SYRINGE WITH TWO MOBILE PISTONS RETAINING A LIQUID FOR INJECTION
US6423050B1 (en) * 2000-06-16 2002-07-23 Zbylut J. Twardowski Method and apparatus for locking of central-vein catheters
US6592555B1 (en) * 2000-06-23 2003-07-15 Wang Wen-Pi Syringe device
US6695817B1 (en) 2000-07-11 2004-02-24 Icu Medical, Inc. Medical valve with positive flow characteristics
JP4626064B2 (en) * 2000-09-28 2011-02-02 生化学工業株式会社 Syringe
US7621887B2 (en) * 2000-10-10 2009-11-24 Meridian Medical Technologies, Inc. Wet/dry automatic injector assembly
US7544189B2 (en) * 2000-10-10 2009-06-09 Meridian Medical Technologies, Inc. Needle and hub assembly for automatic injector
FR2815328B1 (en) * 2000-10-17 2002-12-20 Biodome CONNECTION DEVICE BETWEEN A CONTAINER AND A CONTAINER AND READY-TO-USE ASSEMBLY COMPRISING SUCH A DEVICE
US20020128680A1 (en) * 2001-01-25 2002-09-12 Pavlovic Jennifer L. Distal protection device with electrospun polymer fiber matrix
MXPA03007940A (en) 2001-03-13 2004-10-15 Mdc Invest Holdings Inc Pre-filled safety vial injector.
CN1509195A (en) * 2001-03-13 2004-06-30 MDCͶ�ʿعɹ�˾ Pre-filled safety diluent injector
GB2376048B (en) * 2001-03-31 2004-11-10 David William Armfield Pistons
US6663596B2 (en) * 2001-08-13 2003-12-16 Scimed Life Systems, Inc. Delivering material to a patient
DE10140704A1 (en) * 2001-08-18 2003-03-06 Vetter & Co Apotheker Process for mixing a poorly soluble pharmaceutical substance with a solvent and syringe to apply the process
US20030105433A1 (en) * 2001-11-30 2003-06-05 Ruben Philip H. Disposable syringe and cartridge with pneumatic chamber
US6835191B2 (en) 2001-12-21 2004-12-28 3M Innovative Properties Co. Self-venting movable seal and plunger
FR2836129B1 (en) 2002-02-20 2004-04-02 Biodome CONNECTION DEVICE BETWEEN A CONTAINER AND A CONTAINER AND READY-TO-USE ASSEMBLY COMPRISING SUCH A DEVICE
US6723074B1 (en) * 2002-04-09 2004-04-20 Thor R. Halseth Sequential delivery syringe
US20030199816A1 (en) * 2002-04-17 2003-10-23 Scott Ramming Pre-loaded multi-chamber syringe
US7125394B2 (en) * 2002-06-04 2006-10-24 Syringe, Llc Applicator for dispensing a medicinal substance
US7141036B2 (en) * 2002-06-04 2006-11-28 Syringe, Llc Methods of applying a medicinal substance
US20050010174A1 (en) * 2002-06-04 2005-01-13 Berman Irwin R. Applicator and methods of applying a substance
US7223253B2 (en) * 2002-07-29 2007-05-29 Gore Enterprise Holdings, Inc. Blood aspiration system and methods of use
US7135027B2 (en) * 2002-10-04 2006-11-14 Baxter International, Inc. Devices and methods for mixing and extruding medically useful compositions
US7025744B2 (en) * 2002-10-04 2006-04-11 Dsu Medical Corporation Injection site for male luer or other tubular connector
US8377039B2 (en) 2002-10-04 2013-02-19 Nxstage Medical, Inc. Injection site for male luer or other tubular connector
CA2501968C (en) * 2002-10-11 2013-07-23 Becton, Dickinson And Company Flush syringe having anti-reflux features
US6866653B2 (en) * 2002-10-31 2005-03-15 Kyongtae T. Bae Method and apparatus for sequential delivery of multiple injectable substances stored in a prefilled syringe
US7753085B2 (en) 2002-12-03 2010-07-13 Forhealth Technologies, Inc. Automated drug preparation apparatus including automated drug reconstitution
US10688021B2 (en) 2002-12-03 2020-06-23 Baxter Corporation Englewood Automated drug preparation apparatus including automated drug reconstitution
CN1739161A (en) * 2003-01-13 2006-02-22 皇家飞利浦电子股份有限公司 Navigating to content in a recording
KR100473568B1 (en) * 2003-01-25 2005-03-10 이희영 Closed loop fat transplantation system
US20040167480A1 (en) * 2003-02-21 2004-08-26 Advanced Medical Optics, Inc. Administration of multiple viscoelastic solutions with a multi-compartment syringe
IL155955A0 (en) * 2003-05-15 2003-12-23 Widemed Ltd Adaptive prediction of changes of physiological/pathological states using processing of biomedical signal
US20190357827A1 (en) 2003-08-01 2019-11-28 Dexcom, Inc. Analyte sensor
US8626257B2 (en) 2003-08-01 2014-01-07 Dexcom, Inc. Analyte sensor
US7591801B2 (en) 2004-02-26 2009-09-22 Dexcom, Inc. Integrated delivery device for continuous glucose sensor
US8886273B2 (en) 2003-08-01 2014-11-11 Dexcom, Inc. Analyte sensor
US7920906B2 (en) 2005-03-10 2011-04-05 Dexcom, Inc. System and methods for processing analyte sensor data for sensor calibration
US7097637B2 (en) 2003-08-27 2006-08-29 C. R. Bard, Inc. Safety needle with positive flush
US7431717B2 (en) * 2003-09-30 2008-10-07 Serene Medical, Inc. Central nervous system administration of medications by means of pelvic venous catheterization and reversal of Batson's Plexus
US9247900B2 (en) 2004-07-13 2016-02-02 Dexcom, Inc. Analyte sensor
US8425416B2 (en) 2006-10-04 2013-04-23 Dexcom, Inc. Analyte sensor
US8423114B2 (en) 2006-10-04 2013-04-16 Dexcom, Inc. Dual electrode system for a continuous analyte sensor
US8287453B2 (en) 2003-12-05 2012-10-16 Dexcom, Inc. Analyte sensor
US8364230B2 (en) 2006-10-04 2013-01-29 Dexcom, Inc. Analyte sensor
US8364231B2 (en) 2006-10-04 2013-01-29 Dexcom, Inc. Analyte sensor
US8774886B2 (en) 2006-10-04 2014-07-08 Dexcom, Inc. Analyte sensor
US11633133B2 (en) 2003-12-05 2023-04-25 Dexcom, Inc. Dual electrode system for a continuous analyte sensor
US8425417B2 (en) 2003-12-05 2013-04-23 Dexcom, Inc. Integrated device for continuous in vivo analyte detection and simultaneous control of an infusion device
US7641851B2 (en) 2003-12-23 2010-01-05 Baxter International Inc. Method and apparatus for validation of sterilization process
US20050182384A1 (en) * 2004-02-12 2005-08-18 Medtronic Vascular, Inc. Flushing cannula with integral catheter sheath
US20050187532A1 (en) * 2004-02-24 2005-08-25 Medex, Inc. Diaphragm-based reservoir for a closed blood sampling system
US8808228B2 (en) 2004-02-26 2014-08-19 Dexcom, Inc. Integrated medicament delivery device for use with continuous analyte sensor
EP1576933A1 (en) * 2004-03-11 2005-09-21 3M Espe Ag Capsule for storage, mixing and dispensing materials
US7998106B2 (en) 2004-05-03 2011-08-16 Thorne Jr Gale H Safety dispensing system for hazardous substances
FR2869533B1 (en) 2004-05-03 2006-07-28 Sedat Sa SYRINGE FOR MEDICAL INTERVENTIONS AND NECESSARY FOR RECONSTITUTION OF EXTEMPORANEOUS SUBSTANCES COMPRISING SUCH A SYRINGE
US7101354B2 (en) * 2004-05-03 2006-09-05 Infusive Technologies, Llc Mixing syringe with and without flush
US6997910B2 (en) * 2004-05-03 2006-02-14 Infusive Technologies, Llc Multi-chamber, sequential dose dispensing syringe
JP4662987B2 (en) * 2004-06-14 2011-03-30 パーカー・ハニフィン・コーポレーション Robotic handling system and method with independently operable removable tool
US20050287512A1 (en) * 2004-06-23 2005-12-29 Cullis Herbert M Specimen storing device and method
US7857760B2 (en) 2004-07-13 2010-12-28 Dexcom, Inc. Analyte sensor
US7783333B2 (en) 2004-07-13 2010-08-24 Dexcom, Inc. Transcutaneous medical device with variable stiffness
US20060270922A1 (en) 2004-07-13 2006-11-30 Brauker James H Analyte sensor
US7310544B2 (en) 2004-07-13 2007-12-18 Dexcom, Inc. Methods and systems for inserting a transcutaneous analyte sensor
CN100457204C (en) * 2004-07-30 2009-02-04 赵福元 Needle tube capable of injecting two kinds of medicine liquids
US20060030823A1 (en) * 2004-08-06 2006-02-09 Ju-Ti Wang Auto shut off device in intravenous infusion set
US7731678B2 (en) * 2004-10-13 2010-06-08 Hyprotek, Inc. Syringe devices and methods for mixing and administering medication
EP1723687B1 (en) * 2004-10-29 2010-05-19 Eveready Battery Company, Inc. Fluid regulating microvalve assembly for fluid consuming cells
WO2006052655A2 (en) 2004-11-05 2006-05-18 Icu Medical, Inc. Soft-grip medical connector
US7578793B2 (en) 2004-11-22 2009-08-25 Widemed Ltd. Sleep staging based on cardio-respiratory signals
EP1666084A1 (en) * 2004-12-01 2006-06-07 Societe de Conseils de Recherches et d'Applications Scientifiques (S.C.R.A.S) SAS Injection device for a pharmaceutical active ingredient
EP1666085A1 (en) * 2004-12-01 2006-06-07 Societe de Conseils de Recherches et d'Applications Scientifiques (S.C.R.A.S) SAS Injection device for a solid implant
US20060178644A1 (en) * 2004-12-03 2006-08-10 Reynolds David L Pharmaceutical cartridge assembly and method of filling same
US7783383B2 (en) * 2004-12-22 2010-08-24 Intelligent Hospital Systems Ltd. Automated pharmacy admixture system (APAS)
EP1830782B1 (en) 2004-12-22 2013-06-05 Intelligent Hospital Systems Ltd. Automated pharmacy admixture system (APAS)
MX2007007928A (en) * 2005-01-04 2007-08-21 Artes Medical Inc 4-thio coumarins.
US20060155212A1 (en) * 2005-01-10 2006-07-13 Madonia James R Self flushing luer activated blood sampling devices
WO2006083695A2 (en) * 2005-01-28 2006-08-10 Parker-Hannifin Corporation Sampling probe, gripper and interface for laboratory sample management systems
PL2058020T3 (en) * 2005-02-01 2013-03-29 Kaleo Inc Devices for medicament delivery
US20080269583A1 (en) * 2005-02-07 2008-10-30 Widemed Ltd. Detection and Monitoring of Stress Events During Sleep
US7766900B2 (en) 2005-02-21 2010-08-03 Biomet Manufacturing Corp. Method and apparatus for application of a fluid
WO2006124634A1 (en) * 2005-05-16 2006-11-23 Mallinckrodt Inc. Multi-barrel syringe having integral manifold
WO2006128915A1 (en) * 2005-06-02 2006-12-07 Schwoebel Eckhard Multi-cylinder syringe
CA2612768A1 (en) * 2005-06-30 2007-01-11 Mallinckrodt Inc. Dual chamber syringe
US20070038174A1 (en) * 2005-08-09 2007-02-15 Hopkins Mark A Ophthalmic injector system
US20070060887A1 (en) * 2005-08-22 2007-03-15 Marsh David A Ophthalmic injector
WO2007033319A1 (en) * 2005-09-13 2007-03-22 Edwards Lifesciences Corporation Closed blood sampling system with isolated pressure monitoring
US20070092451A1 (en) * 2005-10-25 2007-04-26 Loveridge Dan E Time indicating containers for dental compositions
US8137307B2 (en) 2005-11-09 2012-03-20 Hyprotek, Inc. Syringe devices, components of syringe devices, and methods of forming components and syringe devices
DE202005017529U1 (en) * 2005-11-09 2006-01-19 Bundesrepublik Deutschland, vertreten durch den Präsidenten des Paul-Ehrlich-Instituts, Bundesamt für Sera und Impfstoffe Device for obtaining cell suspensions with subsequent admixture of additives
US20080314412A1 (en) * 2005-12-05 2008-12-25 Grippo Paul M Self-Cleaning Injection Port for Analytical Applications
US20090032065A1 (en) * 2005-12-08 2009-02-05 Bantz Daniel L Syringe wash station for analytical applications
US7931859B2 (en) * 2005-12-22 2011-04-26 Intelligent Hospital Systems Ltd. Ultraviolet sanitization in pharmacy environments
CA2634754A1 (en) * 2005-12-29 2007-07-12 Nmt Medical, Inc. Syringe activated-valve for flushing a catheter and methods thereof
US8192698B2 (en) * 2006-01-27 2012-06-05 Parker-Hannifin Corporation Sampling probe, gripper and interface for laboratory sample management systems
US20070183986A1 (en) * 2006-02-06 2007-08-09 Ultradent Products, Inc. Methods and systems for mixing a multi-part fluoride varnish composition
US7437958B2 (en) * 2006-02-21 2008-10-21 American Sterilizer Company Sterile single use sampling device
JP2007222472A (en) * 2006-02-24 2007-09-06 Nipro Corp Medical agent minute-amount administration appliance set
US20070255204A1 (en) * 2006-05-01 2007-11-01 Ultradent Products, Inc Time-indicating syringe mixing devices and related methods for storing and dispensing two-part dental compositions
US7776010B2 (en) * 2006-05-01 2010-08-17 Ultradent Products, Inc. Syringe-in-syringe hollow inner barrel/plunger with integral seal and rupturable membrane and related kits, systems, and methods
US20070255201A1 (en) * 2006-05-01 2007-11-01 Ultradent Products, Inc. Time-indicating syringe mixing devices and related methods for storing and dispensing two-part dental compositions
US7811252B2 (en) * 2006-05-17 2010-10-12 Alcon Research, Ltd. Dosage control device
US20070270750A1 (en) * 2006-05-17 2007-11-22 Alcon, Inc. Drug delivery device
US7887521B2 (en) * 2006-05-17 2011-02-15 Alcon Research, Ltd. Ophthalmic injection system
US20070270768A1 (en) * 2006-05-17 2007-11-22 Bruno Dacquay Mechanical Linkage Mechanism For Ophthalmic Injection Device
US7674243B2 (en) * 2006-05-17 2010-03-09 Alcon Inc. Ophthalmic injection device using piezoelectric array
US20070268340A1 (en) * 2006-05-17 2007-11-22 Bruno Dacquay Ophthalmic Injection System and Method Using Piezoelectric Array
US7815603B2 (en) * 2006-05-17 2010-10-19 Alcon Research, Ltd. Ophthalmic injection method
US7862540B2 (en) * 2006-05-17 2011-01-04 Alcon Research, Ltd. Ophthalmic injection device using shape memory alloy
ES2544556T3 (en) 2006-05-25 2015-09-01 Bayer Healthcare Llc Reconstitution device
US20080125712A1 (en) * 2006-09-26 2008-05-29 Alcon Manufacturing, Ltd. Ophthalmic injection system
US20080097379A1 (en) * 2006-09-26 2008-04-24 Alcon Manufacturing, Ltd. Ophthalmic injection method
US20080097390A1 (en) * 2006-09-27 2008-04-24 Alcon Manufacturing, Ltd. Spring actuated delivery system
US8447376B2 (en) 2006-10-04 2013-05-21 Dexcom, Inc. Analyte sensor
US8298142B2 (en) 2006-10-04 2012-10-30 Dexcom, Inc. Analyte sensor
US8562528B2 (en) 2006-10-04 2013-10-22 Dexcom, Inc. Analyte sensor
US8275438B2 (en) 2006-10-04 2012-09-25 Dexcom, Inc. Analyte sensor
US8449464B2 (en) 2006-10-04 2013-05-28 Dexcom, Inc. Analyte sensor
US8478377B2 (en) 2006-10-04 2013-07-02 Dexcom, Inc. Analyte sensor
KR20090067218A (en) * 2006-10-16 2009-06-24 알콘 리서치, 리미티드 Method of operating ophthalmic hand piece with disposable end
US9022970B2 (en) * 2006-10-16 2015-05-05 Alcon Research, Ltd. Ophthalmic injection device including dosage control device
US20080281292A1 (en) * 2006-10-16 2008-11-13 Hickingbotham Dyson W Retractable Injection Port
EP2063829B1 (en) * 2006-10-16 2010-12-08 Alcon Research, Ltd. Universal rechargeable limited reuse assembly for ophthalmic hand piece
MX2009004380A (en) 2006-10-25 2009-05-08 Icu Medical Inc Medical connector.
US7988668B2 (en) * 2006-11-21 2011-08-02 Medtronic, Inc. Microsyringe for pre-packaged delivery of pharmaceuticals
US20100185146A1 (en) * 2006-12-06 2010-07-22 Laura N. Dietch Drug delivery systems
WO2008091251A2 (en) * 2007-01-23 2008-07-31 Infusive Technologies, Llc Mixing syringe with and without flush
US8454558B2 (en) * 2007-02-09 2013-06-04 Ultradent Products, Inc. Syringe-in-syringe hollow inner barrel/plunger with integral seal and rupturable membrane and related kits, systems and methods
FR2914840A1 (en) * 2007-04-16 2008-10-17 Lk2 Soc Responsabilite Limitee Connection for blood sampling device, has sampling valve sampling fluid sample contained in sampling path, where path has Luer lock type syringe that drives part of fluid contained in sampling path towards catheter path
US8372043B2 (en) * 2007-05-01 2013-02-12 Geisinger Clinic Devices and methods for fluid administration
US20080300500A1 (en) * 2007-05-30 2008-12-04 Widemed Ltd. Apnea detection using a capnograph
EP2152350A4 (en) 2007-06-08 2013-03-27 Dexcom Inc Integrated medicament delivery device for use with continuous analyte sensor
US20080302932A1 (en) * 2007-06-08 2008-12-11 Smiths Medical Asd, Inc. Mounting Clip for Fluid Reservoir
US20090018512A1 (en) * 2007-07-13 2009-01-15 Charles Steven T Pneumatically-Powered Ophthalmic Injector
US20090018548A1 (en) * 2007-07-13 2009-01-15 Charles Steven T Pneumatically-Powered Intraocular Lens Injection Device with Removable Cartridge
US7740612B2 (en) * 2007-07-27 2010-06-22 Milestone Scientific, Inc Self-administration injection system
US7740619B2 (en) * 2007-08-01 2010-06-22 Alcon Research, Ltd. Spring driven ophthalmic injection device with safety actuator lockout feature
US20090036842A1 (en) * 2007-08-03 2009-02-05 Raffi Pinedjian Consumable Activation Lever For Injection Device
US7629768B2 (en) * 2007-08-03 2009-12-08 Alcon Research, Ltd. Easy cleaning C-shaped charging base
US7789862B2 (en) * 2007-09-05 2010-09-07 Thorne Consulting & Intellectual Property, LLC Multi-chamber, sequentially dispensing syringe
US8271138B2 (en) * 2007-09-12 2012-09-18 Intelligent Hospital Systems Ltd. Gripper device
CA2639729A1 (en) * 2007-09-27 2009-03-27 Tyco Healthcare Group Lp Multiple stage fluid delivery device and method of use
US9345836B2 (en) 2007-10-02 2016-05-24 Medimop Medical Projects Ltd. Disengagement resistant telescoping assembly and unidirectional method of assembly for such
US9656019B2 (en) 2007-10-02 2017-05-23 Medimop Medical Projects Ltd. Apparatuses for securing components of a drug delivery system during transport and methods of using same
US7967795B1 (en) 2010-01-19 2011-06-28 Lamodel Ltd. Cartridge interface assembly with driving plunger
US10420880B2 (en) 2007-10-02 2019-09-24 West Pharma. Services IL, Ltd. Key for securing components of a drug delivery system during assembly and/or transport and methods of using same
WO2009044401A2 (en) 2007-10-02 2009-04-09 Yossi Gross External drug pump
US8002737B2 (en) * 2007-10-04 2011-08-23 Hyprotek, Inc. Mixing/administration syringe devices, protective packaging and methods of protecting syringe handlers
US9522097B2 (en) 2007-10-04 2016-12-20 Hyprotek, Inc. Mixing/administration syringe devices, protective packaging and methods of protecting syringe handlers
EP2227132B1 (en) 2007-10-09 2023-03-08 DexCom, Inc. Integrated insulin delivery system with continuous glucose sensor
US8225824B2 (en) * 2007-11-16 2012-07-24 Intelligent Hospital Systems, Ltd. Method and apparatus for automated fluid transfer operations
RU2487728C2 (en) * 2007-11-22 2013-07-20 Биовитрум Аб (Пабл) Method and device for sequential delivery of two fluid flows comprising partition
US8383163B2 (en) 2008-01-29 2013-02-26 Ultradent Products, Inc. Fluoride varnish compositions including an organo phosphoric acid adhesion promoting agent
CN101502687B (en) * 2008-02-04 2011-05-04 龚静山 Monotubular double-chamber syringe needle cylinder
US8396528B2 (en) 2008-03-25 2013-03-12 Dexcom, Inc. Analyte sensor
US8182769B2 (en) 2008-04-04 2012-05-22 Biomet Biologics, Llc Clean transportation system
US8518272B2 (en) * 2008-04-04 2013-08-27 Biomet Biologics, Llc Sterile blood separating system
US9101748B2 (en) * 2008-05-08 2015-08-11 Becton, Dickinson And Company Push-button blood control
US8366684B2 (en) * 2008-05-12 2013-02-05 Becton, Dickinson And Company Intravenous catheter blood control device
US8142403B2 (en) * 2008-06-30 2012-03-27 Tyco Healthcare Group Lp Syringe assembly with plunger having a secondary dispensing reservoir
JP6032892B2 (en) * 2008-07-18 2016-11-30 ベクトン・ディキンソン・アンド・カンパニーBecton, Dickinson And Company Cartridge stopper for intradermal administration system
US9393369B2 (en) 2008-09-15 2016-07-19 Medimop Medical Projects Ltd. Stabilized pen injector
US8152778B2 (en) * 2008-09-30 2012-04-10 Tyco Healthcare Group Lp Device for interfacing with standard luer lock syringes
US20100145305A1 (en) * 2008-11-10 2010-06-10 Ruth Alon Low volume accurate injector
US20100152676A1 (en) * 2008-12-16 2010-06-17 Alcon Research, Ltd. Drug Loading Through Plunger
US8152779B2 (en) * 2008-12-30 2012-04-10 Medimop Medical Projects Ltd. Needle assembly for drug pump
US8388583B2 (en) * 2009-08-20 2013-03-05 Becton, Dickinson And Company Systems and methods for providing a flushable catheter assembly
US8469928B2 (en) * 2009-02-11 2013-06-25 Becton, Dickinson And Company Systems and methods for providing a flushable catheter assembly
US8679063B2 (en) * 2009-02-11 2014-03-25 Becton, Dickinson And Company Systems and methods for providing a catheter assembly
US8361038B2 (en) * 2009-02-11 2013-01-29 Becton, Dickinson And Company Systems and methods for providing a flow control valve for a medical device
USRE45896E1 (en) 2009-02-11 2016-02-23 Becton, Dickinson And Company Systems and methods for providing a catheter assembly
US8574203B2 (en) * 2009-02-11 2013-11-05 Becton, Dickinson And Company Systems and methods for providing a flushable catheter assembly
US8747297B2 (en) * 2009-03-02 2014-06-10 Olympus Corporation Endoscopic heart surgery method
JP5415925B2 (en) * 2009-03-02 2014-02-12 オリンパス株式会社 Endoscope
US8386070B2 (en) * 2009-03-18 2013-02-26 Intelligent Hospital Systems, Ltd Automated pharmacy admixture system
US8454579B2 (en) 2009-03-25 2013-06-04 Icu Medical, Inc. Medical connector with automatic valves and volume regulator
AU2010236426B2 (en) 2009-04-14 2013-08-29 Yukon Medical, Llc Fluid transfer device
US20120071836A1 (en) * 2009-04-30 2012-03-22 Sanofi-Aventis Deutschland Gmbh Drive mechanism for a drug delivery device
US8372036B2 (en) * 2009-05-06 2013-02-12 Alcon Research, Ltd. Multi-layer heat assembly for a drug delivery device
US9357950B2 (en) 2009-06-03 2016-06-07 Biometrix Ltd. Apparatus and method of fluid aspiration
US20120136298A1 (en) * 2009-06-04 2012-05-31 Novo Nordisk Healthcare A/G Mixing device with piston coupling arrangement
BR122012017389B8 (en) * 2009-07-01 2021-06-22 Fresenius Medical Care Holdings Inc drug delivery device
US8465471B2 (en) 2009-08-05 2013-06-18 Rocin Laboratories, Inc. Endoscopically-guided electro-cauterizing power-assisted fat aspiration system for aspirating visceral fat tissue within the abdomen of a patient
US8348929B2 (en) 2009-08-05 2013-01-08 Rocin Laboratories, Inc. Endoscopically-guided tissue aspiration system for safely removing fat tissue from a patient
US8323249B2 (en) 2009-08-14 2012-12-04 The Regents Of The University Of Michigan Integrated vascular delivery system
US20110060361A1 (en) * 2009-09-08 2011-03-10 Baxter International Inc. Reconstitution and applicator system for wound sealant product
US10071198B2 (en) 2012-11-02 2018-09-11 West Pharma. Servicees IL, Ltd. Adhesive structure for medical device
US10071196B2 (en) 2012-05-15 2018-09-11 West Pharma. Services IL, Ltd. Method for selectively powering a battery-operated drug-delivery device and device therefor
US8157769B2 (en) * 2009-09-15 2012-04-17 Medimop Medical Projects Ltd. Cartridge insertion assembly for drug delivery system
CN102665615B (en) * 2009-09-22 2015-08-19 奥林巴斯株式会社 Device is guaranteed in space
WO2011037046A1 (en) * 2009-09-22 2011-03-31 オリンパス株式会社 Device for injecting therapeutic solution
JP5567840B2 (en) * 2009-09-22 2014-08-06 オリンパス株式会社 Cell injection device
US9017310B2 (en) * 2009-10-08 2015-04-28 Palo Alto Research Center Incorporated Transmucosal drug delivery device and method including microneedles
US8882748B2 (en) 2009-10-08 2014-11-11 Palo Alto Research Center Incorporated Transmucosal drug delivery device and method including chemical permeation enhancers
US9014799B2 (en) * 2009-10-08 2015-04-21 Palo Alto Research Center Incorporated Transmucosal drug delivery device and method including electrically-actuated permeation enhancement
US8177747B2 (en) * 2009-12-22 2012-05-15 Alcon Research, Ltd. Method and apparatus for drug delivery
US8348898B2 (en) 2010-01-19 2013-01-08 Medimop Medical Projects Ltd. Automatic needle for drug pump
USD644731S1 (en) 2010-03-23 2011-09-06 Icu Medical, Inc. Medical connector
US8251980B2 (en) * 2010-03-30 2012-08-28 Alcon Research, Ltd. Viscous fluid extraction
BR112012025500A2 (en) * 2010-04-05 2016-06-21 Neomend Inc automatic purge system for releasing a hydrogel composition and method for releasing a hydrogel composition
US8876833B2 (en) 2010-04-30 2014-11-04 Kyphon Sarl Multi-port delivery system
US9452261B2 (en) 2010-05-10 2016-09-27 Medimop Medical Projects Ltd. Low volume accurate injector
US8758306B2 (en) 2010-05-17 2014-06-24 Icu Medical, Inc. Medical connectors and methods of use
US8814833B2 (en) 2010-05-19 2014-08-26 Tangent Medical Technologies Llc Safety needle system operable with a medical device
US8771230B2 (en) 2010-05-19 2014-07-08 Tangent Medical Technologies, Llc Integrated vascular delivery system
CA2800735A1 (en) 2010-06-02 2011-12-08 Sanofi-Aventis Deutschland Gmbh Training cartridge for a drug delivery device
US20110301539A1 (en) * 2010-06-08 2011-12-08 Rickard Matthew J A Fill and purge system for a drug reservoir
US8652104B2 (en) 2010-06-25 2014-02-18 Smiths Medical Asd, Inc. Catheter assembly with seal member
US9545495B2 (en) 2010-06-25 2017-01-17 Smiths Medical Asd, Inc. Catheter assembly with seal member
EP2588180B1 (en) * 2010-06-29 2016-12-07 Hospitech Respiration Ltd. Device and method for irrigating-evacuating a body cavity
EP2407194A1 (en) * 2010-07-12 2012-01-18 SOFIC (Sté Française d'Instruments de Chirurgie) Injection system for mixing two injectable compositions prior to injection
US9028425B2 (en) 2010-07-15 2015-05-12 Becton, Dickinson And Company Vented blood sampling device
US8357119B2 (en) 2010-07-15 2013-01-22 Becton, Dickinson And Company Catheter assembly and pierced septum valve
US8361020B2 (en) 2010-07-15 2013-01-29 Becton, Dickinson And Company Catheter assembly and pierced septum valve
EP2407394B1 (en) * 2010-07-16 2013-01-16 Sulzer Mixpac AG Cartridge with rinsing
US8864715B2 (en) 2010-09-08 2014-10-21 Becton, Dickinson And Company Assembly method for catheter with blood control
US8932259B2 (en) 2010-09-13 2015-01-13 Becton, Dickinson And Company Catheter assembly
DE102010045798A1 (en) * 2010-09-20 2012-04-19 Universitätsklinikum Hamburg-Eppendorf The blood collection device
US20120085152A1 (en) * 2010-10-07 2012-04-12 Funk Donald A Fluid analysis tool
US20130233062A1 (en) * 2010-10-07 2013-09-12 Donald A. Funk Fluid analysis tool
US9084849B2 (en) 2011-01-26 2015-07-21 Kaleo, Inc. Medicament delivery devices for administration of a medicament within a prefilled syringe
WO2012106174A1 (en) 2011-01-31 2012-08-09 Fresenius Medical Care Holdings, Inc. Preventing over-delivery of drug
CN106902406B (en) 2011-02-08 2019-11-08 弗雷塞尼斯医疗保健控股公司 Magnetic sensor and related system and method
US9259554B2 (en) 2011-03-07 2016-02-16 Becton, Dickinson And Company Systems and methods to compensate for compression forces in an intravascular device
US8641675B2 (en) 2011-03-07 2014-02-04 Becton, Dickinson And Company Systems and methods for preventing septum damage in an intravascular device
US8616879B2 (en) * 2011-03-22 2013-12-31 Centrix, Inc. Capsule and delivery tip with transition portion for dispensing viscous reactive dental materials
USD702834S1 (en) 2011-03-22 2014-04-15 Medimop Medical Projects Ltd. Cartridge for use in injection device
US11338081B2 (en) * 2011-04-04 2022-05-24 Jihad Mustapha Fluid mixing device
WO2012142502A2 (en) 2011-04-15 2012-10-18 Dexcom Inc. Advanced analyte sensor calibration and error detection
US9289562B2 (en) 2011-04-18 2016-03-22 THORNE CONSULTING and INTELETUAL PROPERTY, LLC Pressure actuated valve for multi-chamber syringe applications
US8992505B2 (en) 2011-04-18 2015-03-31 Thorne Consulting & Intellectual Property, LLC Medical syringe filling and valving
US9950114B2 (en) 2011-05-13 2018-04-24 Thorne Consulting For International Property, Llc Dual-chamber syringe and associated connecting systems
US9333288B2 (en) 2011-09-30 2016-05-10 Becton Dickinson France, S.A.S. Attachable plunger rod and associated packaging
US9089671B2 (en) 2011-10-06 2015-07-28 Becton, Dickinson And Company Systems and methods for sealing a septum within a catheter device
US9155863B2 (en) 2011-10-06 2015-10-13 Becton, Dickinson And Company Multiple use stretching and non-penetrating blood control valves
US9155876B2 (en) 2011-10-06 2015-10-13 Becton, Dickinson And Company Port valve of a blood control catheter
US9155864B2 (en) 2011-10-06 2015-10-13 Becton, Dickinson And Company Multiple use blood control valve with center and circumferential slits
US9126012B2 (en) 2011-10-06 2015-09-08 Becton, Dickinson And Company Intravenous catheter with duckbill valve
US9358364B2 (en) 2011-10-06 2016-06-07 Becton, Dickinson And Company Activator attachment for blood control catheters
EP3216478A1 (en) 2012-01-03 2017-09-13 Hospitech Respiration Ltd. System and method for determining cuff rupture in a cuffed endotracheal tube
US8834449B2 (en) * 2012-01-23 2014-09-16 Ikomed Technologies, Inc. Mixing syringe
US10335545B2 (en) 2012-01-31 2019-07-02 West Pharma. Services IL, Ltd. Time dependent drug delivery apparatus
SG192310A1 (en) 2012-02-02 2013-08-30 Becton Dickinson Holdings Pte Ltd Adaptor for coupling to a medical container
US10668213B2 (en) 2012-03-26 2020-06-02 West Pharma. Services IL, Ltd. Motion activated mechanisms for a drug delivery device
US9072827B2 (en) 2012-03-26 2015-07-07 Medimop Medical Projects Ltd. Fail safe point protector for needle safety flap
US9463280B2 (en) 2012-03-26 2016-10-11 Medimop Medical Projects Ltd. Motion activated septum puncturing drug delivery device
US9144646B2 (en) 2012-04-25 2015-09-29 Fresenius Medical Care Holdings, Inc. Vial spiking devices and related assemblies and methods
US9522235B2 (en) 2012-05-22 2016-12-20 Kaleo, Inc. Devices and methods for delivering medicaments from a multi-chamber container
US9060724B2 (en) 2012-05-30 2015-06-23 Magnolia Medical Technologies, Inc. Fluid diversion mechanism for bodily-fluid sampling
US9022950B2 (en) 2012-05-30 2015-05-05 Magnolia Medical Technologies, Inc. Fluid diversion mechanism for bodily-fluid sampling
US9579486B2 (en) 2012-08-22 2017-02-28 Becton, Dickinson And Company Blood control IV catheter with antimicrobial properties
US9999720B2 (en) 2012-09-27 2018-06-19 Palo Alto Research Center Incorporated Drug reconstitution and delivery device and methods
US9005108B2 (en) 2012-09-27 2015-04-14 Palo Alto Research Center Incorporated Multiple reservoir drug delivery device and methods
EP3906952A1 (en) 2012-10-11 2021-11-10 Magnolia Medical Technologies, Inc. Systems and methods for delivering a fluid to a patient with reduced contamination
KR102023143B1 (en) * 2012-11-08 2019-09-19 술저 믹스팩 아게 Cartridge for at least two flowable components
US9155495B2 (en) 2012-11-30 2015-10-13 Magnolia Medical Technologies, Inc. Syringe-based fluid diversion mechanism for bodily fluid sampling
US10772548B2 (en) 2012-12-04 2020-09-15 Magnolia Medical Technologies, Inc. Sterile bodily-fluid collection device and methods
US9421323B2 (en) 2013-01-03 2016-08-23 Medimop Medical Projects Ltd. Door and doorstop for portable one use drug delivery apparatus
US9744341B2 (en) 2013-01-15 2017-08-29 Palo Alto Research Center Incorporated Devices and methods for intraluminal retention and drug delivery
US9750928B2 (en) 2013-02-13 2017-09-05 Becton, Dickinson And Company Blood control IV catheter with stationary septum activator
US9695323B2 (en) 2013-02-13 2017-07-04 Becton, Dickinson And Company UV curable solventless antimicrobial compositions
US9408981B2 (en) 2013-03-10 2016-08-09 Bayer Healthcare Llc Adjustable volume syringe
US9114215B2 (en) * 2013-03-13 2015-08-25 Bayer Medical Care Inc. Multiple compartment syringe
US9855385B2 (en) 2013-03-13 2018-01-02 Bayer Healthcare Llc Multiple compartment syringe
DE102013104018B4 (en) * 2013-04-22 2022-09-15 Gerresheimer Regensburg Gmbh Plastic syringe having an operator interface for positioning on a syringe operator
US9011164B2 (en) 2013-04-30 2015-04-21 Medimop Medical Projects Ltd. Clip contact for easy installation of printed circuit board PCB
US9889256B2 (en) 2013-05-03 2018-02-13 Medimop Medical Projects Ltd. Sensing a status of an infuser based on sensing motor control and power input
EP3079739B1 (en) 2013-12-11 2023-02-22 ICU Medical, Inc. Check valve
US9297083B2 (en) 2013-12-16 2016-03-29 Palo Alto Research Center Incorporated Electrolytic gas generating devices, actuators, and methods
US9750925B2 (en) 2014-01-21 2017-09-05 Becton, Dickinson And Company Ported catheter adapter having combined port and blood control valve with venting
AU2015214400B2 (en) 2014-02-04 2019-10-03 Icu Medical, Inc. Self-priming systems and methods
US10376686B2 (en) 2014-04-23 2019-08-13 Becton, Dickinson And Company Antimicrobial caps for medical connectors
US9675793B2 (en) 2014-04-23 2017-06-13 Becton, Dickinson And Company Catheter tubing with extraluminal antimicrobial coating
US9789279B2 (en) 2014-04-23 2017-10-17 Becton, Dickinson And Company Antimicrobial obturator for use with vascular access devices
US10232088B2 (en) 2014-07-08 2019-03-19 Becton, Dickinson And Company Antimicrobial coating forming kink resistant feature on a vascular access device
US9801660B2 (en) 2014-07-31 2017-10-31 Palo Alto Research Center Incorporated Implantable fluid delivery devices, systems, and methods
US10278675B2 (en) 2014-07-31 2019-05-07 Palo Alto Research Center Incorporated Implantable estrus detection devices, systems, and methods
USD793551S1 (en) 2014-12-03 2017-08-01 Icu Medical, Inc. Fluid manifold
USD786427S1 (en) 2014-12-03 2017-05-09 Icu Medical, Inc. Fluid manifold
EP3028729B1 (en) 2014-12-05 2020-09-16 elm-plastic GmbH Injector for dispensing a liquid or paste substance, in particular a medicament
DE102015002234A1 (en) 2014-12-05 2016-06-09 Elm - Plastic Gmbh Injector for dispensing a liquid or pasty substance, in particular medicament
CN105769329B (en) * 2014-12-24 2018-02-23 中国科学院理化技术研究所 Disposable squash type alkali metal injection device
CN104606739A (en) * 2015-01-17 2015-05-13 陈伟权 Anti-thrombotic safety cap for venous indwelling needle and using method thereof
WO2016122732A1 (en) * 2015-01-30 2016-08-04 Emd Millipore Corporation Fluid transfer device, system and method
US10251813B2 (en) 2015-03-04 2019-04-09 West Pharma. Services IL, Ltd. Flexibly mounted cartridge alignment collar for drug delivery device
US9795534B2 (en) 2015-03-04 2017-10-24 Medimop Medical Projects Ltd. Compliant coupling assembly for cartridge coupling of a drug delivery device
CA2980004C (en) 2015-03-24 2023-10-10 Kaleo, Inc. Devices and methods for delivering a lyophilized medicament
US10293120B2 (en) 2015-04-10 2019-05-21 West Pharma. Services IL, Ltd. Redundant injection device status indication
US9744297B2 (en) 2015-04-10 2017-08-29 Medimop Medical Projects Ltd. Needle cannula position as an input to operational control of an injection device
US10149943B2 (en) 2015-05-29 2018-12-11 West Pharma. Services IL, Ltd. Linear rotation stabilizer for a telescoping syringe stopper driverdriving assembly
WO2016201406A1 (en) 2015-06-12 2016-12-15 Bullington Gregory J Devices and methods for syringe-based fluid transfer for bodily-fluid sampling
US10357429B2 (en) * 2015-07-16 2019-07-23 West Pharma. Services IL, Ltd. Liquid drug transfer devices for secure telescopic snap fit on injection vials
AU2016297643B2 (en) * 2015-07-22 2020-10-22 Cardioguidance Biomedical, Llc Guidewire navigation system with direct visualization feature
US10182939B2 (en) 2015-09-16 2019-01-22 Novartis Ag Hydraulic injector and methods for intra-ocular lens insertion
US10576207B2 (en) 2015-10-09 2020-03-03 West Pharma. Services IL, Ltd. Angled syringe patch injector
US10086145B2 (en) * 2015-09-22 2018-10-02 West Pharma Services Il, Ltd. Rotation resistant friction adapter for plunger driver of drug delivery device
US9987432B2 (en) * 2015-09-22 2018-06-05 West Pharma. Services IL, Ltd. Rotation resistant friction adapter for plunger driver of drug delivery device
CN108430536B (en) 2015-10-09 2022-04-08 西医药服务以色列分公司 Method of filling a custom syringe
US10245416B2 (en) 2015-10-28 2019-04-02 Becton, Dickinson And Company Intravenous catheter device with integrated extension tube
US10525237B2 (en) 2015-10-28 2020-01-07 Becton, Dickinson And Company Ergonomic IV systems and methods
US10639455B2 (en) 2015-10-28 2020-05-05 Becton, Dickinson And Company Closed IV access device with paddle grip needle hub and flash chamber
US10814106B2 (en) 2015-10-28 2020-10-27 Becton, Dickinson And Company Soft push tabs for catheter adapter
US10357636B2 (en) 2015-10-28 2019-07-23 Becton, Dickinson And Company IV access device having an angled paddle grip
US10744305B2 (en) 2015-10-28 2020-08-18 Becton, Dickinson And Company Ergonomic IV systems and methods
US10493244B2 (en) 2015-10-28 2019-12-03 Becton, Dickinson And Company Extension tubing strain relief
US10549072B2 (en) 2015-10-28 2020-02-04 Becton, Dickinson And Company Integrated catheter with independent fluid paths
CN111544704B (en) 2016-01-21 2022-06-03 西医药服务以色列有限公司 Force containment in autoinjectors
JP6885960B2 (en) 2016-01-21 2021-06-16 ウェスト ファーマ サービシーズ イスラエル リミテッド Drug delivery device with visual indicators
WO2017127215A1 (en) 2016-01-21 2017-07-27 Medimop Medical Projects Ltd. Needle insertion and retraction mechanism
WO2017161076A1 (en) 2016-03-16 2017-09-21 Medimop Medical Projects Ltd. Staged telescopic screw assembly having different visual indicators
US10376647B2 (en) 2016-03-18 2019-08-13 West Pharma. Services IL, Ltd. Anti-rotation mechanism for telescopic screw assembly
JP6957525B2 (en) 2016-06-02 2021-11-02 ウェスト ファーマ サービシーズ イスラエル リミテッド Needle evacuation by 3 positions
JP6869327B2 (en) 2016-08-01 2021-05-12 ウェスト ファーマ サービシーズ イスラエル リミテッド Anti-rotation cartridge
EP3490635B1 (en) 2016-08-01 2021-11-17 West Pharma. Services Il, Ltd. Partial door closure prevention spring
CN106039480A (en) * 2016-08-04 2016-10-26 山东威高集团医用高分子制品股份有限公司 Pre-filled syringe for continuous treatment
US10159973B2 (en) * 2016-08-31 2018-12-25 Toshiba Medical Systems Corporation Sample liquid preparing apparatus, test kit, and sample liquid preparing method
US10322235B2 (en) 2016-09-30 2019-06-18 Thorne Consulting & Intellectual Property, LLC Multiple chamber syringe piston and mixing devices
USD837368S1 (en) 2016-10-05 2019-01-01 Becton, Dickinson And Company Catheter adapter grip
USD844781S1 (en) 2016-10-05 2019-04-02 Becton, Dickinson And Company Needle hub
US10238852B2 (en) 2016-10-05 2019-03-26 Becton, Dickinson And Company Septum housing
USD819802S1 (en) 2016-10-05 2018-06-05 Becton, Dickinson And Company Catheter adapter
USD835262S1 (en) 2016-10-05 2018-12-04 Becton, Dickinson And Company Intravenous catheter assembly
GB2556088A (en) * 2016-11-18 2018-05-23 Owen Mumford Ltd Packaging and devices for mixing medicament substances
DE102017202607A1 (en) 2017-02-17 2018-08-23 Vetter Pharma-Fertigung GmbH & Co. KG Drug container for storing and providing at least two medicament substances which can be mixed with one another and methods for operating such a medicament container
CN110869072B (en) 2017-05-30 2021-12-10 西部制药服务有限公司(以色列) Modular drive mechanism for a wearable injector
AU2018334138A1 (en) 2017-09-12 2020-03-12 Magnolia Medical Technologies, Inc. Fluid control devices and methods of using the same
CA3077720A1 (en) 2017-10-24 2019-05-02 Dexcom, Inc. Pre-connected analyte sensors
US11331022B2 (en) 2017-10-24 2022-05-17 Dexcom, Inc. Pre-connected analyte sensors
US10595761B2 (en) 2017-11-01 2020-03-24 Edwards Lifesciences Corporation Adapter for use with a multi-port control valve used in blood sampling, blood pressure measurement systems
US20190125232A1 (en) 2017-11-01 2019-05-02 Edwards Lifesciences Corporation Multi-port control valve for use in blood sampling, blood pressure measurement systems
CN115553822A (en) 2017-12-07 2023-01-03 木兰医药技术股份有限公司 Fluid control device and method of use
JP7402799B2 (en) 2017-12-22 2023-12-21 ウェスト ファーマ サービシーズ イスラエル リミテッド Syringes available with different cartridge sizes
WO2020036858A1 (en) 2018-08-13 2020-02-20 Monumedical, Llc Syringe with multi-stage filling and dispensing
US20210353868A1 (en) * 2018-09-13 2021-11-18 Cedars-Sinai Medical Center Hydraulic syringe
WO2020163744A1 (en) 2019-02-08 2020-08-13 Magnolia Medical Technologies, Inc. Devices and methods for bodily fluid collection and distribution
CN113784793B (en) 2019-03-11 2023-09-19 木兰医药技术股份有限公司 Fluid control device and method of using the same
WO2022190982A1 (en) * 2021-03-08 2022-09-15 テルモ株式会社 Pre-filled syringe
WO2023076673A1 (en) * 2021-10-29 2023-05-04 Kuracina Thomas C Method and apparatus to reduce the deadspace in syringes and small-bore devices
WO2023159050A1 (en) * 2022-02-15 2023-08-24 Haran Todd Michael Multistage fluidic device
USD980067S1 (en) * 2022-04-27 2023-03-07 Xiamen Yangchangsheng Silicone Rubber Products Co., Ltd. Water bottle cap

Family Cites Families (159)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2357238A (en) * 1943-11-18 1944-08-29 Averal T Trimble Process and apparatus for treating blood
US2546672A (en) 1947-07-25 1951-03-27 Tecalemit Ltd Nipple or lubricant-receiving device
US2847996A (en) * 1953-08-13 1958-08-19 Miljam Instr Corp Hypodermic syringe
US2737948A (en) * 1954-08-23 1956-03-13 Pfizer & Co C Disposable cartridge for hypodermic syringe
US2989053A (en) * 1956-01-17 1961-06-20 Baxter Don Inc Hypodermic needle
US2937643A (en) * 1957-10-11 1960-05-24 Eric C Elliot Device for fluid transference
US2922420A (en) * 1957-11-29 1960-01-26 Sierra Eng Co Epidural needle
US3067742A (en) * 1960-05-10 1962-12-11 American Home Prod Smallpox vaccine system
FR1373027A (en) * 1963-05-22 1964-09-25 Improved device for opening a container or a sealed conduit, in particular for perfusion and blood transfusion
US3291151A (en) * 1963-11-06 1966-12-13 Selmer M Loken Fluid exchange system
US3344785A (en) * 1965-02-01 1967-10-03 Pharmaseal Lab Valve for exchange transfusion system
US3563240A (en) * 1966-07-20 1971-02-16 Jules Silver Dual unit syringe
DE1278703B (en) * 1967-01-21 1968-09-26 Penicillin Ges Dauelsberg & Co Two-chamber syringe
US3577992A (en) 1967-08-31 1971-05-11 Brunswick Corp Valve for use with a conduit having a lumen
US3494359A (en) * 1969-03-17 1970-02-10 Silver Jules Two compartment syringe with a single barrel
FR2049513A5 (en) * 1969-06-12 1971-03-26 Monsallier Julien Blood sampler for external circulations
US3606889A (en) * 1969-07-30 1971-09-21 Dennis Arblaster Guard accessory for catheter
US3633758A (en) * 1970-01-09 1972-01-11 North American Instr Corp Catheter storage rack
AU1394570A (en) * 1970-04-16 1971-10-21 Fort David Laboratories, Inc Partially assembled bulk parenteral solution container and administration set
US3680558A (en) * 1970-05-27 1972-08-01 Robert F Kapelowitz Syringe with multiple compartments
US3659587A (en) * 1970-06-30 1972-05-02 Affiliated Hospital Prod Valved connector arrangement
US3648704A (en) * 1970-07-17 1972-03-14 Frederick E Jackson Disposable catheter apparatus
US3730170A (en) * 1971-04-29 1973-05-01 T Michael Apparatus for distributing a sample of blood to a plurality of cultures
US3807119A (en) * 1972-06-21 1974-04-30 W Shields Method of assembling a multiple compartment hypodermic syringe
US3796211A (en) * 1972-08-07 1974-03-12 Medics Res & Dev Inc Biopsy sampling method and device for the female genital tract
US3835855A (en) * 1972-10-10 1974-09-17 C Barr Multi-chambered syringe
US3835835A (en) * 1972-11-07 1974-09-17 Richardson Merrell Inc Two compartment locking sampling syringe
US3851649A (en) * 1973-03-21 1974-12-03 Kendall & Co Catheterization package
US3986508A (en) * 1973-08-22 1976-10-19 Abcor, Inc. Sterilizable, medical connector for blood processing
US4016879A (en) * 1973-08-22 1977-04-12 Dynasciences Corporation Multi-mode cannulating apparatus
US3894540A (en) * 1973-10-09 1975-07-15 Bonner F J Jun Catheter
NL172403C (en) * 1974-04-08 1983-09-01 Duphar Int Res SYRINGE WITH A CARTRIDGE AND A CARTRIDGE, WITH THE CARTRIDGE CONTAINING PATTERN LOCKERS, AND THE CARTRIDGE CONTAINER FOR AN INJECTION SYRINGE.
US3929309A (en) * 1974-08-26 1975-12-30 Pierce Louis B Head rest
US3985122A (en) * 1975-06-04 1976-10-12 Medical Development Corporation Multi-piston syringe device
US4014328A (en) * 1975-06-23 1977-03-29 Cluff Kenneth C Blood sampling and infusion chamber
US4051852A (en) * 1975-06-26 1977-10-04 The Kendall Company Aspirating device
US4013064A (en) * 1975-06-26 1977-03-22 The Kendall Company Port means for a liquid transport system
US4051849A (en) * 1976-04-06 1977-10-04 Poncy Mark P Catheter feeding system
US4058121A (en) * 1976-06-29 1977-11-15 American Hospital Supply Corporation Vented needle for medical liquids
US4068659A (en) * 1976-07-12 1978-01-17 Deseret Pharmaceutical Co., Inc. Catheter placement assembly
US4078565A (en) * 1976-10-04 1978-03-14 Abbott Laboratories Readily activated hypodermic syringe
SE415728B (en) * 1977-03-07 1980-10-27 Gambro Ab COUPLING
US4197848A (en) * 1978-01-06 1980-04-15 Baxter Travenol Laboratories, Inc. Closed urinary irrigation site
US4437858A (en) * 1978-01-16 1984-03-20 Ty Perla J Separator disc and hypodermic syringe incorporating the same and method
US4219021A (en) * 1978-02-27 1980-08-26 Fink Joseph L Multi-position stop-cock valve for intravenous administration of multiple medications
US4276880A (en) * 1978-09-14 1981-07-07 Oscar Malmin Cannula and process
SE414272B (en) * 1978-10-17 1980-07-21 Viggo Ab CANNEL OR CATETER DEVICE
US4776843A (en) * 1980-11-21 1988-10-11 Minntech Corporation Blood access systems
US4496350A (en) * 1980-04-08 1985-01-29 Renal Systems, Inc. Blood access device
US4327723A (en) * 1980-05-13 1982-05-04 Arrow International, Inc. Catheter shield
US4364383A (en) * 1980-08-25 1982-12-21 Vcelka John L I.V. Flashback indication
US4335717A (en) * 1980-10-10 1982-06-22 Abbott Laboratories I.V. Administration set with retrograde volume
AU7485681A (en) * 1980-10-22 1982-04-29 Travenol European Research And Development Centre Spike connector
US4379506A (en) * 1981-04-02 1983-04-12 Davidson Alan C Catheter assembly
EP0072058A1 (en) * 1981-08-10 1983-02-16 Duphar International Research B.V Multiple-compartment syringe
DE3270641D1 (en) * 1981-11-11 1986-05-22 Contraves Ag Syringe for a sequential injection of two fluids into blood vessels of living bodies
US4439184A (en) * 1982-05-03 1984-03-27 Concord Laboratories, Inc. Two-dose syringe
US4464174A (en) * 1982-09-27 1984-08-07 Silver Industries, Inc. Two compartment mixing syringe seal
US4511359A (en) * 1982-09-29 1985-04-16 Manresa, Inc. Sterile connection device
DE8235862U1 (en) * 1982-12-21 1983-06-16 B. Braun Melsungen Ag, 3508 Melsungen INJECTION DEVICE FOR AN INFUSION OR TRANSFUSION SYSTEM
US4752292A (en) * 1983-01-24 1988-06-21 Icu Medical, Inc. Medical connector
US4715865A (en) 1984-06-29 1987-12-29 Exxon Research And Engineering Company Method for controlling viscosity of organic liquids and compositions
DE8402311U1 (en) * 1984-01-27 1984-04-19 B. Braun Melsungen Ag, 3508 Melsungen INJECTION DEVICE FOR AN INFUSION OR TRANSFUSION SYSTEM
CA1221596A (en) * 1984-03-09 1987-05-12 David Evans Surgical needle
US4568334A (en) * 1984-04-25 1986-02-04 Lynn Lawrence A Intravascular catheter preparation and dispensing container assembly
US4588403A (en) * 1984-06-01 1986-05-13 American Hospital Supply Corporation Vented syringe adapter assembly
DE3508013A1 (en) * 1984-07-28 1986-02-06 Peter 7730 Villingen-Schwenningen Krebs COMBINATION NEEDLE FOR THE AXILLAERE PLEXUS-BRACHIALIS-ANESTHESIA
US4634427A (en) * 1984-09-04 1987-01-06 American Hospital Supply Company Implantable demand medication delivery assembly
US4759756A (en) * 1984-09-14 1988-07-26 Baxter Travenol Laboratories, Inc. Reconstitution device
US4578063A (en) * 1984-09-14 1986-03-25 W. L. Gore & Assoc., Inc. Central venous catheter
JPS61206445A (en) * 1985-03-11 1986-09-12 テルモ株式会社 Air passing needle and its production
US4699612A (en) * 1985-04-01 1987-10-13 Hamacher Edward N Infusion needle
US4675004A (en) * 1985-04-16 1987-06-23 Quinton Instrument Company Dual-lumen fistula needle
US4609371A (en) * 1985-06-24 1986-09-02 Pizzino Joanne L Dual syringe for either simultaneous or sequential injection of liquids
US4610666A (en) * 1985-06-24 1986-09-09 Pizzino Joanne L Dual syringe
DE3687530T2 (en) * 1985-06-27 1993-07-22 Duphar Int Res SYRINGE.
US4666438A (en) * 1985-07-02 1987-05-19 Raulerson J Daniel Needle for membrane penetration
EP0208975A3 (en) * 1985-07-04 1987-05-20 Antonio Gomez Gomez Syringe for producing vacuum-controlled suction
DE3524824A1 (en) * 1985-07-11 1987-01-15 Fresenius Ag DEVICE FOR SAMPLING AND INFUSION
US4650475A (en) * 1985-07-18 1987-03-17 Carol Smith Method and apparatus for the injection of pharmaceuticals
US4929235A (en) * 1985-07-31 1990-05-29 Universal Medical Instrument Corp. Self-sealing percutaneous tube introducer
US4838877A (en) * 1985-08-06 1989-06-13 Massau Bruce A Polymeric hypodermic device
US4675007A (en) * 1985-10-03 1987-06-23 Concept, Inc. Coupling device for attachment to an end of a catheter
GB8527646D0 (en) * 1985-11-08 1985-12-11 Cox J A Devices for sampling drainage
FR2589738A1 (en) * 1985-11-14 1987-05-15 Lascar Marcel DOUBLE CHAMBER SYRINGE
US4655747A (en) * 1986-01-30 1987-04-07 Allen Jr Robert E Dual chambered syringe
US4654034A (en) * 1986-02-03 1987-03-31 Masters Edwin J Safety needle cap
US4650468A (en) * 1986-02-26 1987-03-17 Jennings Jr Baldwin P Medical syringe
US4834152A (en) * 1986-02-27 1989-05-30 Intelligent Medicine, Inc. Storage receptacle sealing and transfer apparatus
US4673386A (en) * 1986-03-06 1987-06-16 Gordon Mark G Blood sampler device
CH666870A5 (en) * 1986-04-10 1988-08-31 Cosmonor Sa DEVICE FOR PACKAGING LIQUID OR LIQUID AND SOLID SUBSTANCES.
US4675005A (en) * 1986-05-08 1987-06-23 Deluccia James Retractable disposable syringe
US4702737A (en) * 1986-07-14 1987-10-27 Pizzino Joanne L Dual dose syringe
US4715854A (en) * 1986-07-17 1987-12-29 Vaillancourt Vincent L Multidose disposable syringe and method of filling same
US4693706A (en) * 1986-08-11 1987-09-15 Mark L. Anderson Two compartment mixing syringe
US4763648A (en) * 1986-09-12 1988-08-16 Migada, Inc. Method and apparatus for arterial and venous blood sampling
US4981140A (en) * 1986-09-12 1991-01-01 Philip Wyatt Method and apparatus for arterial and venous blood sampling
US4710180A (en) * 1986-10-06 1987-12-01 Johnson Gerald W Lipoject needle
US4799494A (en) * 1986-10-22 1989-01-24 Wang Ko P Percutaneous aspiration lung biopsy needle assembly
US4721506A (en) * 1986-11-07 1988-01-26 Teves Leonides Y Flat-inclined tip needle
US4989606A (en) * 1987-01-30 1991-02-05 Minnesota Mining And Manufactoring Company Intravascular blood gas sensing system
US4830013A (en) * 1987-01-30 1989-05-16 Minnesota Mining And Manufacturing Co. Intravascular blood parameter measurement system
US5251873B1 (en) 1992-06-04 1995-05-02 Vernay Laboratories Medical coupling site.
US5295658A (en) 1987-04-27 1994-03-22 Vernay Laboratories, Inc. Medical coupling site including slit reinforcing members
US4865583A (en) * 1987-05-04 1989-09-12 Tu Ho C Combination blood sampling and intravenous infusion apparatus and method
DE3775054D1 (en) * 1987-06-16 1992-01-16 Akzo Nv TWO-CHAMBER SYRINGE AND MANUFACTURING METHOD.
US4768568A (en) * 1987-07-07 1988-09-06 Survival Technology, Inc. Hazardous material vial apparatus providing expansible sealed and filter vented chambers
US5178607A (en) * 1987-07-31 1993-01-12 Lynn Lawrence A Blood aspiration assembly septum and blunt needle aspirator
US4838855A (en) * 1987-07-31 1989-06-13 Lynn Lawrence A Blood aspiration assembly and method
US5114400A (en) * 1990-06-19 1992-05-19 Lynn Lawrence A Blood withdrawal apparatus and method
DE8714659U1 (en) * 1987-11-04 1987-12-10 Clinico Infusionstechnik Gmbh & Co Medizinische Kunststoffprodukte Kg, 6430 Bad Hersfeld, De
US5211638A (en) 1988-01-25 1993-05-18 Baxter International Inc. Pre-slit injection site
EP0544653B1 (en) 1988-01-25 1996-06-05 Baxter International Inc. Injection site
CA1335167C (en) * 1988-01-25 1995-04-11 Steven C. Jepson Pre-slit injection site and associated cannula
US5100394A (en) 1988-01-25 1992-03-31 Baxter International Inc. Pre-slit injection site
US4932944A (en) * 1988-03-09 1990-06-12 The University Of Virginia Alumni Patents Foundation Intravenous port injection and connector system
US4981469A (en) * 1988-04-18 1991-01-01 Dij Catheter Corp. Septum adapter assembly and external needle adapter fitting
US4950257A (en) * 1988-09-15 1990-08-21 Mallinckrodt, Inc. Catheter introducer with flexible tip
US5007903A (en) * 1988-11-22 1991-04-16 Real World Design & Development Company Syringe adapted to prevent needle sticks
IL88947A (en) * 1989-01-13 1993-02-21 Mordechai Ravid Tel Aviv Uzi K Biopsy syringe device and method of using same
IE62767B1 (en) * 1989-03-17 1995-02-22 Baxter Int Pre-slit injection site and tapered cannula
US5104379A (en) * 1989-04-03 1992-04-14 Olympus Optical Co., Ltd. Medical instrument and valve to be mounted on a mount piece of that instrument
US4998927A (en) * 1989-08-18 1991-03-12 Vaillancourt Vincent L Connector
US5149327A (en) * 1989-09-05 1992-09-22 Terumo Kabushiki Kaisha Medical valve, catheter with valve, and catheter assembly
US4979942A (en) * 1989-10-16 1990-12-25 Johnson & Johnson Medical, Inc. Two component syringe delivery system
US4979941A (en) * 1989-12-05 1990-12-25 International Medication Systems, Limited Device suitable for mixing medication
DE4000764A1 (en) * 1990-01-12 1991-07-18 Braun Melsungen Ag APPROACH
US5078691A (en) * 1990-03-01 1992-01-07 Hamacher Edward N Multiple-dose fluid delivery system and method
CA2016870C (en) * 1990-05-15 1994-03-29 Arnie Drudik Dispenser for storing and mixing several components
US5048537A (en) * 1990-05-15 1991-09-17 Medex, Inc. Method and apparatus for sampling blood
DK174390D0 (en) * 1990-07-20 1990-07-20 Novo Nordisk As two-chamber injector
US5215537A (en) * 1990-09-13 1993-06-01 Lynn Lawrence A Septum for a blunt cannula
US5203775A (en) 1990-09-18 1993-04-20 Medex, Inc. Needleless connector sample site
US5147323A (en) * 1991-03-08 1992-09-15 Habley Medical Technology Corporation Multiple cartridge syringe
DE9105229U1 (en) 1991-04-27 1991-06-13 B. Braun Melsungen Ag, 3508 Melsungen, De
US5199948A (en) 1991-05-02 1993-04-06 Mcgaw, Inc. Needleless valve
US5102388A (en) * 1991-07-15 1992-04-07 Richmond John E Sequential delivery syringe
US5201725A (en) * 1991-09-26 1993-04-13 Ivac Needle free i.v. adapter
US5242432A (en) * 1991-09-26 1993-09-07 Ivac Needleless adapter
US5360413A (en) * 1991-12-06 1994-11-01 Filtertek, Inc. Needleless access device
US5211370A (en) * 1992-01-06 1993-05-18 Powers Ronald J Variable orifice sealing valve
US5215538A (en) * 1992-02-05 1993-06-01 Abbott Laboratories Connector-activated in-line valve
US5273533A (en) * 1992-03-11 1993-12-28 Care Medical Products, Inc. Medical valve
US5501426A (en) 1992-06-04 1996-03-26 Vernay Laboratories, Inc. Medical coupling site valve body
US5533708A (en) 1992-06-04 1996-07-09 Vernay Laboratories, Inc. Medical coupling site valve body
US5300034A (en) 1992-07-29 1994-04-05 Minnesota Mining And Manufacturing Company Iv injection site for the reception of a blunt cannula
US5603706A (en) 1992-09-29 1997-02-18 Wyatt; Philip Infusion apparatus
US5324266A (en) * 1992-12-23 1994-06-28 Abbott Laboratories In-line sampling system incorporating an improved blood sampling device
US5449145A (en) 1993-10-08 1995-09-12 Surgin Surgical Instrumentation, Inc. Valve device for controlling flows in surgical applications
US5509433A (en) * 1993-10-13 1996-04-23 Paradis; Joseph R. Control of fluid flow
US5429610A (en) * 1993-11-19 1995-07-04 Vaillancourt; Vincent L. Dual chamber syringe for collecting samples and blood collecting system
WO1995015195A1 (en) * 1993-11-30 1995-06-08 Medex, Inc. Plastic needleless valve housing for standard male luer locks
US5396925A (en) * 1993-12-16 1995-03-14 Abbott Laboratories Anti-free flow valve, enabling fluid flow as a function of pressure and selectively opened to enable free flow
US5403293A (en) 1994-01-03 1995-04-04 Abbott Laboratories Molded partial pre-slit reseal
US5522804A (en) * 1994-02-15 1996-06-04 Lynn; Lawrence A. Aspiration, mixing, and injection syringe
US5549651A (en) * 1994-05-25 1996-08-27 Lynn; Lawrence A. Luer-receiving medical valve and fluid transfer method
US5390898A (en) 1994-04-06 1995-02-21 Habley Medical Technology Corporation Needleless dual direction check valve
US5474544A (en) 1994-05-25 1995-12-12 Lynn; Lawrence A. Luer-receiving medical valve
US5470319A (en) 1994-06-20 1995-11-28 Critical Device Corporation Needleless injection site

Cited By (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1438977A3 (en) * 2003-01-17 2004-10-13 ZLB Behring GmbH Sterile cover for an injection syringe
US20040162527A1 (en) * 2003-01-17 2004-08-19 Gerhard Moersdorf Sterile sheath for an injection syringe
US10888664B2 (en) * 2004-12-08 2021-01-12 Roche Diabetes Care, Inc. Adapter for an injection appliance
US20140364813A1 (en) * 2004-12-08 2014-12-11 Roche Diagnostics International Ag Adapter for injection appliance
US7790115B2 (en) 2005-07-15 2010-09-07 Dentaco Dentalindustrie-Und Marketing Gmbh Pipetting apparatus
US20070014697A1 (en) * 2005-07-15 2007-01-18 Dentaco Dentalindustrie-Und Marketing Gmbh Pipetting apparatus
EP1743700A1 (en) * 2005-07-15 2007-01-17 Dentaco Dentalindustrie und -marketing GmbH Pipetting device
US8475404B2 (en) 2007-08-21 2013-07-02 Yukon Medical, Llc Vial access and injection system
US20090072169A1 (en) * 2007-09-17 2009-03-19 Perry Polsinelli Leak Resistant Syringe Cover
US7755071B2 (en) * 2007-09-17 2010-07-13 Perry Polsinelli Leak resistant syringe cover
WO2009048366A1 (en) * 2007-10-10 2009-04-16 Ortoviva Ab Mixing system and mixing method for medical purposes
US20090266420A1 (en) * 2007-10-10 2009-10-29 Ortoviva Ab Mixing system and mixing method for medical purposes
US8267571B2 (en) 2007-10-10 2012-09-18 OrtoWay AB Mixing system and mixing method for medical purposes
US20120271279A1 (en) * 2008-01-01 2012-10-25 Rudolf Matusch Disposable injector with a manually actuated piston and with a twin chamber system
US8663193B2 (en) * 2008-01-01 2014-03-04 Lts Lohmann Therapie-Systeme Ag Disposable injector with a manually actuated piston and with a twin chamber system
US8821436B2 (en) 2008-04-01 2014-09-02 Yukon Medical, Llc Dual container fluid transfer device
US8663160B2 (en) 2008-09-09 2014-03-04 Baxter International Inc. Device to indicate priming of an infusion line
US8398590B2 (en) 2008-09-09 2013-03-19 Baxter International Inc. Device to indicate priming of an infusion line
US20100063445A1 (en) * 2008-09-09 2010-03-11 Baxter International Inc. Device to Indicate Priming of an Infusion Line
US11724038B2 (en) 2009-08-21 2023-08-15 Becton Dickinson France Syringe assembly with inverse delivery
US20110046604A1 (en) * 2009-08-21 2011-02-24 Becton Dickinson France S.A.S. Syringe Assembly with Inverse Delivery
US9352096B2 (en) 2009-08-21 2016-05-31 Becton Dickinson France Syringe assembly with inverse delivery
US10507288B2 (en) 2009-08-21 2019-12-17 Becton Dickinson France Syringe assembly with inverse delivery
US11491279B2 (en) 2009-08-21 2022-11-08 Becton Dickinson France Syringe assembly with inverse delivery
WO2011068544A1 (en) * 2009-12-04 2011-06-09 Becton, Dickinson And Company Cartridge for containing and dispensing a medicament
US9623184B2 (en) 2009-12-04 2017-04-18 Becton, Dickinson And Company Cartridge for containing and dispensing a medicament
US10751471B2 (en) 2009-12-04 2020-08-25 Becton, Dickinson And Company Cartridge for containing and dispensing a medicament
USD655017S1 (en) 2010-06-17 2012-02-28 Yukon Medical, Llc Shroud
USD681230S1 (en) 2011-09-08 2013-04-30 Yukon Medical, Llc Shroud
USD769444S1 (en) 2012-06-28 2016-10-18 Yukon Medical, Llc Adapter device
US10206614B2 (en) 2015-01-20 2019-02-19 Paw Bioscience Products, Llc Pre-sterilized syringe system and method of use
WO2016118336A1 (en) * 2015-01-20 2016-07-28 Paw Bioscience Products, Inc. Pre-sterilized syringe system and method of use
USD765838S1 (en) 2015-03-26 2016-09-06 Tech Group Europe Limited Syringe retention clip
CN113694315A (en) * 2016-09-19 2021-11-26 麦迪麦珀医疗工程有限公司 Drug delivery device and method of dispensing a drug
US11674614B2 (en) 2020-10-09 2023-06-13 Icu Medical, Inc. Fluid transfer device and method of use for same

Also Published As

Publication number Publication date
WO1995021639A1 (en) 1995-08-17
EP0744972A1 (en) 1996-12-04
US5769825A (en) 1998-06-23
EP0744972A4 (en) 1999-12-01
US5743886A (en) 1998-04-28
US5522804A (en) 1996-06-04
US5549569A (en) 1996-08-27
AU1744095A (en) 1995-08-29
US5697915A (en) 1997-12-16
JPH10500030A (en) 1998-01-06
US5643218A (en) 1997-07-01
US6228065B1 (en) 2001-05-08
DE69531774T2 (en) 2004-07-01
EP0744972B1 (en) 2003-09-17
DE69531774D1 (en) 2003-10-23

Similar Documents

Publication Publication Date Title
US5522804A (en) Aspiration, mixing, and injection syringe
EP0324257B1 (en) Liquid transfer assemblies
US6045538A (en) Method and apparatus for loading syringes without the need for hypodermic needles
EP0817654B1 (en) Pre-filled syringe drug delivery system
KR101507828B1 (en) Method and apparatus for contamination-free transfer of a hazardous drug
JP2988661B2 (en) Fluid transfer device for accessing fluid from vials and ampules and method for transferring fluid using the device
EP2467117B1 (en) Multiple vial drug mixing system
US4775376A (en) Method and apparatus for catching fluids purged from a syringe
JPS6214863A (en) Syringe assembly for administering two components
EP1107806A1 (en) Syringe for transfer of medication from a prefilled medication container
JPH0380029B2 (en)
JP2023511120A (en) vial adapter device
KR19980079298A (en) Syringe Filling and Carrying Device
JPS61501552A (en) A device for preparing injectable drugs

Legal Events

Date Code Title Description
STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION